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Streptomyces roseochromogenes, NCIB 10984, hydroxylates exogenous 
progesterone to 16a hydroxyprogesterone and thereafter in a second phase 
bioconversion to 2ß, 16a-dihydroxyprogesterone. Characterisation of this 
reaction was carried out at the whole cell level. The cellular components 
responsible for this reaction were also purified to homogeneity. S. 
roseochromogenes contains a cytochrome P450 and two electron transfer 
proteins, roseoredoxin and roseoredoxin reductase. A reconstituted incubation 
containing these purified proteins and the natural electron donor, NADH. 
produced identical hydroxyprogesterone metabolites as intact cells. 
In sodium periodate (Na104) supported incubations, the initial rate of 
progesterone hydroxylation was marginally higher than in the natural 
reconstituted system but the product yield was significantly lower. The yield 
data showed that the reconstituted natural pathway, supported multiple rounds 
of hydroxylation in contrast to a likely single round by a minority of P450s in 
the periodate reaction. 
When S. roseochromogenes was incubated with exogenous progesterone for 
25 h the major metabolite, 16a-hydroxyprogesterone was produced in 3.6 fold 
excess to the minor metabolite 2ß, 16a-dihydroxyprogesterone. In a 
reconstituted system containing highly purified progesterone 16a-hydroxylase 
cytochrome P450, roseoredoxin and roseoredoxin reductase, both metabolites 
were produced but in a 10: 1 ratio. When S. roseochromogenes was pre- 
incubated with progesterone and the purified components of the hydroxylase 
system assayed as before, the ratio of 16a-hydroxyprogesterone to 2ß, 16a- 
dihydroxyprogesterone produced, decreased to 2.8: 1, virtually identical to the 
ratio in whole cell biotransformations. Reconstitution assays containing all 
combinations of hydroxylase proteins purified from progesterone pre- 
incubated and control cells, identified roseoredoxin as solely responsible for 
the observed changes in in vitro metabolite ratios. The fact that the 2.8: 1 ratio 
3 
was also obtained when S. roseochromogenes was exposed to cycloheximide 
prior to progesterone pre-incubation; pointed to post translation modification 
of roseoredoxin. Separation of two isoforms by 2-D isoelectric focusing 
supported this proposition. 
A partial 10 amino acid sequence was obtained for both the cytochrome P450 
and roseoredoxin for the purpose of probe design for eventual cloning. An 
amino acid sequence search revealed this P450 to be unique and unlike any 
other known P450 sequence. These two proteins were also successfully 
crystallised by hanging drop vapour diffusion trials, giving isomorphous 
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1.1 Aims of this work 
To identify and characterise the nature of the biotransformation of progesterone 
by Streptomyces roseochromogenes and to investigate the nature of the enzyme 
system responsible for this steroid transformation. Enzyme purification and 
reconstitution in vitro will be approached with a view to elucidating the 
regulation of such an unusual biotransformation in Streptomyces species. 
Following functional determination, structural analysis of the enzyme system 
will then be pursued through crystallising and amino acid sequencing. This 
elucidation will be carried out with the ultimate goal of probe design with 
potential for progression to the identification of analogous steroid 
transformation systems in other species, thereby firmly establishing the role of 
steroid biotransformation in Streptomyces within the field of prokaryotic P450 
steroid hydroxylating systems. Asymmetric specific activation of unreactive 
centres of highly saturated molecules such as steroids is a major objective in 
synthetic chemistry. Development of regimes for the retention of such 
stereospecific catalysis by non membrane bound enzymes in vitro, is therefore 
important. 
1.2 This Thesis 
Chapters presented in this work are individually introduced and subsequently 
discussed, to give a background to the subject matter of each chapter. 
Following this work, it is now known that the steroid biotransformation by this 
Streptomv ces species is a 2ß and 16a hydroxylation, mediated by a cvtochrome 
P450 system. Therefore, cytochromes P450 and steroid biotransformation are 
discussed in chapter 1. 
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1.3 BIOTRANSFORMATION 
The first observation of biotransformation was in 1857 when Louis Pasteur 
observed the fermentation of lactic acid from sugar by yeast. Biocataly sis and 
bioconversion are alternative names for biotransformation which is defined as 
the synthesis of chemical compounds from precursor substrates, not by 
synthetic chemical processes but by a whole cell or cell-free biological system. 
The most widely studied whole cell biotransformations are by fungi. For 
example, the Biotransformation of testosterone, a male sex hormone and 
pregnenolone, a precursor of many steroidal hormones catalysed by the fungus 
Botrytis cinerea (Farooq & Tahara 2000). Testosterone yielded 7,17- 
dihydroxyandrostan-3-one and pregnenolone yielded 3,11,16-trihydroxypregn- 
5-en-20-one and 11,16-dihydroxypregn-4-ene-3,20-dione. Cephalosporium 
aphidicola hydroxylates 3,5-cycloandrostanes to their respective 6-ketones 
(Bensasson et al., 1999). Testosterone is hydroxylated to 5-dihydrotestosterone 
by two species of Penicillium : P. chrysogenum and P. crustosum (Cabeza et 
al., 1999). 
Microorganisms from soil samples were screened for hydrocortisone and 
prednisolone production, the fungus which showed hydrocortisone production 
was Cunninghamella blakesleeana whereas the bacteria which showed 
prednisolone production ability were Bacillus sphaericus (Manosroi et al., 
1999). Bacterial Biotransformation being of great significance also. Indeed a 
soil bacterium Streptomyces roseochromogenes, is the subject of the work 
presented here (Berrie et al., 1999). 
Obtaining stereospecific biotransformations is of great biotechno logical 
importance. Finding such reactions of recalcitrant centres of large carbon 
compounds mediated by cytochromes P450 is one biotechnological usage of 
biotransformation. Cytochromes P450 are of great use because they have wide 
substrate specificities, many of them have been characterised and their 
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properties in vitro have been reported for many P450 systems. The 
Streptomyces genus has several examples of cvtochrome P450 mediated 
catalysis which are surveyed in chapter 3 but such mediations are not reported 
for steroidal biotransformation. Streptomyces lividans encodes a highly specific 
non-P450 esterase fusidic acid enzyme (FusH) that converts the steroid 
antibiotic, fusidic acid into an inactive derivative (VonDerHaar et al., 1997). 
As discussed in chapter 3, steroidal bioconversion is documented in 
Streptomyces but not its P450 catalysis. This thesis reports rare steroidal 
biotransformation, namely 2ß and 16a hydroxylation of progesterone. 
Streptomyces stereoselective steroid bioconversion is reported for example, at 
skeletal positions 3a, 2013,313 and 1713 by S. hydrogenans (Feller & Traeger, 
1985). Stereoselective P450 hydroxylation of steroids at every carbon skeletal 
position is now reported for fungi. Such a comprehensive library does not yet 
exist for bacteria and more specifically streptomyces. 
BIOTRANSFORMATIONS OF STEROIDS BY OTHER 
STREPTOMYCES SPECIES: 
Table 1.1 illustrates the usefulness of a Streptomyces P450 library. 
The classes of biotransformation reactions catalysed by enzymes in bacteria fall 
into many categories. For the purposes of this work, we are primarily interested 
in the oxidation of steroids and more specifically the hydroxylation of the 
steroid hormone, progesterone. Oxidation is the most important category of 
microbial transformations. As discussed, it is extremely difficult to achieve the 
stereospecific targeting of a particular carbon centre within the 
perhydrocyclopentanophenanthrene ring system of steroids or indeed of the side 
chain. 
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Table 1.1 Steroid skeletal carbon position reactions biotransformed by Streptomyces 
species. 
Availability of biotransformation systems is important in terms of the 
development of new drugs such as anti-inflammatory agents. It was the 
iý 
discovery that cortisone 21-acetate had anti-inflammatory properties which 
triggered the field of fungal steroid biotransformation. The advantages of using 
micro-organism systems of biotransformation is exemplified by cortisone. 
which would require thirty chemical steps to synthetically form from 
deoxycholic acid. 11(i hydroxylation however is achieved quickly by the 
fungus Rhizopus arrhizus (Peterson & Murray, 1952). 
1.4 CYTOCHROMES P450 
The advantages of being able to identify cytochrome P450 as responsible for a 
biotransformation are discussed above. 
Cytochromes P450 are a large group of enzymes which are haem proteins 
(Omura & Sato 1964[l]). They are found in essentially all eukaryotes and in 
some bacteria. They catalyse a wide range of chemical reactions by acting as 
monooxygenases when in the presence of 02 and NAD(P)H and one or more 
electron-transfer proteins (Guengerich, 1983). Monooxygenase, means that 
only one of the oxygen atoms of molecular oxygen, is incorporated in the 
substrate. These enzymes catalyse the oxygenation of an array of hydrophobic 
carbon compounds. When in the reduced state and bound to carbon monoxide, 
they show a characteristic absorption peak at 450 nm (Omura & Sato 1964[21). 
1.5 CYTOCHROMES P450 NOMENCLATURE 
Cytochromes P450 are a superfamily of haem containing protein that catalyse 
the metabolism of many lipophilic endogenous substances and exogenous 
substrates. The nomenclature for the CYP superfamily is based upon divergent 
evolution of the genes (de Wildt . et al., 
1999). CYP genes il hich share at least 
40 % homology are grouped in a family denoted by an Arabic number. For 
example CYP3. A subfamily, which is indicated by a letter, represents highly 
36 
related genes. For example, the designation CYP3A. This is a subfamily of 
CYP3 genes which are the most abundant liver P450s. Many drugs are mainly 
metabolised by subfamily CYP3A (Wrighton et al., 1996). The addition of a 
further arabic numeral designates the individual gene. For example CYP3A4. 
The CYP isoforms of the CYP3A subfamily have at least 85 % sequence 
homology. 
1.6 SPECTRAL PROPERTIES OF CYTOCHROMES P450 
Spectral properties of the P450 molecule vary greatly due to the 'state' of the 
molecule (Remmer et al., 1966). The state of the molecule varies due to the 
arrangement of the double bonds of the haem moiety and these are influenced 
by the axial bonds to the centrally co-ordinately bonded iron ion. Spectral 
changes come about through changes in the organisation of the d orbital 
electrons. Iron has five electrons in the d orbital, thus one is unpaired and the 
iron is therefore low spin. This occurs when there is no substrate bound 
(Malmström, 1982). When substrate binds, the five electrons are all unpaired 
thus two electrons occupy the higher energy d orbital. In this case the iron is 
referred to as high spin (Jefcoate, 1978). The spectral changes induced by 
binding at the active site are discussed in more detail in chapter 5. 
1.7 STRUCTURE OF CYTOCHROMES P450 
These enzymes contain protoporphyrin as cofactor. Unlike most other haem 
proteins, the P450 haem is not covalently bound to the protein. Six co-ordinate 
covalent bonds can be formed by the iron of haem. Four of the bonds are with 
the four pyrrole nitrogen atoms of haem and are planar. The fifth bond in P450 
always involves a thiolate ion with a cysteine residue in the protein. This 
attaches the haem to the protein. The sixth bond is not always present but when 
1% 
present is usually to water (Grasdalen et al., 1976). The fifth and sixth bonds 
are axial to the plane of the protoporphyrin ring. 
Various aspects of P450 structure are surveyed in chapter 8. 
1.8 BINDING OF SUBSTRATE TO P450 AND IDENTIFICATION 
OF AMINO ACID RESIDUES INVOLVED - AN APPLICATION 
OF P450 MODELLING 
Current understanding of substrate binding has arisen through modelling 
eukaryotic P450 structures on soluble bacterial P450 X-ray structures and their 
primary sequences, particularly P450 101 (Gunsalus & Wagner 1978). This 
modelling technique has faults and seems to require many assumptions such as 
the effect upon catalysis of the hydrophobic domain but for the purposes of 
substrate binding interactions, has proved very useful (Poulos et al., 1985). 
Conformational change induced in a P450 when it binds substrate is associated 
with a shift of the Soret peak from 420 nm to 390 nm (Omura & Sato 1964[21), 
although these figures vary very slightly from one P450 to another. Binding of 
substrate results in displacement of the iron at the centre of the haem moiety 
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Obstruction of the sixth ligand, which in most P450s is water, causes a shift of 
the iron from the plane of the porphyrin toward the fifth ligand (O'Keefe et al. 
1978 ). This makes the complex more susceptible to reduction due to the 
increase in ionic radius of the newly formed high-spin pentacoordinate iron. 
Other evidence to support this view was presented in 1970 ( Tsai et al. 1970 
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with studies on the binding between P450 from Pseudomonas putida and its 
substrate, camphor. EPR signals of this soluble P450 were observed and the 
low spin signal decreased upon binding with camphor as the high spin signal 
increased. 
Much evidence for the way substrates bind P450s has been gathered through 
site directed mutagenesis and to some extent, computer modelling. This work 
has its roots in the X-ray structure of P4SOcam. 
Site directed mutagenesis, selective chemical modification. construction and 
expression of chimeric cytochromes P450 or computational chemistry can be 
used to obtain information about substrate binding in this group of enzymes. 
Chimeric proteins' containing sequences of P450 1A1 &I A2 have been 
constructed (Pompon 1988) (Pompon & Nicholas 1989). A region of 35 
residues (Aligned positions 253-299) has been proposed to play a major role in 
the control of P450 1A1 activity toward carcinogenic polycyclic aromatic 
hydrocarbons (Pompon & Nicholas 1989). This region slightly overlaps a 
peptide sequence from aligned sequences 294-350 that has been suggested to 
play a role in the binding of fatty acids to P450 2C2 (lmai et al., 1989). 
Chimeras of P450 2C2 laurate hydroxylase (rabbit liver) & 2C14 testosterone 
16a hydroxylase (rat liver), which exhibits 82% amino acid sequence 
homology but have different substrate selectivities, have been constructed to 
identify amino acids responsible for substrate binding (Imai & Nakamura 
1989). 
P450 2A1 & 2A2 display 88% amino acid sequence similarity and exhibit 
different hydroxylation specificity toward testosterone. Sequence 
dissimilarities are primarily localised within four discrete regions of the 
polypeptides that are separated by regions of absolute sequence identity. From 
the hydroxylation profiles of various chimeras of P450 2A1 & 2A2 it was 
proposed that substrate specificity is determined by a region positioned between 
Also for a novel human-bacterial P450 chimera (Shimoji et al. 1998) 
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alignment positions 365 & 461, which corresponds to the I&J helices of P450 
101 (P. putida P450 101 model) (Hanioka et al.. 1990). In P450 101, the I 
helix lies directly over the haem and is involved in substrate binding (Poulos 
et al., 1987). In this region, 13 amino acid differences exist between P450 211 
& 2A2. One of these differences occurs at alignment position 392 exactly 
matching the single amino acid substitution G310D by which lanosterol 14- 
demethylase P450 51 is changed into an inactive enzyme P450 SG I (Ishida ct 
al., 1988). Mutations of the active site residues F87 and Y96 greatly enhanced 
the activity of cytochrome P450(cam) (CYP101) from Pseudomonas putidu for 
the oxidation of the polycyclic aromatic hydrocarbons phenanthrene. 
fluoranthene, pyrene and benzo[a]pyrene (Harford Cross et al., 2000), thereby 
enabling development of computational models of P450 catalysis. Computer 
modelling has predicted that G1u302 of aromatase P450 19 at alignment 
position 392 forms part of the active site of this enzyme (Graham-Lorence et 
al., 1991) and site-directed mutagenesis has confirmed the prediction. 
Substitution of Glu 302 to Ala, Val or Gin resulted in complete loss of activity, 
whereas mutagenesis to the functionally similar amino acid Asp resulted in only 
a 30% decrease in activity. Furthermore, in the same region (Aligned positions 
365-461) the tripeptide A1a305-A1a307-Pro308 (Aligned positions 396-398) 
was found to be important in substrate binding (Graham-Lorence et al., 1991). 
P450s belonging to the family 4, share a common 16 residue peptide alignment 
positions 386-401 that is unique among these P450s and has been suggested as 
being involved in substrate recognition. (Gasser & Philpot 1989). The 
construction of a functional chimera from approximately 50% bacterial 
(cytosolic) cytochrome P450cam and 50% mammalian (membrane-bound) 
cytochrome P450 2C9 has been reported (Shimoji et al., 1998). The protein is 
soluble and catalyses the oxidation of 4-chlorotoluene using molecular oxygen 
and reducing equivalents from bacterial putidaredoxin and putidaredoxin 
reductase. This chimera provides a novel method for addressing structure- 
function relationships and may prove useful in the design of oxidants for benign 
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and stereospecific synthesis, as well as catalysts for bioremediation of polluted 
areas. These results provided the first evidence that bacterial P450 enzymes 
and mammalian P450 enzymes may share a common tertiary structure (Shimoji 
ei al., 1998). The mechanisms of human ovarian steroidogenesis have also 
been studied by the formation of a range of chimeric P450s using fragments of 
the 5'-untranslated region of bovine P450(17 (x) and human P450SCC (Simpson 
et al., 1991). 
More recently, the computational molecular dynamics of substrate binding have 
been modelled upon the P450 of Bacillus megaterium (fatty acid hydroxylase). 
Computer simulations have been used to examine substrate induced 
conformational change. Cytochrome P450 BM3, of bacterial origin, is one of 
only five isozymes of the ubiquitous family of over 400 metabolising 
haemoproteins with a known crystal structure and only one of two with both 
substrate-free and substrate-bound forms determined. P450 BM3 is of particular 
interest since it has a similar function and similar substrates as mammalian 
P450s particularly of the 4A subfamily. Thus, the extent to which the substrate 
free form of P450 BM3 undergoes conformational change upon binding of a 
typical fatty acid substrate, palmitoleic acid, has been the subject of recent 
study ( Chang & Loew 1999). Specifically, molecular dynamic's simulations 
were performed for each of the two substrate-free forms found in the 
asymmetric X-ray structure and for the two corresponding substrate-bound 
forms, constructed by docking palmitloeic acid into each of them. Comparisons 
of the results showed that palmitoleic acid binding had little effect on the 
conformation of the more closed substrate-free form of P450 BM3. By 
contrast, in the more open substrate-free form, this same substrate induced a 
closing of the entrance to the substrate-binding channel ( Chang & I. oe%\ 
1999). 
The construction of a three-dimensional model of human ('YP2EI has been 
reported. It is based on homology with the haemoprotein domain of the 
unusual bacterial P450, CYP102. Interactive docking of a number of human 
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CYP2EI substrates is consistent with their known positions of C'YP2E l- 
mediated metabolism (Lewis et al. 2000). Amino acid residues within the 
putative active site of human CYP2E l. including those associated with the 
binding of substrates and inhibitors, are shown to correspond with those 
identified by site-directed mutagenesis experiments conducted on CYP2 family 
isoforms and they are known to affect substrate metabolism regioselectivity 
(Lewis et al. 2000). Molecular models, generated using molecular replacement 
or distance geometry methods, can be used to dock substrates and/or inhibitors 
in the active site to explain various aspects of enzyme function. The majority 
of modelling research has dealt with enzyme-substrate interactions in the active 
site. The analysis of these interactions has helped us to better understand the 
mechanism of P450 catalysis and provided the structural basis for the regio- 
and stereospecificity of substrate oxidation as well as susceptibility to inhibition 
or inactivation. The models have been utilised to identify and/or confirm key 
residues and to interpret rationally experimental data. The alteration in activity 
in a mutant P450 can be related to changes in enzyme-substrate/inhibitor 
interactions, such as the removal or appearance of van der Waals overlaps or 
changes in compound mobility. Homology models can also help to analyse 
P450-redox partner interactions and identify critical determinants of protein 
stability. We can expect further development of molecular modelling methods 
and their increasing contribution into research on P450 function as an integral 
part of a combined theoretical-experimental approach (Szklarz et al., 2000). 
1.9 STEROID BINDING SITES OF CYTOCHROMES P450 
Steroid-metabolising cytochromes P450 share a region of high homology which 
might be involved in the binding of steroids (Mornon ei ul., 1989). 
Homologous sequences in human progesterone, mineralocorticoid, oestrogen 
and androgen receptors have been identified (Picardo-Leonard & Miller 1989). 
As all these proteins must bind the steroid nucleus, sequence similarities are 
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expected. The consensus steroid binding site is characterised by a sequence 
from alignment positions 448-468: L-(P. L)-L-L-(+/-)-X-X-(RK)-(I), 1': )-X-L- 
(R, K)-L-(+/-)-P-V, where L=Leu, (P, L)=Pro or Leu, (+/-) is and' changed 
residue, X is an unchanged amino acid, (R, K) is Arg or Lys, (D, F) is Asp or 
Glu, P is Pro V is Val. 
In P450 2C2, amino acids in the region from aligned positions 137-182 are 
essential for hydroxylase activity (Imai et al., 1989). 
The region from aligned positions 137-182 forms part of the substrate binding 
domain of P450 2C4 & 2C5 (Kronbach et al. 1989). P450 2C5 catalyses 
progesterone 21-hydroxylation with a low apparent Km and at rates similar to 
adrenal 21-hydroxylase P450 21A. P450 2C4 exhibits a 10-fold higher apparent 
Km than 2C5 for binding progesterone but has no 21-hydroxylase activity. 
Constructing hybrids between these two enzymes showed that region 113-118 
(aligned positions 168-175) contains the sequence responsible for affinity of 
P450 2C4 & 2C5 toward progesterone (Kronbach et al., 1989). Only one 
mutation, VI 13A (aligned position 168) was required to lower the Km of P450 
2C4 for progesterone hydroxylation (Johnson et al., 1990 and Kronbach et al.. 
1991[2]). The same mutation in P450 2C I conferred progesterone 21- 
hydroxylase activity on this enzyme (Kronbach et al., 1991 [1]). Thr-115 & 
Asn-118 of P450 2C4 (aligned positions 170 & 175) were shown to be located 
at the surface of the enzyme (Kronbach et al., 1991[2]). 
Substrate orientation in 2B1 & 2B2 is determined by Ile-I 14 & Leu-58 (aligned 
positions 168 &175) (Aoyama et al., 1989). Both enzymes hydroxylate 
testosterone in the 16a & 16P positions as well as producing 17-keto and 16ß- 
hydroxy-17 keto derivatives. When Ile-I 14 and Leu-58 of P450 2B1 & 2B' 
were both replaced with Phe, the mutated enzymes did not produce the 16P 
hydroxylated products of testosterone (Aoyama et al., 1989). 
Alignment position 168 in P450 coh and 2A3 (Val-1 17 & Ala- respectively) 
is 
located in the active site (Lindberg & Neigishi 1989). These two enzymes 
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differ by only 11 amino acid residues in their primary structure but exhibit 
divergent catalytic activities. Each of these residues has been separately altered 
by site-directed mutagenesis. The activities of the two enzymes depends 
critically on the identity of amino acid residues at alignment positions 168.284 
& 468. Substitution of Phe-209 of P450coh (Aligned position 284) by Leu 
converts the specificity of the enzyme from 7-hydroxylation of coumarin to the 
steroid hydroxylation of P450 2A3. Enzyme kinetic studies showed that Phe 
209 constitutes part of the substrate binding site ( Juvonen R. O. et al.. 1991). 
The proposed active-site residue at alignment position 468 forms part of the 
suggested steroid binding site (positions 448-468). Taking these data into 
consideration, one amino acid position and two regions are very interesting: 
alignment position 168, the region from positions 392-398, and the steroid 
binding site(positions 448-468). Alignment position 168 might match with 
helix B' of P450 101, which contains the active site residue Tyr-96. Region 
392-398 is homologous to a part of the I helix of P450 101 (cam), whereas 
region 448-468 coincides with helix K and a P3-sheet of P450 101 (cam) 
containing the active site Val-295 (Ouzounis & Melvin 1991). Although the 
sequence homology between membrane-bound P450s in the region is high, it is 
still sufficiently divergent to explain the observed differences in the substrate 
selectivities. Therefore, residues near these alignment positions in all P450s 
may constitute part of the active site. 
Sequence alignment of human cytochrome P450 3A4 with bacterial enzymes of 
known structure has provided a basis from which to predict residues involved in 
substrate oxidation. Substitutions were made at four residues (1301. F304, 
A305, and T309). In testosterone hydroxylase assays, all of the mutants 
displayed rates of total product formation similar to wild-type 3A4. Ho« e\ er, 
with progesterone as the substrate, mutants F304A. A305V, and T309A 
exhibited altered product ratios and/or changes in the rates of product formation 
(Domanski et al., 1998). 
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Homology modelling of mammalian steroidogenic cv-tochromes P450 (CYP) 
from families CYP II. CYP 17, CYP 19 and CYP21 based on a novel protein 
sequence alignment with CYP102 , generated models from the CYP102 crystal 
structure template (Lewis & Lee Robichaud 1998). These results were 
consistent with experimental information from site directed mutagenesis 
studies, steroidal substrate specificity and active site inhibitor studies. 
Interactive docking studies with both substrates and inhibitors of these enzymes 
indicated key residue interactions with the putative active site regions of each 
isoform investigated. This pointed to potential determinants of substrate 
specificity within these related enzymes (Lewis & Lee Robichaud 1998). 
It is important to remember that remote site substitutions may affect substrate 
binding, the electron transfer process, oxygen binding or the incorporation of 
the active oxygen species. Also the validity of conclusions drawn on active site 
residues will depend on the validity of the alignment of a particular P450 and 
P450 101. 
1.10 THE P450 CATALYTIC CYCLE AND THE PEROXIDE SHUNT 
PATHWAY 
All investigations in this report, except for reconstitution of the P450 steroid 
hydroxylase, in chapters 6 and 7, make use of the peroxide shunt pathway. This 
is because P450s are multicomponent enzyme systems. Other proteins are 
required for the transfer of electrons from NAD(P)H to P450. Typically in 
prokaryotes, which fall into the type II P450 category, require ferredoxin 
reductase and ferredoxin for this electron transfer to P450. 
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These electron transfers are represented by the lower part of the above cycle in 
Figure 1.10a. In order to eliminate the need for these and to 'short-cut' the 
cycle, an oxidising agent is added to assays of P450 activity. In these 
investigations, sodium periodate (Hrycay et al. 1975 ) is used. 
The active site of P450 contains iron protoporphyrin IX, bound in part by 
hydrophobic forces. The fifth ligand is a thiolate (-S-) anion provided by a 
cysteine residue, a feature that contributes to the unusual spectral and catalytic 
properties of P450, and the sixth co-ordination position may be occupied by an 
exchageable H2O molecule. 
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Upon reduction of the iron, 02 (or in competition. CO) can be bound to the 
sixth position. 
The stoichiometry of P450 catalysed reaction is: 
RH + 02 + NAD(P)H + H+ -> ROH + H2O NAD(P)+ equ. 1. 
Where RH is the substrate. 
Step 1: 
The first step in the reaction cycle is substrate binding. This perturbs the spin 
state equilibrium of the cytochrome and facilitates uptake of the first electron. 
This is step 2. (Fe3+-RH + e- -* Fe 
2+-RH). 
Substrates that undergoes reduction rather than oxygenation, such as epoxides, 
N-oxides, nitro & azo compounds, and lipid hydroperoxides, accept two 
electrons in a stepwise fashion to give RH(H2). To initiate the oxidative 
reactions, 02 is bound (step 3) to the ferrous P450 with co-ordination to iron 
trans to the thiolate. This intermediate resonance forms are, Fe 2+ (02) -> Fe 
3+ 
(02-), which are in equilibrium. The substrate remains bound to the P450. 
Step 4: transfer of the second electron then occurs, (Fe2+022"-RH + e- 
Fe3+022--RH) This is with the possible involvement in microsomal systems of 
cytochrome b5, whose reduction potential is higher than that of P450 reductase 
(Porter & Coon, 1991). 
Step 5 is not well understood but involves splitting of the oxygen-oxygen bond 
with the uptake of two protons at some stage and the generation of an 
"activated oxygen", perhaps an iron-oxene (Fe=O)species. and the release of 
H2O. 
Several resonance forms are possible for the active oxygen intermediate, 
considering the redox possibilities with the sulphur, iron and oxygen atoms. 
Step 6: oxygen insertion into the substrate is believed to involve hydrogen 
abstraction from the substrate and recombination of the resulting transient 
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hydroxyl and carbon radicals to give the product. Dissociation of the ROH then 
restores the P450 to the starting ferric state (step 7). 
Peroxycompounds (XOOH) may substitute for 02 and reducing equivalents in a 
shorten form of the cycle known as the "peroxide shunt". Homolytic cleavage 
of oxygen occurs with the formation of an iron-bound hydroxyl radical and an 
alkoxy radical (XO*) capable of hydrogen abstraction from the substrate. 
It remains to be determined what factors control the regio- and stereoselectiv-ity 
(see ' substrate binding ' section) of hydroxylation and the identity of the 
powerful oxidant that is necessary for oxygen insertion into the substrate 
progesterone without activating groups at or near to the position attacked, when 
transformed by S. roseochromogenes. 
1.11 CYTOCHROMES P450 ELECTRON TRANSPORT SYSTEMS 
Electrons are derived from either NADH or from NADPH and the reactions 
can be summarised as : 
S+ NAD(P)H + H+ + 02 SO + NAD(P)+ + H2O equ 2. 
Where S is the substrate. 
The P450 molecule is not just an electron transporter like other cytochromes. 
rather it is responsible for catalysing the monooxygenation of various substrates 
utilising molecular oxygen and electrons. Electrons therefore need to be 
transferred to the P450 from NAD(P)H. The haemoprotein itself is not able to 
react directly with reduced pyridine nucleotides. Other electron transfer 
proteins are present in most systems for this function. There are two types of 






















Figure 1.11a Representation of Types land II P450 systems. Type II having one extra 
electron transfer protein requirement than Type I systems. 
(generally microsomal) and Type II (generally bacterial and mitochondrial). 
These are represented in Figure 1.7a. The two types of multicomponent system 
differ in that, type I occurs in the microsomes of eukaryotic cells. It consists of 
a FAD and FMN containing reductase and electrons are transferred from 
NADPH via this to the P450 component. The hydrophobic N- terminal 
domain of the NADPH-Cytochrome P450 reductase binds the membrane and 






flow from FAD to FMN then to the P450 in two sequential one electron steps. 
Each reductase can transfer electrons to more than one P450 in mammalian 
systems ( Black & Coon, 1987 ). 
Type II systems occur in mitochondria and bacteria. These systems posses an 
FAD containing reductase and a small redox iron-sulphur protein, a ferredoxin. 
All P450 systems identified to date share a common catalytic cycle described 
above (Koymans et al., 1993). 
1.12 THE ROLE OF IRON IN P450 CATALYSIS 
A characteristic feature of P450 is the large blue shift in the Soret visible 
absorption band from ca 419nm to ca 390nm when substrates bind, indicating a 
low- to high-spin transition in the Fe atom. In the low spin state the 5d 
electrons are maximally paired giving a net spin of +1/2, whereas in the high 
spin state the 5d electrons are maximally unpaired giving a net spin of +5/2 
(Fisher & Sligar, 1985). 
These spin changes and their effect on the spectral properties of P450 reflect 
changes in the co-ordination environment of the Fe atom with the low-spin 
spectrum indicative of a strong ligand field axially co-ordinated to the Fe atom 
on the distal side of the haem. The proximal ligand, the sulphur atom of the 
cysteine residue, remains attached to the Fe atom in both the low and high spin 
forms. 
In P450cam the redox potential of the Fe also changes on substrate binding. 
The potential shifts from ca -300mV in the absence of substrate to -173mV 
when camphor binds, which means that it is thermodynamically more 
favourable to reduce the iron when substrate is bound. It is the binding of 
substrate which permits the splicing of oxygen. 
The source of electrons required in the catalytic cycle is the iron-sulphur protein 
putidaredoxin. which possesses a redox potential of ca -196mV. Therefore. 
reduction of substrate-bound enzyme is thermodynamically possible whereas 
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that of the free enzyme is not, ensuring that reducing equivalents are consumed 
only in the presence of substrate. The modulation of reduction is achieved 
entirely by a change in the redox potential and by a change of spin state. 
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The oxygen in these complexes is not ionic but co-ordinately bound. Thus the 
oxygen would not exhibit properties of dioxygen ions. Covalently bound 
oxygen does in many respects resemble either of the two ionic species above in 
Figure 1.12a, i. e: superoxide & peroxide (Malmström 1982). 
The vast majority of oxygenated transition element complexes are diamagnetic 
but several are paramagnetic. The role of iron in P450 catalysis has also been 
studied by bacterial P450 modelling as discussed in the previous section and by 
replacement of the iron centre by other metal ions. For the purposes of 
modelling, a catalyst has been synthesised comprising a manganese porphyrin 
carrying four beta-cyclodextrin groups. It catalyses the hydroxylation of 
substrates of appropriate size carrying tert-butyiphenyl groups that can 
hydrophobically bind into the eyelodextrin cavities ( Breslow et al.. 1997 ). In 
one example as many as 650 catalytic turnovers are seen before the catalyst is 
oxidatively destroyed and with a rate comparable to that of typical cytochrome 
P450 enzymes. In another example, a steroid derivative is regio- and 
stereoselectively hydroxylated at a single unactivated carbon atom but more 
slowly and with fewer turnovers. The carbon attacked is not the most 
chemically reactive, and the selectivity is determined by the geometry of the 
catalyst-substrate complex. Substrates with more flexible binding geometries 
give more than a single product ( Breslow ct al., 2000 ). 
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1.13 OXYGEN ACTIVATION: A PREREQUISITE FOR ITS 
INSERTION INTO SUBSTRATE 
It is the redox state of the iron centre of the P450 molecule which determines its 
ability to insert a single atom of oxygen into a substrate. Whether this 
mechanism is the same in all P450's is unclear and whether the binding of 
substrate and oxygen are always linked is also unclear. Recent structural 
studies have suggested that substrate binding sites and distal oxygen binding 
pockets are not identical ( Andersson et al., 1997). The redox chemistry of 
oxygen underlies the catalytic cycles of peroxidases and oxygenases. 
Successive 1-electron reductions of dioxygen yield superoxide, hydrogen 
peroxide, the -OH radical and H2O with 1-electron potentials (E o) in volts as 
shown below: 
02 -0.33V, 0-2' +0.89V, H202 +0.38V, 
H2O + OH +2.32V 
The two electron couples linking dioxygen, H202 and H2O have redox 
potentials that are the mean of the corresponding 1-electron values since E must 
be the same for the different pathways. 
02 +0.28v H202 +1.35v 2H20 
The four electron reduction E 'o (02/2H20) =0.815v, will be mean of the 2- 
electron values (White & Coon, 1980). 
The 1-electron reduction of H202 has an unremarkable potential E 'o +0.38v but 
generates a very potent oxidising agent OH-. With Fe2+ as the reductant this is 
the Fenton reaction. Depending on how the iron atom is complexed, the OH- 
radical can remain associated in an iron-oxo complex or be released in the free 
state. Fe2+ + l12O2->[Fe(IV)=O]2+ + HBO or Fe3+ + OH- + OH-. {Fe(IV) 
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=Ferryl valence state). 
The catalytic cycles of cytochromes P450 involve Fe(IV) or higher states of 
iron. Ferryl iron of the Fenton reaction can be almost as reactive as free 
hydroxyl radical. Peroxidase and cytochromes P450 have succeeded in taming 
the reactivity of Fe(IV) so that the enzyme does not become inactivated and 
substrate is modified in a specific way (White & Coon, 1980). These factors 
are the determinants of the arrangement of electron transfer proteins in P450 
systems and also determinants, to some extent of the type of biotransformation 
which can be achieved. 
P450 catalyses the hydroxylation of a wide variety of organic substrates with 
the concomitant dehydrogenation of NAD(P)H. For the oxygenated P450 
species to be formed, a substrate must be bound and the haem-bound iron must 
be in the reduced Fe2+ valence state. The oxygenated species has a spectrum 
similar to those of oxyhaemoglobin and oxymyoglobin. 
The specific interaction of the haem group with the protein residues in the 
active site determines the ability of the enzyme to hydroxylate bound substrate 
and the characteristics of a specific reaction. The nature of the fifth ligand in 
P450 molecules is critical. Originally on the basis of an unusual EPR spectrum, 
this ligand was thought to be a thiolate anion of a cysteine residue. Subsequent 
physical, biochemical and modelling studies confirmed the prediction 
(Malmström 1982). The sixth ligand is thought to be easily exchangeable 
H20., accounting for the low-spin to high-spin transition of P450 on binding of 
substrate. 
The reduction of Fei+-enzyme is a one electron process, characterised by a 
half-reduction potential of -326mV. This very low potential can be attributed to 
the thiolate ligation. It favours the binding of 02 to the Fe2+ form with 
concomitant transfer of an electron to give Fe3+. 02"- (superoxide radical). 02'_ 
is released from the oxyenzyme if no further supply of electrons is available. 
The resting forms of P450 exist in various states of low-spin high-spin 
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equilibria (Malmström 1982). An extensive EPR study has shown that the 
protein can exist in two conformations. One has high-spin Fei+. which has a 
higher affinity for substrate (Butler & Hoey 1993). 
(RH)Fe2+(O2) is probably converted to (RH)Fe3+(O2-) before receiving the 
second electron to give (RH)Fe3+(022-) ie Fe3+ peroxide. The least 
understood step is the conversion of the peroxide intermediate species to the 
hydroxylating form, after the breaking of the 0=0 bonds with the release of 
one molecule of H20- 
The Homolytic vs Heterolytic Cleavage Theories 
Oxygenation is the feature characteristic of cytochromes P450. The potential 
for oxygenation of a particular substrate is determined by the ability of a P450 
to splice oxygen upon binding to substrate. It is therefore worth considering 
oxygen insertion at this point. 
The Heterolytic Pathway 
The peroxide lysis step is the fundamental difference between the oxenoid and 
quasi-Fenton pathways, the steps after this point being virtually common to the 
two pathways. Heterolysis of the peroxyacid leaves an oxygen atom (perhaps 
protonated) coordinated to the iron. The relatively electron-rich iron in the 
peroxyacid complex could loose a negative charge to carboxylate, which is a 
good leaving group. 
S-Fe "02- <-> S"Fe'vO" <-> S'Fel"O" 
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Figure 1.13a. Heterolytic cleavage of the peroxide bond. The oxenoid pathway. 
The single iron-bound oxygen atom is the basis for the designation oxenoid 
pathway. 
The Homolytic Pathway 
In this pathway, the homolytic peroxide scission resembles the Fenton reaction 
of ferrous ions with peroxides, hence the descriptor for the pathway, quasi- 
Fenton. 
Fe 2+ + H202 -> Fe 
3+ + Off + OH- 
In the P450 catalysed reaction the actual one-electron donor-initiating 
homolysis is thiolate, the iron merely acting as a conduit between the sulphur 
and the oxygen. The products are the amidyl radical and a thiyl ferric hydroxide 
complex. 
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Figure 1.13b. The homolytic cleavage of the peroxide bond. The quasi-Fenton reaction. 
Oxygen Insertion into Substrate 
It is believed that oxygen insertion into a substrate is a two-step event involving 
hydrogen abstraction from the substrate and subsequent recombination of the 
carbon radical and iron-bound hydroxyl radical pair. In the heterolytic pathway, 
the oxenoid species, S*Fe"'O-, performs the initial hydrogen abstraction and 
becomes the hydroxyl radical that virtually immediately recombines with the 
nascent carbon radical. This process is called oxygen rebound (Groves & 
McClusky 1976). 
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1.14 REGULATION OF CYTOCHROME P450 ACTIVITY 
The promoters for two inducible herbicide-metabolising cytochrome P450 
genes, in Streptomyces griseolus have been identified (another Streptomyccs 
species being the subject of this work). Transcription from either promoter «was 
shown to be induced by sulfonylurea (chlorimuron ethyl) or phenobarbital. The 
cytochrome P450-encoding gene (suaC or subC), ferredoxin (suaB or subB) 
were identified. An inducible, site-specific DNA-binding activity was 
identified that bound to two similar 8-bp inverted repeat sequences near the sua 
promoter (suaP). A noninducible DNA-binding activity, distinct from that 
which bound to suaP, was found that bound to an 11-bp inverted repeat at the 
sub transcription start point (Patel & Omer, 1992). 
A 4-base pair sequence (AAAG) is found to have a regulatory role in the 
expression of the P450 BM-1 gene in B. megaterium. This sequence is found in 
all eukaryotic and prokaryotic systems which contain barbiturate inducible 
P450s and is known as a Barbie box. Mutation of the Barbie box lead to the 
constitutive synthesis of cytochrome P450BM-1 and a 10-fold increase of 
expression of Bm1 P 1, a small gene located upstream of the P450BM-1 gene, 
that encodes a putative regulatory protein (Shaw ei al., 2000). Mutation of the 
P450BM-3 Barbie box significantly increased the expression of both P450BM- 
3 and Bm3P1 (another small gene located upstream of the P450BM-3 gene that 
encodes a second putative regulatory protein) in response to pentobarbital 
induction but left the basal levels unaffected. Bm3R 1, a repressor of the 
P450BM-3 gene, was found to specifically interact with the Barbie box 
sequences of the B. megaterium P450 genes (Liang et al., 1995). 
There are numerous other mechanisms of P450 regulation described, such as 
translational activation as found in the mechanism of P450 progesterone 14a 
hydroxylase regulation in the fungus Mucor hicmuli. s, where rRNA 
sequestration is part of the regulatory process. Exposure to substrate releases 
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sequestered P450 mRNA for translation thereby maintaining a dynamic pool of 
sequestered mRNA (Antoniou et al., 1994). Another example of the 
sequestration of mRNA as part of a regulatory P450 mechanism is found in the 
domestic hen. In the granulosa layer of developing domestic hen follicles the 
expression of P450 17a-OH mRNA does not directly reflect P450 17a-OH 
enzyme activity. Moreover, P450 17a-OH mRNA levels dramatically decrease 
in granulosa cells from preovulatory (compared to developing) follicles. It was 
proposed that FSH initiates P450 17a-OH enzyme activity to a lesser extent 
regulates mRNA levels at the time a follicle is recruited into the preovulatory 
hierarchy and that this action is mediated, at least in part, by the adenyl 
cyclase/cAMP second messenger pathway. Growth factors such as epidermal 
growth factor act to prevent premature expression of P450 17a -OH activity in 
the granulosa layer of follicles that have yet to enter the rapid growth phase of 
follicle development (Li & Johnson, 1993). 
The transcriptional repression of P450 genes is a common regulatory 
mechanism in mammalian systems such as the steroid 15a hydroxylase of male 
mice. Steroid 15 a-hydroxylase is a female-specific enzyme in the liver of 
inbred mouse strain DBA/2J. Assays indicated that the P450 gene is 
transcriptionally repressed in male mice. BALB/cJ is a variant strain in which 
the gene is expressed in the males as well as in the females. Genetic crosses 
between DBA/2J and BALB/cJ indicated that expression of the P450 gene in 
BALB/cJ males is inherited as a recessive trait and is regulated by a single 
locus (Aida & Negishi, 1993). 
Cell signalling regulation of P450 activity has also been identified as a P450 
control mechanism in developmental stages of the bacterium Myxococcus 
xanthus by C signal-dependent promoters of P450 which allow catabolism or 
anabolism of unusual compounds. These sequences, called C box sequences 
are cis-acting regulatory elements important for the expression of H. xanthus 
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genes that depend upon intercellular C signalling during development (Fisseha 
et al., 1999). 
A dual control P450 system has been identified in the fungus Fusarium 
oxysporum nitric oxide reductase (P450nor) cytochrome P450 gene, CYP 55. It 
is regulated in response to oxygen tension by a DNA oxygen binding sensor 
system. Nitrate and nitrite are the actual inducers of P450nor and its expression 
is predominantly regulated at the transcriptional level by a system responding to 
nitrate/nitrite (Tomura et al., 1994). 
One of the most widely studied bacterial P450 systems is P450cam from 
Pseudomonas putida. It is often used as a model for mammalian P450 
molecules by virtue of being the first P450 crystal structure to be mapped. The 
problems associated with this are discussed in chapter 5. 
There is evidence of autoregulation in the P450 of Pseudomonas putida. The 
regulatory, gene camR on the CAM plasmid of P. putida negatively controls 
expression of the cytochrome P450cam hydroxylase operon (camDCAB) for 
the camphor degradation pathway and is oriented in a direction opposite to that 
of the camDCAB operon. The camR gene was found to be autogenously 
regulated by its own product (Aramaki et al., 1993). 
The bacteria Bacillus megaterium contains a transcriptional repressor Bm3R1. 
Binding of this to DNA is inhibited by fatty acids. The inactivation of 
Bm3R1/DNA binding activity results in the activation of transcription of the 
operon encoding a fatty acid hydroxylase, cytochrome P450 102. This 
represents a protective mechanism by which B. megaterium detoxifies harmful 
foreign lipids. Polyunsaturated fatty acids (PUFA) activate the transcription of 
the CYP102 operon. PUFA effects are due to binding directly to Bm3RI. 
Treatment with the CYP 102 inducer, nafenopin, protected cells against PUFA 
toxicity. Resistance to PUFA toxicity is also observed in a Bm3RI -deficient 
cells that constitutively expresses CYP102. The resistant phenotype of this 
Bm3Rl mutant strain is reversed by chemical inactivation of CYP102. Bm3RI 
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can act as a direct sensor of toxic fatty acids. This was the first evidence of a 
P450 control system, where fatty acids bind to a prokaryotic transcription factor 
(Palmer et al., 1998). 
B. megaterium also possesses a P450 positive regulatory protein of the 
barbiturate-inducible P450BM-1 gene (CYP 106). BM 1P1 and BM 1 P2 are 
positive regulatory proteins involved in the expression of the P450BM- I gene. 
They act by blocking binding of the repressor protein, Bm3Rl (mentioned 
above), to the regulatory region of P450BM-1 (He, et al., 1995). 
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1.15 STEROIDS 
Steroids are part of a large group of metabolites called terpenes. Terpenes are 
based upon a repeating unit known as the isoprene unit, Figure 1.15a. Hence, 
each group of terpenoids are grouped according to the number of repeated units 
in their basic structure. Therefore each group differs from the next by its 




Figure 1.15a The isoprene subunit. 'The steroid building block. ' 




, triterpenes. The steroids are closely related 
to the triterpenes. 
Steroids are polycyclic hydrocarbon compounds which are relatively insoluble 
in water and soluble in organic solvents. They are important biologically 
because they form hormones, a vital group of biomolecules which are involved 
in control mechanisms within multicellular organisms. There are two 
communication systems within animals : the central nervous system and the 
blood system. The former communicating on an electrochemical basis and the 
latter communicating on a chemical basis. The steroid hormones are 
transported in animals via the blood stream however their release and 
concentration control is often by the nervous system. So the two 
communication systems are very much interlinked. The blood system is of 
course essentially aqueous and although steroids are relatively non-polar they 
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are transported in the blood as esters (in combination with fatty acids) 
Steroids all contain a common hydrophobic nucleus based on phenanthrene 
reduced to give perhydrophenanthrene i. e: three cyclohexane rings and has a 
fourth, five membered ring making the perhydrocyclopentanophenanthrene 









Reduction of phenanthrene forms perhydrophenanthrene. 
the perhydrocyclopentanophenanthrene ring system - the basic carbon 
skeleton of steroids, illustrating the numbering convention. 
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12 17 
The steroid nucleus is of a planar nature and substituents on the nucleus are 
designated as 'a - substituents' if orientated away from the observer (behind the 
plane) and 'ß - substituents' if orientated toward the observer. As this is only a 
projection it is convention to regard any substituent in the same plane as the 18 
and 19 methyl groups as P. The 18 and 19 methyl groups are attached to the 13 
and 10 carbons respectively. A compound which does not contain this four 
membered ring cannot be regarded as a steroid. The basic 
perhydrocyclopentanophenanthrene nucleus can be modified in various ways to 
produce the parent hydrocarbons of the naturally occurring steroid groups. The 
source of all steroid hormones is cholesterol which is ingested in food and also 
synthesised in the liver from leucine or acetate. 
1.16 STEROID FUNCTION 
Steroids comprise a wide range of hormones such as pregnanes, androstanes, 
oestranes, glucocorticoids and mineralocorticoids whose functions are chemical 
communication. Cholesterol is the most important steroid and is a precursor of 
bile salts which are required for lipid absorption and digestion. Bile salts were 
the first source of steroids for research in the 1930's. Cholesterol also serves as 
a precursor of vitamin-D, required in the absorption of calcium. 
1.17 BIOSYNTHESIS OF MAMMALIAN STEROID HORMONES 
The biosynthetic pathway of steroid hormone synthesis is thought to be the 
same in all steroid secreting organs such as the ovaries, placenta, testis and 
adrenals (Hall 1984). All steroid hormones have a common precursor, 
cholesterol. Steroids are secondary alcohols, but differ from other alcohols in 
that they are crystalline solids with melting points in the range 100-2000 C. 
Steroids were originally given the name sterols (Gr. stereos, solid + -ol). 
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Cholesterol is a monounsaturated sterol derived from head to tail linkage of 
isoprene units, Figure 1.15a. Isoprene is not a naturally occurring compound. 
although the isoprene rule is useful in structure elucidation. The isoprene unit 
occurs as isopentenyl pyrophosphate and dimethylallyl pyrophosphate. Figures 













Figure 1.17c. dimethylallyl pyrophosphate 
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1.18 PROGESTERONE SYNTHESIS AND UTILISATION 
H 
Pregnenolone is the major product of the initial side chain cleavage of 

















P major pathway 
HO dehydroepiandrosterone The side-chain cleavage of cholesterol 
Figure 1.18a. The side chain cleavage of cholesterol. Cholesterol being the source of 
mamalian steroids. The major and minor metabolic pathways are indicated. The reactions are 
catalysed by cytochrome P450 isoforms. 
Isomerisation of pregnenolone gives rise to progesterone, the steroid hormone 
of the placenta and corpus luteum and of the maintenance of pregnancy. 
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cholesterol 
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Figure 1.18b. Isomerisation of pregnenolone. 
Progesterone contains the A4-3-oxo group of the A ring a characteristic 
common to all secreted steroid hormones except the oestrogens. Figure 1.18c 
shows the two fates of progesterone within the adrenal cortex. Three atoms of 
oxygen are inserted into three distinct positions of the progesterone molecule by 
enzymes in the microsomes. An atom of oxygen is inserted at the 17a position 
and at the 21 position. The third oxygen atom is inserted at the 11 ß position and 
this is catalysed by a mitochondrial multi P450 enzyme system. 17a, 21 & 11 ß 
is the preferred sequence for glucocorticoid synthesis but minor variations to 
this do occur and under normal conditions remain minor pathways unless 
pathological. For example in congenital adrenal hyperplasia there is a 
deficiency of 21 hydroxylase. In the zona glomerulosa, progesterone is 
converted into the mineralocorticoid, aldosterone. First it is hydroxylated at the 
21 position by a microsomal hydroxylase system then, at the 11 ß position by a 
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------------------------------------ The synthesis of the C21 corticosteroids in the adrenal cortex 
major pathway - lop 
minor pathway - ------ 
Figure 1.18c The two fates of progesterone within the adrenal cortex. 
These reactions are catalysed by two CYP3 isoforms (3A4 
and 3A5). 
Aldosterone, Figure 1.18c, is involved in the maintenance of salt balance and 
cortisone is required in the process of protein synthesis and inflammation. 
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1.19 ANDROGEN SYNTHESIS 
Androgens are also synthesised from cholesterol cleavage and interesting I,,, - are 
also synthesised in the adrenals from 17a-hydroxyprogesterone and 11- 
deoxycortisol to yield androstenedione. Testosterone is present in human 
plasma about ten times more concentrated in men than in women. This is due to 
the testicular synthesis of testosterone. Figure 1.19d shows adrenal androgen 
















----- - more than one enzyme 6"J 
oestnol 
Figure 1.19d. Synthesis of androgens and oestrogens. 
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1.20 Overview 
The survey above illustrates the huge complexity and number of steroid 
structures. This section commenced with the example of chemical synthetic 
pathways to the formation of cortisone which would require thirty separate 
steps but can simply be achieved by biotransformation. This concept has huge 
medical implications in terms of P450 modelling techniques for the 
determination of active site structures of drug and carcinogen metabolising 
P450s. Indeed 16a hydroxylation of oestrogens is implicated in breast cancer 
pathology. This is further discussed in chapter 5 but microbial steroid 16a 
hydroxylation is reported (Younglai & Solomon 1967) as is mammalian 16a 
hydroxylation (Wong et al., 1989). However the bacterial hydroxylase is not 
reported to be a P450. The advantage of characterising and purifying bacterial 
P450s lies in their solubility. Purification and X-ray structural analysis of 
membrane bound P450s has proved difficult. For example human CYP2EI 
which oxygenates ethanol (Bell Parikh & Guengerich, 1999) has been 
structurally modelled by homology with the CYP102 of B. megaterium (Lewis 
et al., 2000). However a structurally determined eukarotic P450 is reported 
(Graham & Peterson, 1999). Molecular modelling of steroidogenic 
cytochromes P450 from families CYP 11, CYP 17, CYP 19 and CYP21 based on 
the CYP102 crystal structure are also reported (Lewis & Robichaud, 1998). 
These issues are discussed further in chapter 8. P450 catalysis has many 
carcinogenic implications, for example P4502B1 from rat liver catalyses the 
bioconversion of nicotine to cotinine. P4502B 1 mRNA showed dose dependent 
patterns of induction in other tissues expressing P450 2131, such as the lung. 
The human homologue of this P450 is P450 2B6. Therefore a useful model of 
biotransformation is afforded by rat hepatic P450 (Miksys et al.. 2000). The 
development of enzyme systems which are capable of either producing useful 
compounds for agriculture such as plants expressing antifungal activity and 
pharmacology, such as the development of antifungal agents is therefore . ital. 
70 
Industrially applied biocatalysis is also a growing area of P450 application such 
as production of pravastatin by a Streptomyces. expressing P450sca (Matsuoka 
et al., 1989) an important cholesterol-lowering agent. The basis of industrial 
applications of biocatalysis lies in the availability of sound biotransformation 




Procedures / Methods 
2.1 Whole Cell Biotransformation by and 
Cell Growth of Streptomyces 
roseochromogenes 
2.1.1 Growth and Maintenance of Bacterial Cells on Solid Media 
Streptomyces roseochromogenes strain was stored on YMG agar slopes at 4 °C. 
The slope medium comprised yeast extract 4.0 g/l, malt extract 10.0 g/l, glucose 
4.0 g/l and agar 15.0 g/l, in distilled water (Smith et al., 1988). Cells were 
aseptically inoculated onto the slopes inside small screw-cap bottles. Cells 
were grown in an incubator at 25 °C for 3 days, prior to transfer of the slopes to 
a refrigerator for storage. Organisms were subcultured every four months. 
2.1.2 Growth of Bacterial Cells in Liquid Media 
Organisms were grown in 200m1 of sterile liquid YMG medium by aseptically 
inoculating small pieces of the agar slopes into 2.0 1 flasks containing 
submerged coiled wires to aid mixing and aeration. Prior to inoculation of the 
liquid media, the pH was adjusted to 7.2. The cultures were then incubated in a 
thermostatically controlled orbital shaker at 25°C and 100 rpm, for 48 hours. 
2.1.3 Harvesting of Bacterial Cell Cultures 
Following two days of growth, the thick yellow bacterial suspension from each 
flask was transferred into a 500 ml centrifuge pot. The cells were centrifuged 
in a Sorvall 5B refrigerated superspeed centrifuge, using a6x 500 ml rotor at 
8000 rpm and 0-4 °C for 30 min. The supernatant was discarded and the 
pelleted cells wrapped in aluminium foil and stored at -70 °C until required. 
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2.1.4 Whole Cell Biotransformation of Progesterone 
Progesterone stock was prepared containing 20.0 mg/ml (0.064 M) in absolute 
ethanol and after a 200 ml cell culture had undergone incubation for 24 h, 1.0 
ml of the above stock was added aseptically to flasks. The final progesterone 
concentration was 0.32 mM. Orbital incubation was then continued as 
described above, for a further 24 h. 
2.1.5 Extraction of Steroidal Products from Cell Culture 
After 24h incubation with progesterone, 20.0 ml chloroform was added to the 
200 ml culture and mixed by swirling for 1.0 min. The contents of the culture 
vessel were then poured into a separating funnel and left at 0-4 °C until the 
chloroform and aqueous layers had separated. The lower chloroform layer was 
then removed and divided into aliquots of 1.0 ml for storage at 0-4 °C. 
2.1.6 Large-Scale Whole Cell Biotransformation of Progesterone for 
Structural Analysis of Metabolites 
The time for maximum transformation of progesterone into metabolites was 
determined and progesterone transformation was repeated with appropriately 
scaled up volumes of media and amounts of progesterone. 
The metabolites were separated from each other for NMR analysis. Separation 
was performed on TLC plates as described above except that the steroidal 
mixture was applied in a long stripe across the lower edge of the TLC plate, 
rather than as spots. Progress in the separation of the long bands was 
determined by observing the TLC plates under UV light. The plates were re- 
run if the separation was insufficient. Bands were cut from the TLC plate and 
eluted in HPLC-grade methanol overnight. After elution, the pieces of TLC 
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plate were removed from the methanol and the methanol evaporated. This 
process was repeated for each metabolite band on the TLC plates, until enough 
of each had been obtained. The minimum mass of each sample required for 'H 
NMR analysis. was 0.5 mg. Purified metabolites were dissolved in CDCII for 
NMR spectroscopy structural analysis, in a Brucker WH 400MHz spectrometer. 
Structures were assigned by comparing signals of key individual skeletal 
protons and of substituents e. g. : 4-H, 17a-H, 18H, 19H, 21 H and the methine 
proton of the substituent CHOH functionality thereof, to counterparts in 
authentic standards and also by comparing the value of the chemical shifts to 
published signals ( Kirk et al., 1990). 
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2.2 Preparation of Cell Free Extracts 
and Analysis of Cell Free 
Transformation by Streptomyces 
rosoechromogenes 
2.2.1a Cell Disruption by Homogenisation 
Frozen cell pellets were thawed by placing them in sterile phosphate buffer (0.1 
M K2HPO4 
, 0.2 mM EDTA, 1.0 mM DTT, 10 % glycerol, pepstatin 0.7 
mg/ml, leupeptin 0.5 mg/l, pH 7.2) ; at 1.5 ml buffer per g of cell pellet (Frower 
ei al., 1989 ). Once thawed the suspension was transferred to a round bottomed 
baffled flask and ice-cold acid washed sand was added, 0.5 g per ml of soaking 
buffer. The flask was then placed over the vertical shaft of a four-blade MSE 
homogeniser. Cells were homogenised for three minutes (6 x 30 s) with an 
interval of 1 min between each burst of homogenisation, when the baffled flask 
was placed on ice to counter the heating effect of the homogenisation. 
Sand and cell debris were then removed by centrifugation in a Sorvall 5B 
superspeed refrigerated centrifuge, using an 8x 50 ml rotor operated at 0-4 °C 
and 15000 rpm for 30 min. The supernatant (S 15) was decanted from the pellet 
and retained on ice then re-centrifuged under the same conditions. 
2.2. lb Cell Disruption by Sonication 
Cell pellets were prepared as above in 2.2.1 a. Thawed cells were then placed in 
a 50 ml beaker in 25 ml aliquots and the shaft of a Dynatech Sonic 
Dismembrator Model 150 sonicator introduced. Cells were sonicated at a 
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relative setting of 63 in 30 s bursts before being placed back on ice. The cell 
debris was then removed by centrifugation as in 2.2.1 a. 
2.2.2 Transformation of Progesterone in Cell-Free Extracts 
Cells were thawed, homogenised and the cell debris removed as described 
above in section 2.2.1a. To 0.5 ml of the resulting S15 fraction, 3.0 mM 
progesterone in EtOH was added and 2.0 mM sodium periodate ( NaIO4 ). This 
incubation mixture was made up to 1.0 ml with incubation buffer: 0.1 M 
K2HPO4 
, 
EDTA 10 mM, DTT 0.5 mM, pH 7.2. Control incubations were 
also compiled. One control contained 0.5 ml of incubation buffer in place of 
the 0.5 ml of S 15 fraction. A second contained 0.5 ml of S 15 which had been 
boiled for 30 s and cooled to see if spots would appear on TLC analysis. 
Progesterone transformation by S15 extracts was optimised by varying 
concentrations of progesterone, sodium periodate, DTT, EDTA, also varied 
were pH, temperature and volume of S15 fraction added. Temperature was 
fixed by incubating assays in a Gallenkamp, orbitally shaking themostatically 
controlled incubator. pH was adjusted using a Corning pH meter 140. After 
optimisation, this assay was used in all fractions obtained in purification, to 
determine the presence of the steroid hydroxylase activity. 
In all cases, following the incubation, the steroidal products were extracted 
from the incubation mixture as described in section 2.5.2. 
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2.3 Cytochromes P450: Analytical Protocols 
2.3.1 Monitoring Haem Absorbance in chromatography Fractions to 
Locate Cytochrome P450 
As discussed in the introduction, the haem moiety of cytochrome P450 is not 
covalently attached to the protein structure. For this reason haem concentration 
is not an accurate measure of P450 concentration even if it is approaching 
homogeneity in any given sample. However, monitoring the 417 nm 
absorbance of proteins eluted during column chromatography was found to be a 
very useful guide as to which fraction should be assayed for hydroxylase 
activity. Of 1.0 ml fractions collected from the columns described above, their 
absorbances at 280 nm and 417 nm were measured to give an elution profile for 
total protein and for haem, respectively. The 417 nm absorbance profile proved 
most useful in locating maximum progesterone hydroxylase activity. 
2.3.2 Selective Staining of Haem Proteins in Polyacrylamide Gels 
(peroxidase activity) 
Haem proteins were located in PAGE gels by the hydrogen peroxide - 
benzidine staining method described by Thomas et al., 1976. Where the haem 
protein catalysed decomposition of hydrogen peroxide is employed (Thomas et 
al., 1976). This activity can be linked to a benzidine based substrate to 
produce a chromophore; the chromophore being indicative of haem protein 
presence on a polyacrylamide gel. 
6.3 mM stock 3,3', 5,5'-tetramethylbenzidine (TMBZ) in methanol and 0.5 M 
stock sodium acetate, were mixed in a3: 7 ratio, to a volume sufficient to soak 
the gels. The pH was adjusted to 5.0 prior to immersing the gels in this solution 
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for 2.0 hours in the dark at 4 °C. To this solution H202 Evas added to a 
concentration of 30 mM. A blue stain appeared within an hour. 
2.3.3 Obtaining a Dithionite Reduced Carbon Monoxide Difference 
Spectrum 
Two cuvettes, containing either cell extract, partially purified protein from any 
of the above stages or pure protein in orthophosphate buffer, were placed in a 
Pye Unicam PU 8800 double beam spectrophotometer and the absorbance 
range 390 nm - 520 nm (Ruckpaul, 1990) was scanned and a base line set. One 
cuvette remained in the spectrophotometer while a few granules of sodium 
dithionite were added to the other cuvette. The contents were mixed by gently 
inverting five times. Carbon monoxide gas was then bubbled through the 
dithionite reduced sample for 1.5 min at a rate of one bubble/sec. This cuvette 
was replaced in the spectrophotometer and the absorbances read from 390 - 
520 nm, against the sample blank ( Omura & Sato, 1964 [1]). 
The amounts of sodium dithionite added were varied and so to were the 
concentrations of protein sample in the cuvette, until an optimum spectrum was 
obtained. 
2.3.4 Determination of Cytochrome P450 Concentration in Cell Free 
Extracts 
A P450 sample was placed into one of two cuvettes. Sample buffer was placed 
into the second cuvette as a blank. The absorbance of the sample was read at 
490 nm and at 450 nm. A millimolar extinction coefficient of 91 cm -1 mM-1 
was used to calculate the P450 concentration ( Omura & Sato, 1964 [2] ) using 
the equation : 
[P450] = A4p-ý 90 
Co 
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2.3.5 Obtaining S. roseochromogenes, Progesterone HydroxyIase 
Cytochrome P450 Substrate and Inhibitor Binding Spectra 
Spectrophotometric analysis of the interaction between the cytochrome P450 
progesterone 2ß, 16a-hydroxylase from S. roseochromogenes and substrate. 
progesterone and inhibitor, ketoconazole (Jefcoate. 1978) «-as carried out using 
a Phillips PU 8800 double beam spectrophotometer. 
Active fractions from each stage of the purification process were used to obtain 
the spectra. For each assay 1 ml of fraction was placed in a cuvette in the 
double beam spectrophotometer and the absorbances of w, ýavelengths from 350 - 
510 nm recorded and an absorbance baseline obtained. 0.1 ml of either 
ketoconazole or progesterone, in varying concentrations in EtOH / 0.1 M 
phosphate buffer 30: 70 v/v was added with varying concentrations of the 
substrate or inhibitor. Absorbances were recorded across the 350 - 510 nm 
range to determine the effects of varying concentration. Comparison was also 
made between spectra obtained from different stages of the P450 purification 
process (chapter 4). 
2.3.6 Inhibition of Catalysis by Ketoconazole 
Ketoconazole was added to cell-free incubations of both partially purified and 
purified progesterone hydroxylase, at concentrations of 0.5 - 8.0 µg / ml. 
Progesterone was added at 4.0 mM and sodium periodate ( Hrycay et al. 1975 ) 
at 2.25 mM. Incubations were carried out for 3h before steroidal metabolites 
were extracted as described in 2.5.2. Methanol dissolved metabolites were 
observed by TLC and analysed spectrophotometrically, using a Pye Unicam PU 
8800 UV/vis spectrophotometer. 
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2.4 Steroidal Analysis 
2.4.1 Cell-Free Assay of Progesterone Transformation 
During initial screening and during purification stages, fractions were examined 
for progesterone hydroxylase activity to ensure that activity had been retained 
and also to ensure that the specific products of the hydroxylase catalysis were 
retained. The incubation mixture was prepared as described in section 2.2.2 
and products were extracted from this incubation as described in section 2.4.2. 
2.4.2 Extraction of Steroidal Products from Small Scale Cell-Free 
Incubations 
Following the incubation described in section 2.5.1,1.0 ml of chloroform was 
added to the incubation mixture. The contents of the Bijou bottle were then 
vortexed and left at 4 °C for 30 min allowing the chloroform and aqueous 
layers to separate. A glass Pasteur pipette was then introduced gently and the 
lower chloroform layer withdrawn and transferred into a 2.0 ml Eppendorf 
microfuge tube. The tube was placed over a thermostatically controlled water 
bath at 65 °C and evaporated to dryness. The dry steroidal contents of the tube 
were redissolved in 20 µl methanol prior to TLC analysis (section 2.4.3). 
2.4.3 TLC Analysis of Progesterone Transformed in Whole-Cell or Cell- 
Free Incubations 
One of the 1.0 ml steroid samples in chloroform prepared as in section 2.4.2. 
was placed over a thermostatically controlled water bath at 65 °C and incubated 
until the chloroform had evaporated. The steroidal products were redissolved 
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in 20 µl methanol and mixed. Two other tubes were also prepared as controls. 
One tube contained 20 µl of 20 mg/ml stock progesterone in ethanol. The third 
contained 20 µl of the cell culture from which the steroidal products had been 
extracted as described above. These three samples were then spotted in 5.0 µ1 
aliquots onto a Kieselgel 60 F254 fluorescent high performance TLC plate. 1.0 
cm from the lower edge and 1.0 cm apart. The sample spots were dried for I 
min under an electric fan. The lower edge of the TLC plate was placed in 
solvent, ethyl acetate : toluene : petroleum ether. 4: 3: 3 v/v in a chromatography 
tank and allowed to develop until the solvent front had risen about 10 cm up the 
TLC plate. The TLC plate was then removed from the chromatography tank 
and dried under a heated air flow. The steroidal separation was observed under 
UV light. Dark spots on a fluorescent green background, afforded by the UV 
absorbance of the 4-en-3-one chromophore of ring A, indicated the extent of 
migration and the number of steroidal products. 
2.4.4 Quantification of Steroidal Biotransformation Products 
Two different procedures were employed to determine the extent of steroid 
transformation under different conditions and at different stages of the 
purification process. Yields of progesterone metabolites produced by S. 
roseochromogenes were determined by TLC and HPLC. In the TLC method 
exactly 5.0 mg of progesterone was added to each incubation and dried 
transformation products were dissolved in exactly 100 . tl IIPLC-grade 
methanol. Equal A242 absorbance units of sample contained in ca 5 µl were 
spotted onto fluorescent high-performance Kieselgel 60 F254 TLC plates, which 
were developed in an ethyl acetate/ether/toluene (4: 3: 3 by volume) solvent 
system. Steroids were viewed under UV light, by and plates were 
photographed. Individual spots were scraped from the TLC plate and eluted in 
HPLC-grade methanol. Dried steroids were re-dissolved in exactly' 1.0 ml of 
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methanol and the UV absorbance at 242 nm was measured. The absolute 
amount of steroid present was determined by reference to a calibration curve. 
Reverse phase high performance liquid chromatography (RP-HPLC) of 
steroidal metabolites was performed as follows. 
The solvent used for RP-HPLC was MilliQ water : methanol, 60 : 40 -,, /v, \w filch 
was degassed for 1.0 h prior to priming a Gilson model 303 HPLC pump. 
Solvent was allowed to flow for 1.0 h through a Whatman Partisil PXS 
5/25ODS column with a guard column attached. Solvent was passed through 
an LDC/ MiltonRoy UV MonitorlII fixed wavelength detector (?, 254nm), to 
detect steroidal products. The UV monitor was connected to a Hewlett Packard 
Integrator to record the absorbance signals. 
The integrator was set to calculate concentration of steroid by proportionality to 
the area under individual peaks. 
2.4.5 Elucidation of the Pathway of 16a-monohydroxy and 2(3,16a- 
dihydroxy progesterone synthesis by S. roseochromogenes 
To determine whether the 16a-monohydroxylated progesterone metabolite was 
the direct precursor of the 2ß, 16a-dihydroxylated product, the incubation was 
carried out using 1.0 mM [4-14C] hydroxyprogesterone plus 1.0 mM unlabelled 
progesterone. The extracted products were separated by TLC as described 
earlier. Spots were cut from the TLC plate and counted, to locate the 
radiolabelled product. Hydroxylation assays were analysed by HPLC, 
methanol : water, 60 : 40 v/v as solvent, as described above. 
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2.5 More General Analytical Procedures 
2.5.1 Determination of Protein Concentrations 
Protein concentration was determined essentially by the Coomassie blue dye 
binding method developed by Read & Northcote (Read & Northcote, 1981) and 
adapted by Dr. Mark Carroll at Queen Mary & Westfield College, Department 
of Biomedical Sciences. 
50 mg Coomassie Blue G250 were dissolved in 50 ml of ethanol and 150 ml of 
phosphoric acid added with constant stirring followed by distilled water to a 
final volume between 1 and 2 1, so that the solution was pale brown with a a, ax 
of 470 nm. To a 100 µl sample, 10 µl of 2M NaOH, were added and mixed. 
1.0 ml of Bradford reagent prepared above was added and the absorbance read 
at 595 nm after 2 min against a reagent blank. A standard curve was created 
using varying concentrations of protein. 
The original Coomassie procedure developed by M. Bradford (Bradford, 1976), 
is only linear up to about 4 µg protein compared to 50 µg protein, by this 
adaptation. 
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2.5.2 Sodium Dodecyl Sulphate - Polyacrylamide Gel Electrophoresis of 
Proteins 
10 % SDS-polyacrylamide gel electrophoresis was carried out in a BioRad 
Miniprotean II double electrophoresis cell using a modified protocol of Laemlii 
(1970). 
The 10 % resolving gel in 1.0 M tris buffer at pH 8.8 was degassed for 10 min. 
Then 200 µl ammonium persulphate and 20 µl TEMED were added before 
pouring the gels. Approximately 50 µl of water was added on top of the 
resolving gel to aid polymerisation. The 6% stacking gel in 1.0 M tris, pH 6.8 
was degassed and 50 µl ammonium persulphate and 10 µl TEMED were added. 
After the resolving gel had set, excess water was removed and the stacking gel 
poured on top. 
Protein samples were prepared by adding 15 pl of solubilising buffer, which 
comprised 20 % bromophenol blue w/v, 12.5 % ß-mercaptoethanol v/v, 25 % 
(Marshall & Williams, 1984) glycerol v/v adjusted to pH 6.8, to 15 µl of 
fraction and 10 µl of 20 % SDS. Samples were then microfuged before being 
vortexed, microfuged again and then boiled for 5 min, before being loaded into 
the gel wells with a syringe. 
After running, the plates were prized apart and the gel washed with 10 % TCA 
(100 ml) for 15 - 20 min, to fix the protein and then washed with 100 ml water 
for about 5 min. This was followed by a wash with MeOH : water : Acetic acid 
(45 : 45 : 10) for about 15 min. Gels were then stained in Coomassie blue or 
silver stained. Gels were washed twice in MeOH / acetic acid solution for 30 
min each time. Gels were dried by soaking them in water : acetic acid 
glycerol 90: 10: 2, for 1.0 h and fully dried in a BioRad 200 gel dryer. 
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2.5.3 Silver Staining of Proteins in Polvacrvlamide Gels 
The silver staining of gels was carried out essentially according to the method 
of Rabilloud T. et al., 1988. 
2.5.4 Polyacrylamide Gel Isoelectric Focusing (IEF) of Purified 
Progesterone 2ß, 16a-Hydroxylase Protein 
Polyacrylamide gel solution was prepared as in section 2.5.2, containing an 8% 
gel matrix and 2.4 % w/v ampholine ( pH 3.5 - 9.5 ). Gels were run in a 
BioRad Miniprotean II double electrophoresis cell. Electrode solutions were : 
anode buffer, 1M phosphoric acid and cathode buffer, IM sodium hydroxide. 
The gels were prerun at 100 V for 30 min, 150 V for 30 min. then 250 V for 30 
min. Samples were then loaded and run at 250 V for 2 h, 300 V for 1.5 h and 
finally 400 V for 1.5 h. 
The gels were then fixed with 10 % TCA and silver stained as described in 
section 2.5.3. 
2.5.5 Two-Dimensional Polyacrylamide Gel Electrophoresis 
Preparation of IEF gels 
IEF gels were prepared essentially by the method of Hochstrasser et al., 1988. 
3.0 g Urea were mixed with 0.8 ml stock acrylamide solution (29.2 g 
acrylamide and 0.8 g bisacrylamide in 100 ml distilled water, filtered through a 
Millipore filter) , 
0.06 g CHAPS , 
0.6 ml 10 % w/v Nonidet P40 (in ultra-high 
purity water). The ampholines used were, 0.1 ml ampholines pH 3- 10 and 0.5 
ml ampholines pH 4-8( Harrington et al. 1991). This volume was made up to 
just under 6.0 ml with ultra-high purity water. The solution was stirred and 
warmed gently, until all solids were dissolved. The volume was then adjusted 
to 6.0 ml. 
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The solution was degassed for 5 min and polymerised by adding 5.0 µl TEMED 
and 10 µl of freshly prepared 10 % ammonium persulphate solution. Gel rod 
tubes were filled and overlaid with 100 µl of water saturated with isobutanol. 
The rod polyacrylamide gels were left to polymerise at room temperature. 
Sample buffer was prepared by dissolving 5.5 g urea , 0.1 g CHAPS , 
0.2 ml 
10 % ampholines (pH 3- 10) , 1.0 ml NP-40 and 0.1 g DTT in water and then 
made up to 10.0 ml. This was divided into aliquots and stored at -20 C. 
A protein sample of 10 µl was taken and 20µl of sample buffer was added to 
this. This preparation was vortexed for I Os and incubated at room temperature 
for 30 min. The sample was then microfuged for 1 min, prior to applying to the 
top of a rod gel. 
Isoelectric focusing was performed in the following manner. Two rod 
polyacrylamide gels were set up for each protein sample, in a BioRad Model 
175 chamber attachment for a BioRad Miniprotean II electrophoresis cell. A 
syringe with a fine needle was used to apply anolyte to the bottom of each gel 
to fill any air space. Overlay buffer containing urea and ampholine was added 
to the top of each gel to expel trapped air. The electrophoresis chamber was 
placed on a magnetic stirrer and a 2.5 cm stir bar placed inside with 500 ml 
anolyte (10 mM H3PO4 ). Catholyte (freshly made & degassed 20 mM NaOH) 
was placed in the upper chamber sufficient to cover the tops of the rod gels. 
The gels were pre-focused at 200 V for 15 min, 300 V for 15 min and finally 
400 V for 15 min. The anolyte and catolyte were discarded and protein samples 
applied to the tops of each rod gel, followed by overlay buffer. Focusing was 
carried out at 1000 V for 3h with continuous magnetic stirring. 
After focusing, the rod gels were removed from the tubes by placing in a gel 
extractor with a syringe attachment containing water. The gels were gently 
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forced out onto parafilm and 200 µl of Laemlii sample buffer used to stain the 
length of the gel. After 10 min, the IEF gel was transferred to the top of a 10 % 
polyacrylamide slab gel in a BioRad Miniprotean II electrophoresis cell, which 
was prepared as described in section 2.5.2 but which contained a flat upper 
surface along the top, rather than the sample wells. Also the stacking gel depth 
was only 5 mm rather than 2 cm. This second dimension gel was run at 200 V 
until the bromophenol blue band had just migrated off the lower end of the gel. 
The gels were then fixed as in section 2.5.2 and silver stained as in section 
2.5.3. 
2.5.6 Non-Denaturing Polyacrylamide gel Electrophoresis 
Gels were poured and comprised a 6% stacking gel and 10 % resolving gel as 
described by Laemlii, 1970. Gels were run in a BioRad Miniprotean II double 
electrophoresis cell. This SDS-polyacrylamide gel electrophoresis procedure 
was used to examine the final pure protein samples along with any 
contaminants, on the basis of charge and size respectively. Non-denaturing gels 
were prepared in the same way as SDS gels (section 2.5.2) except that SDS was 
omitted from the sample buffer and ß-mercaptoethanol was omitted from the 
samples. Samples were not heated and the electrode buffer contained no SDS. 
2.5.7 Electroblotting of Purified Steroid Hydroxylase for Partial Amino- 
Acid Sequencing 
Following resolution of homogenous P450 by SDS-polyacrylamide gel 
electrophoresis, the slab gel was soaked in 10 mM CAPS (pH 11) and 10 % 
methanol v/v (transfer medium) for 30 min. (Matsudaira 1987). A PVDF 
membrane was soaked in methanol for 15 min. 300 ml of 10 mM CAPS as 
poured into a Bio-Rad Trans-blot SD semi-dry transfer cell. Three sheets of 
blotting paper were layered onto the metallic plate in the blotter and the PVD1 
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membrane placed on top of the blotting paper. The gel was placed onto the 
membrane and 3 more sheets of blotting paper were layered on top of the (-, Cl. 
Proteins from the gel were electroeluted at 0.5 A for I h. 
The PVDF membrane was removed and washed for 5 min in distilled water. 
The membrane was stained with Coomassie blue and stored at -20 °C until 
sequencing. 
2.5.8 Sephadex G-2000 Molecular Sieve Gel-Filtration to Determine the 
size of Progesterone 20,16a Hydroxylase P450 
20 g of Sephadex G-2000 was weighed and swollen in 0.1 M orthophosphatc 
buffer whilst stirring with a glass rod. The slurry was then autoclaved at 121 
°C for 15 min. After cooling the Sephadex was degassed on ice for Ih and 
then poured into a glass column to give a bed volume of 70 ml. The column 
was washed with the buffer as described in section 2.2.2 (running buffer). 
Active post MIMETIC affinity column fraction (1 ml) was applied to the top 
of the column along with other proteins of known molecular mass. 
The standard proteins run through the column for calibration, were: 
cytochrome c Mr 13370, myoglobin Mr 16900, chymotrypsinogen Mr 23240, 
ovalbumin Mr 43000, phosphorylase a Mr 92000, catalase Mr 247500. 
2 ml Fractions were collected using a Pharmacia Frac- 100 fraction collector and 
their elution volume recorded (Ve). A standard curve of molecular mass v 
elution volume was prepared. 1.0 ml of purified progesterone hydroxylase was 
then applied to the column and 2.0 ml fractions were collected. When the 
protein had eluted, Ve was determined and the molecular mass calculated from 
the calibration curve prepared above. The protein fractions which contained the 
eluted progesterone were combined and assayed for hydroxylase activity. 
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2.6 Molecular Biology 
2.6.1 Partial Amino Acid Sequence of the Purified P450 
Purified protein (7 µg/ml) dissolved in 0.1 M K2HPO4 buffer containing 0.5 
mM DTT, and 10 mM EDTA and 10 % v/v glycerol was divided into aliquots 
of 0.1 ml. The protein was partially digested with modified porcine trypsin. N- 
terminal sequencing of amino acid residues was carried out by acid cleavage of 
isothiocyanate bound N-terminal residues. Hydrolysed amino acids were 
identified by HPLC analysis, each amino acid residue being identified by its 
retention time compared with retention times of authentic amino acid standards. 
Using searches available on the internet, it was then possible to search for 
similar protein sequences. 
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Chapter 3 
Whole Cell Biotransformation of 
Progesterone by Streptomyces 
roseochromogenes and Metabolite 




This chapter is primarily concerned with an investigation of the effects of 
culture conditions upon the growth of S. roseochromogene. 5 and its ability to 
biotransform exogenous progesterone. The emphasis here is on the 
microbiological aspects of the preliminary investigation into progesterone 
biotransformation by S. roseochromogenes. 
This chapter also describes the identification of metabolites, by 'H nuclear 
magnetic resonance spectroscopy (NMR). 
3.2 MATERIALS 
Streplomyces roseochromogenes strain 10984 was purchased from the 
National Collection of Industrial and Marine Bacteria (NCIB) Ltd., 
Aberdeen, Scotland. 
Unless otherwise stated, materials used here were of AnalaR quality. 
Progesterone was purchased from Sigma Chemicals Co., Poole, Dorset. 
For cell growth, yeast extract and malt extract were also purchased from 
Sigma Chemicals Co. 
D(+)-glucose, chloroform, ethyl acetate, HPLC grade methanol and glycerol 
were purchased from BDH Laboratory Supplies, Poole, Dorset. 
Kieselgel 60 F254 TLC plates were purchased from Merck Ltd., Darmstadt, 
Germany. 
3.3 METHODS 
3.3.1 Steroid Transformation by S. roseochromogenes 
For small-scale analytical experiments, cells were grown at 25 °C for 48 h 
with continuous shaking (Smith et. al., 1988) (100 rpm in an orbital 
incubator) in 50 ml YMG in 500 ml conical flasks containing coiled wires to 
aid aeration and dispersal of biomass. After an initial 24 h of growth, 
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progesterone (0.25 ml of a 20 mg/ml stock solution in ethanol) was added to 
each culture flask. After a further 24 h, cells were harvested by 
centrifugation in an 8x 50 ml angle rotor spun for 30 min at 8000 rpm and 
4°C in a Sorvall 5B centrifuge. The supernatant was decanted and extracted 
with two equal volumes of chloroform. The organic layers were collected, 
combined and evaporated to dryness. 
To obtain sufficient pure metabolites for structure determination. 
progesterone transformation incubations were increased fourfold. 
3.3.2 Measurement of S. roseochromogenes Biomass 
Where measurement of cell growth or biomass of S. roseochromogenes was 
required, a 1.0 ml sample of cell culture was removed and diluted x 10 with 
water and the absorbance measured at 600 nm against a blank of water. The 
extent of cell growth was then obtained from a biomass calibration curve. 
3.3.3 Purification and Structure Determination of Progesterone 
Metabolites Produced by S. roseochromogenes 
Metabolites for structure determination were purified from scaled up 
incubations, as described previously in chapter 2. 
3.3.4 Investigation of the Optimal Conditions for Growth of S. 
roseochromogenes Cells 
The conditions under which cell cultures were grown was investigated in 
order to optimise the amount of hydroxylase ultimately recoverable from 
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harvested biomass. For this purpose two parameters were monitored. The 
first was the effects of culture conditions upon cell growth and the second 
was the degree of biotransformation of progesterone per unit biomass 
produced. 
3.3.5 Identification of Progesterone Metabolites Produced by S. 
rosechromogenes strain 10984 by 'H Nuclear Magnetic 
Resonance Spectroscopy 
Metabolites for structure determination were purified as described in 
chapter 2 from scaled-up incubations. Analyses were by 
'H NMR 
spectroscopy on a Bruker WH400 MHz spectrometer. 16a 
Hydroxyprogesterone was identified by the "fingerprint" method (Smith et 
al., 1988), which involved superimposing spectra of authentic 
monohydroxy steroid standards on the spectrum of putative 16a 
hydroxyprogesterone. A full range of dihydroxyprogesterone spectra was 
not available to permit identification of 2ß, 16a dihydroxyprogesterone by 
fingerprinting. The structure of this metabolite was assigned by summing 
the individual shifts of the key characterising signals of the 
monohydroxylated counterparts. This gave predicted 'H shifts for the 
unknown dihydroxylated compound. The assignment was confirmed by a 
full 2-D H COSY spectrum analysis (homonuclear correlation 
spectroscopy). 
Spectra presented in this chapter are with reference to Me4Si as an internal 
standard. Spectra were obtained at 303 K and the solvent used was CDC13. 
Where D was 99.8 %. 
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3.3.6 Time Course of Progesterone Transformation by S. 
roseochromogenes Strain 10984 
In a 25 h incubation of a 200 ml culture, 2.0 ml samples of culture medium 
were removed aseptically at the time intervals shown in Table 3.4a. 
For HPLC analysis, progesterone metabolites were separated in 60% 
aqueous methanol on an analytical reverse-phase Whatman Partisil PXS 
5/25 ODS column. Column effluent was passed through an Pye Unicam PU 
4020 UV detector set at 254 nm. Metabolite concentrations were calculated 
from the areas of the individual peaks eluting from the column measured on 
a Hewlett Packard Integrator. 
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3.4 RESULTS 
3.4.1 Growth Curve for S. roseochromogenes 
The profile in Figure 3.4.1 a, shows the growth of cells in a 200 ml culture 
grown in an orbital shaking incubator in a21 culture vessel containing a 
coiled wire wound around the inner circumference of the base of the culture 
vessel. A1 ml sample was aseptically extracted every 2 h. 
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Figure. 3.4.1a Growth of S. roseochromogenes cells at 25 °C, for the 
determination of optimal cell incubation time. 
The optimum time for late logarithmic growth from the time of inoculation 
was found to be 30 h. Figure 3.4. la shows the growth profile in terms of the 
increase in turbidity of the culture medium with time. A 35 h incubation of 
31 of cell culture in 200 ml aliquots, yielded on average 46 g of cells after 
harvest. 
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3.4.2 Quantification of Metabolite Production by Whole Cells of 
Streptomyces roseochromogenes 
Cell cultures were incubated with 4.0 mM progesterone for increasing 
lengths of time, before 20 ml of culture was removed, quenched with 
chloroform and metabolites extracted and run on TLC plates. 
Whole Cell Biatransfor nation of Progesterone 
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Figure. 3.4.2a S. roseochromogenes, whole cell biotransformation of 
progesterone as determined by TLC elution. 
The metabolites were quantified as described earlier. Figure 3.4.2a shows 
the profile of metabolite production with time. The upper profile shows the 
production of 16a-hydroxyprogesterone and the lower profile shows the 
production of 20,16a-dihydroxyprogesterone. 
2ß-hydroxyprogesterone was not found to be a product. 
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3.4.3 The Effect of pH upon Cell Growth of S. roseochromogenes 
Cells were grown at varying pH values of as indicated in Figure. 3.4.3a, 
each for 20 h. At 20 h the absorbance of a 10 fold dilution with water was 
taken. The profile shows that growth was optimal at pH 7.2. 
3 5 0 . 
3 
m 2 5- -- . 
2 






Figure 3.4.3a Cell growth at varying pH in 200 ml culture. For the 
purpose of identifying the optimum initial pH for cell 
culture. 
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3.4.4 The effect of pH on the Transformation of Progesterone by S. 
roseochromogenes 
These profiles were obtained by growing cells in the manner described 
above but the initial pH was different in each case. Although the growth 
medium was made up at the pH specified, cell growth resulted in pH change 
over time. The pH of the growth medium therefore refers to initial pH. 
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Figure 3.4.4a. Transformation profiles by S. roseochromogenes of 




The above profiles show a growth medium of initial pH 7 was optimal for 
maximum progesterone biotransformation by whole cell cultures of S. 
roseochromogenes. 
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3.4.5 The Effect of Temperature on Cell Growth of S. 
roseoch romogenes 
Growth at the temperatures indicated in Figure 3.4.5a, was achieved in a 
thermostatically controlled orbital incubator, except at 37 °C, where the 200 
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Figure 3.4.5a. Growth of S. roseochromogenes at varying temperatures. 
The data represented in Figure 3.4.5a show that the optimum growth 
temperature was 25 °C. The highest temperature of 37 °C, was least 
conducive to growth, as this resulted in the lowest increase in culture 
turbidity; lower than cultures grown at the coolest temperature of 15 °C. 
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3.4.6 The Effect of Temperature on the Transformation of 
Progesterone by S. roseochromogenes 
The comparison of progesterone biotrans format ion at 10 'C and 25 'C 
shown in Figure 3.4.6a, illustrates a lesser extent of hydroxylation of 
progesterone into both metabolites at 10 °C, a temperature less than the 
optimal 25 °C. 
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Figure 3.4.6a Progesterone biotransformation by S. roseochromogenes. 
A minor metabolite production at 25 °C 
B major metabolite production at 25 °C 
C minor metabolite production at 10 °C 
D major metabolite production at 10 °C 
Progesterone was maximally transformed into both the major and minor 
metabolite at the higher temperature of 25° C. Although the profiles are 
similar at 10° C. the amount of each progesterone metabolite produced was 
decreased. 
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3.4.7 Incubation of S. roseochromogenes Cells with Progesterone 
When progesterone was added to cell cultures, a very similar growth profile 
was observed to that shown in figure 3.4.1 a. Progesterone was added to a 
concentration of 0.1,0.2,0.3,0.4 & 0.5 mM to observe the effect on 
growth parameters. Progesterone did not alter the growth rate nor the 
biomass recovered, and optimum incubation time remained at 35 h for 
maximal growth of cells. Progesterone was added to cell cultures for the 
purpose of metabolite collection for NMR analysis, described later in this 
chapter. 
Progesterone was added to a 10 h cell culture and incubation was continued 
for 25 h before steroidal metabolites were extracted in chloroform. A TLC 
analysis of the products was performed and the results are shown in Figure 
3.4.7a. 
Figure 3.4.7a Photograph under u. v. light showing the two metabolites, as 
determined by NMR. Migration is from left to right. 
Lane 1: Right spot- 2ß, 16a dihydroxyprogesterone, 
Middle spot- 16a hydroxyprogesterone 
Left spot- untransformed progesterone 
Lane 2: Same as lane I. 
Lane 3: Progesterone alone. 
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3.4.8 Identification of Progesterone Metabolites Produced by S. 
rosechromogenes Strain 10984 by 'H Nuclear Magnetic 
Resonance Spectroscopy 
Two metabolites were purified from a 25 h progesterone transformation 
incubation. These metabolites were identified by 
1H NMR spectroscopy as 
2ß, 16a-dihydroxyprogesterone and 16a-monohydroxyprogesterone. 
The NMR identifying features of 16a-hydroxyprogesterone 
The l 7a-H signal, a doublet, (Fig. NMR 3 and Fig. NMR 4), is split only by 
16ß-H, contrasting with the triplet pattern observed in progesterone (Fig. 
NMR I and NMR 2) and all its derivatives hydroxylated at skeletal sites 
other than C-16 (Smith et al., 1989[2]). The 18-H3 singlet is virtually 
unaffected by 16a-OH. The distinctive 1613-H multiplet is at lower field (b 
4.86), Table NMR 1, than the CHOH proton for any other hydroxylated 
progesterone as a result of the proximity of 163-H to the 20-oxo group. 
Progesterone 
(untransformed) 









1 2.04 2.03 (-0.01) 1.56 (-0.48) -0.49 1.55 
2a 
CHOR 
2.35 2.35 (0.00) 4.20 (1.85) 1.85 4.20 
1613 
CHOR 
2.19 4.86 (2.67) 2.19 (0.00) 2.67 4.86 
4 5.73 5.75 (0.02) 5.82 (0.09) 0.11 5.84 
17a 2.54 2.54 (0.00) 2.54 (0.00) 0.00 2.54 
18 0.67 0.68 0.01) 0.67 (0.00) 0.01 0.68 
19 1.20 1.19 (-0.01) 1.18 (-0.02) -0.03 1.17 
21 2.13 ::: 1 2.18 (0.05) 2.13 (0.00) 0.05 2.18 
Table NMR 1. Chemical shifts for protons [S(ppm from Me4Si)]. Where the figures in 
parentheses are shifts relative to the corresponding proton in 
progesterone. 
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Figure NMR 1. The progesterone NMR spectrum from 0-2.7 ppm 
illustrating four characteristic signals: 17a-H at 2.54 ppm, 21-H at 2.13 
ppm, 19-H at 1.20 ppm and 18-H at 0.67 ppm. The fifth major 
characteristic signal for progesterone (4-H) can be seen in Figure NMR2. 
Figure NM R 2. The progesterone NMR spectrum from 0- 12.5 ppm 
showing all five characteristic signals as follows: 4-H at 5.73 ppm (signal 
5), 17a-H at 2.54 ppm (signal 4), 21-H at 2.13 ppm (signal 3), 19-H at 1.20 
ppm (signal 2) and 18-H at 0.67 ppm (signal 1). 
Figure NMR 3. The NMR spectrum of the major progesterone 
metabolite produced by S. roseochromogenes, identified as 16a 
hydroxyprogesterone, 0-2.7 ppm. As in Table NMR 1, four of the, 16a 
hydroxyprogesterone shifts, from progesterone (in parentheses) are shown 
as follows: 
17o -H , 
2.54 ppm (0.00) 
21-11 
, 
2.18 ppm (0.05) 
19-H 
, 
1.19 ppm (-0.01) 
18-H 
, 
0.68 ppm (0.01) 
The 4-H signal can be observed in Figure NMR 4. 
Figure NMR 4. The NMR spectrum of the major progesterone 
metabolite produced by S. roseochromogenes, identified as 16a 
hydroxyprogesterone. As in Table NMR 1, the 16a hydroxyprogesterone 
shifts, from progesterone (in parentheses) are shown as follows: 
4-11 
, 
5.75 ppm (0.02) 
17a-H 
, 
2.54 ppm (0.00) 
21-H 
, 
2.18 ppm (0.05) 
19-H 
. 
1.19 ppm (-0.01) 
18-H 
, 




















































































































ä cy 0 
"w- }1 
0p 8ýp41 zZ 
n `" 6. 




































" oX o">> öIs azoiaz 
11 
önoöwwöantl' 1! 4 EUUiýJýiaö 
T Ono 
o so 4 f, wOn rv amn .. V fNf OýD-4 
ö 

























NMR data for 2ß, 16a-dihydroxyprogesterone (* s, singlet; m, multiplet) 
The 'H NMR spectrum of 20,16a-dihydroxyprogesterone has not been 
previously published. Therefore, this compound was identified by matching 
the measured values for the chemical shifts of key identifying signals of the 
unknown metabolite to theoretical values calculated for 2ß, 16a- 
dihydroxyprogesterone (Table NMR 1). The calculations involved summing 
the published values of the key identifying protons in 2ß- and 16a- 
monohydroxyprogesterone (Kirk et al., 1990). 2D COSY analysis 
confirmed the structure. The features of structural significance of 2(3,16a- 
dihydroxyprogesterone are summarised as follows. 
The unknown compound retained the fundamental signals of the 
progesterone skeleton, i. e. 4-H (s*, b 5.84, ), 18-H3 (s, b 0.68), 19-H3 (s, b 
1.17), 21 -H3 (s, b 2.18) and displayed the features of dihydroxylation with 
two clearly separated mid-field multiplets at 6 4.86 and S 4.2 attributable to 
methine protons of secondary hydroxylated carbon atoms, the 2a and 16P 
protons as predicted. See Table NMR 1. This transformation was confirmed 
by the following spectral data obtained from Figures NMR 5 and NMR 6. 
The characteristic triplet of 17a-H in progesterone was coincident with a 
predicted doublet (S 2.54) consequent on splitting by the 16ß-H. 16a 
Hydroxylation was confirmed by the strong correlation of the 17-H in the 
COSY with the distinctive mid-field multiplet (2.69 ppm) at b 4.88 extant at 
lower field than any other CHOH proton of a hydroxyprogesterone as a 
result of the proximity of the 16ß-H to the 20-oxo group (as mentioned 
above for 16a hydroxyprogesterone). Correlation of COSY cross peaks of 
the mid-field multiplet CHOH signal at 6 4.20 with 1 a-H at b 2.49, which 
was significantly shifted to low field (0.77 ppm) relative to progesterone, 
and to 1 ß-H (S 1.56) and unusually shifted to high field (-0.48 ppm) relative 
to progesterone, confirmed 2ß hydroxylation. 
109 
Figure NMR5. The NMR spectrum of the minor progesterone 
metabolite produced by S. roseochromogenes, identified as 2ß, 16a- 
dihydroxyprogesterone. As in Table NMR 1, the 2ß, 16a 
dihydroxyprogesterone predicted shifts from progesterone (in parentheses) 
are shown and are the same as recorded in the NMR spectrum: 
17a-H 
, 
2.54 ppm (0.00) 
21-H 
, 
2.18 ppm (0.05) 
19-H 
, 
1.17 ppm (-0.03) 
18-H 
, 
0.68 ppm (0.01) 
The 4-H predicted signal is observed in Figure NMR 6. 
Figure NMR6. The NMR spectrum of the minor progesterone 
metabolite produced by S. roseochromogenes, identified as 2(3,16a- 
dihydroxyprogesterone. As in Table NMR 1, the 2ß, 16a 
dihydroxyprogesterone predicted shifts from progesterone (in parentheses) 
are shown and are the same as recorded in the NMR spectrum: 
4-H 
. 5.84 ppm (0.11) 
17a-H , 2.54 ppm (0.00) 
21-H 2.18 ppm (0.05) 
19-H , 1.17 ppm (-0.03) 
18-11 , 0.68 ppm (0.01) 
Figure NMR 6 also shows the 2a, 4.2 ppm predicted signal and the 1613, 
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3.4.9 Amplification of Progesterone Hydroxylase Concentration in 
Streptomyces roseoch ronwgen es Whole Cells 
Many cytochromes P450 are chemically inducible ( Conney et al. 1973 
[2]). The most extensively studied inducible P450 systems are those from 
rat liver. Rat liver P450s are inducible by a variety of compounds. For 
example P450 1Al can be elevated 100 fold following exposure to 2,3,7,8, - 
tetrachlorodibenzo p-dioxin (dioxin) (Waxman & Azaroff, 1992). The 11 ß 
hydroxylation activity in the fungus Cochliobolus lunatus is amplifiable by 
20-hydroxymethyl 1,4-pregnadien-3-one ( Jänig et al. 1992 ). The steroid 
153- hydroxylase P450 of Bacillus megaterium ATCC 13368 is inducible 
by phenobarbitone and by ß-naphthoflavone and 16(x-cyanopregneno lone 
(Berg & Rafter 1981). 
Although there has been relatively little work carried out on P450 systems 
from the Sireptomyces, a few have been found to be inducible. The 
herbicide metabolising P450s in Streptomyces griseolus are phenobarbital 
and sulphonylurea inducible (O'Keefe et al. 1988 , 
Patel & Omer 1992). 
Soybean flour contains the isoflavanoid genistein, which amplifies the P450 
concentration in Streptomyces griseus ( Trower et al. 1989 ). 
As some P450s are substrate inducible this was investigated with S. 
roseochromogenes. The increase in the progesterone 16a hydroxylase 
activity was extremely small and ranged from a2 to 6% increase, for cells 
grown in the presence of 4 mM progesterone for 35 h at 37 °C and therefore 
considered for this investigation to be negligible. 
Cells were also grown in the presence of soybean flour and separately in the 
presence of 0-4 mM genistein, to find if a similar response was detected to 
that observed in S. griseus (Trower, 1989). Genistein did not amplify the 
progesterone 16a-hydroxylase P450 concentration in S roseochromogenes. 
Another compound. coumarin was screened for its ability to amplify the 
P450 concentration. Coumarin has a p-coumaryl moiety like the 




Figure 3.4. A Genistein, an isoflavanoid found to induce P450 concentration in S. 
griseus but not in S. roseochromogenes. 
genistein. However, coumarin is a smaller molecule because it lacks an 
extra phenyl group and a hydroxyl group which are present in genistein. 
Coumarin did amplify the P450 concentration in cells; the extent of which 
was found to be concentration dependent. Figures 3.4.9a-e, show the 




Figure 3.4. B Coumarin, found to augment 16a hydroxylase P-450 concentration in S. 
roseochromogenes cells. 
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Figures 3.4.9a-e show the effect coumarin in the growth medium had on the 
rate and extent of progesterone transformation. Fig. 3.4.9a shows that in the 
absence of coumarin, after 23 h, 32 % of the progesterone was transformed. 
Fig. 3.4.9d shows the optimum concentration of coumarin to be 1.5 mM. 
After 23 h in the presence of 1.5 mM coumarin, 48 % of the progesterone 
was transformed. This represents an amplification in hydroxylase activity 
of 50° o. When increased to 2.0 mM, coumarin gave rise to only a 27 % 
increase in the transformation of progesterone, somewhat lower than that for 
2.0 mM coumarin. In the presence of 1.0 mM coumarin it appeared that 
transformation Nv as not maximally amplified. 
116 
3.4.10 Progesterone Transformation Products and Quantification 
Following Progesterone 16a hydroxylase P450 Amplification 
As two metabolites were produced from the transformation of progesterone, 
the metabolites were quantified to determine whether the production of each 
was amplified or amplification applied to only one product. Figures 3.4.1Oa 
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Figure 3.4.10a. Incubation of S. roseochromogenes cells with 
progesterone in the absence of coumarin. 
Figure 3.4.10a shows the production of each metabolite in the absence of 
coumarin. Progesterone is maximally transformed after 20 h. Figure 
3.4.1 Ob shows the production of each metabolite when cells were incubated 
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Figure. 3.4.10b Incubation of S. roseochromogenes cells with 
progesterone in the presence of coumarin. 
Progesterone was maximally transformed after 14 h. In the presence of 
coumarin, the transformation proceeded up to 48 % which was a 50 % 
increase in the hydroxylase activity from that shown in Fig. 3.4.10a. 
Maximum transformation occurred sooner in the presence of coumarin and 
to a greater extent, than in its absence. Amplification of the two 
hydroxylase activities was approximately equal, i. e : there was not an 
increase in the proportion of one metabolite over the other. In the presence 
of coumarin, 2ß, 16a-dihydroxyprogesterone comprised 14.6 % of the 
transformation products and 16a hydroxyprogesterone the remaining 85 %. 
In the absence of coumarin, 2ß, 16a-dihydroxyprogesterone comprised 15.1 
% of the transformation products and 16a- hydroxyprogesterone, the 
remaining 84 %. This was not considered to be a significant difference. 
The biomass yields at the end of each incubation were virtually identical. 
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3.4.11 The Metabolite Production Profile over a 25 h Whole Cell 
Incubation 
16a-Hydroxyprogesterone, the major metabolite of progesterone 
transformation, first appeared in the culture medium after 6h of incubation 
(Table 3.4a). This metabolite was actively produced throughout the entire 25 
h incubation but the rate of production significantly slowed after 22 h. A 
second phase metabolite, 2ß, 16a-dihydroxyprogesterone, was first detected 
in the culture medium 2h after the initial appearance of 16a- 
hydroxyprogesterone. This compound steadily accumulated during the next 
13 h of transformation, but at less than half the rate of synthesis of 16a- 
hydroxyprogesterone. Production also virtually ceased at 21 h. 2ß- 
Hydroxyprogesterone, the counterpart monohydroxy metabolite to 16a- 
hydroxyprogesterone, was not observed at any time during the 24 h 
transformation period. At the end of transformation, 25% of substrate 
progesterone had been converted into hydroxylated products of which ca 
72% was 16a-hydroxyprogesterone and ca 28% was 2ß, 16a- 
d ihydroxyprogesterone. 
Figure 3.4.11 a, shows the HPLC analysis of this 25 h incubation. The 
legend gives the metabolite identification of each peak. These peaks 
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The components of the growth medium were varied as were the conditions 
under which incubation was maintained. After varying the components of 
the growth medium, a final optimum mixture was obtained. This is outlined 
in the assay below but the full description of its elucidation is omitted. 
In summary, from the results here, the conditions used throughout this work 
for the growth of S. roseochromogenes cells are shown in table 3.5a. 
Growth Requirement Result 
Yeast Extract in growth medium 4.0 g/1 
Malt extract in growth medium 10.0 g/1 
Glucose in growth medium 4.0 g/l 
pH of growth medium 7.2 
Temperature 25°C 
Growth time for cells 48 h 
Rotation for orbital incubation 100 rpm for 50 ml in 500 ml flasks 
containing coiled wires. 
Table 3.5a Growth conditions for S. roseochromogenes cells. 
I'he quantification of progesterone metabolites by TLC elution as described 
here, was abandoned from this point onward in favour of the far more 
precise method of HPLC, the description of which is given in chapter 2. 
1 [PLC gave much more reproducible results than the TLC elution method. 
With TI. C' elution it appeared that total removal of the dihydroxylated 
metabolite from the TI, C plate could not be guaranteed. 
Progesterone metabolite identification here, was of importance as this is the 
first description of the NMR identifying features of 2ß, 16u- 
d ihydrox\-progesterone. 
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This chapter described the microbiological aspects of the progesterone 
biotransformation by S. roseochromogenes and provides the basis for 
investigation into the nature of the hydroxylase. 
Steroid biotransformation is well documented in both prokaryotic and 
eukaryotic organisms such as in the rat (Ferrer ei al., 1990). human 
(Domanski et al., 1998), fungi (Smith et al., 1994) and bacteria 
Rauschenbach et al., 1993). The whole cell biotransformation of 
xenobiotics and steroids was investigated in cultured respiratory epithelial 
cells from rainbow trout (Oncorhynchus mykiss) gills (Leguen et al., 2000). 
Carbon position 16 of testosterone was hydroxylated by trout gill cells, the 
steroid position of interest in the work presented here. Such 
biotransformations are associated with cytochromes P450. This is generally 
not the case in Sireptomyces species. Steroid biotransformation has been 
identified in Strepiomyces (Shirasaka & Tsuruta, 1960) but identification of 
cytochromes P450 in Streptomyces has generally been associated with 
antibiotic biosynthesis. For example, in Streptomyces fradiae the 
biosynthesis of tylosin is completed by the conversion of the deoxyallosyl 
moiety of tylosin via bis-O-methylation at 2-OH and 3-OH. Hydroxylation 
of the polyketide lactone (following its insertion) at C23, is catalysed by the 
cytochrome P450 enzyme. A ferredoxin is expressed within the same gene 
cluster as the P450 and other enzymes involved in tylosin biosynthesis (Bate 
& Cundliffe, 1999). A single cytochrome P450, PicK, is responsible for the 
hydroxylations of YC-17 and narbomycin that generate methymycin, 
neomethymycin and picromycin in Streptomyces venezuelae (Graziani et al., 
1998). 
Oligonucleotide primers were applied to amplify DNA fragments of P450 
hydroxylase genes. The designed primers were based on several regions of 
strong similarity to P450 hydroxylases from a variety of Streptomyces; in 
the regions of an oxygen binding site and a haem ligand pocket. These 
primers were used to amplify DNA fragments from different Streptomyces 
species such as S. lividans, S. parvulus and S. coelicolor. The deduced 
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amino acid sequences of the isolated fragments revealed significant 
similarities to known P450 hydroxylases including the product of the suaC 
or subC genes from S. griseolus (Hyun et al.. 1998) that is capable of 
metabolising a number of sulfonylurea herbicides such as chlorimuron ethyl 
(O'Keefe et al., 1988 and 1993), and to the product of the P450sca2 from S. 
carbophilus which hydroxylates compactin to pravastatin, a tissue-selective 
inhibitor of 3-hydroxy-3-methylglutamyl-coenzyme A reductase (Matsouka 
et al., 1989). This method should help researchers in cloning the P450 
hydroxylase genes involved in the biosynthesis of useful compounds (Hyun 
et al., 1998). 
In Streptomyces cinnamonensis metyrapone (9.0 mM), a P450 inhibitor, 
caused partial inhibition of the biosynthesis of monensin and coproduction 
of new metabolites, 26-deoxymonensins A and B by P450 O-demethylation 
(Pospisil et al., 1994). 
Steroid biotransformation has been identified in Sireptomyces hydrogenans. 
This is a 20-hydroxysteroid dehydrogenase but not identified as a P450 
(Hilhorst et al., 1984). 
A variety of soil micro-organisms such as Pseudomonas, Rhodococcus and 
Streptomyce. s' species produce cholesterol oxidase (CO), a bifunctional 
flavoenzyme, which catalyses the oxidation and isomerisation of 3- 
hydroxy-5-ene-steroids to 3-keto-4-ene-steroids. Although not a P450 
enzyme it is a widely used material in various industrial fields. CO is an 
important ingredient in most commercially available assay kits for serum 
cholesterol screening. CO has a broad range of substrate specificity towards 
various -hydroxy-steroids and has many potential applications as it is stable 
in the presence of water-immiscible solvents at high concentrations, thus 
making possible the conversion of water-insoluble substrates (Kitamoto, 
1999). 
In several streptomvices examples such as the P450 production of geosmin 
(1,10-trans-dimethyl-trans-(9)-decalol) produced by Streplomyces tendae 
(Dionigi ci al.. 1994), P450 monooxygenase activity arises from induction 
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of a P450 and associated ferredoxin, or of a P450 only. suggesting that some 
essential electron donor proteins (reductase and ferredoxin) are not co- 
ordinately regulated with the P450 (O'Keefe & Harder, 1991 [1]). The 
properties of these systems suggest an adaptive strategy whose dual purpose 
is to maintain a competitive advantage via the production of secondary 
metabolites, such as in the demethylation of veratrole by cytochrome P450 
in Streptomyce. s setonii (Sutherland, 1986) (O'Keefe & Harder. 1991 [1]). 




Cell Free Biotransformation of 
Progesterone by Streptomyces 
roseochromogenes 
4.1 INTRODUCTION 
Optimising Conditions for the Examination of the Cell-Free 
Biotransformation of Progesterone by S. roseochromogenes 
In order to assess the effectiveness of any procedure used in an enzyme 
purification process, it is important to be able to assay the activity of the 
enzyme under optimum conditions. This then provides useful information on 
the progress of a purification protocol. 
The following sections aim to optimise the conditions for progesterone 
transformation by the 16a hydroxylase from Streptomyces roseochromogenes, 
with the aim of subsequently purifying the protein. 
The Progesterone 2ß, 16a Hydroxylase of Streptomyces roseochromogenes 
may be a Cytochrome P450 
I'he genus Streptomyces is a rich source of cytochrome P450 monoxygenase 
enzymes that are involved in a wide variety of biosynthetic and xenobiotic 
transformation reactions. In Streptomyces antibioticus, this enzyme is 
responsible for C-8 epoxidation of the lactone ring of the antibiotic 
oleandomycin (Rodriguez et. al., 1995). The DNA sequence of the S. 
antihioticus P450 is related to the eryF gene of S. erythraea 
(Sac"c"haropolyspora crythraea) which codes for a soluble cytochrome P450 
(CYP 107) that stereospecifically 6-hydroxylates 6-deoxyerythronolide B to 
erythronolide B during erythromycin A biosynthesis (Shiafiee & Hutchinson 
1987). In S. carhophilus P450sca hydroxylates compactin to pravastatin, a 
tissue-selective inhibitor of 3-hydroxy-3-methylglutamyl-coenzyme A 
reductase (Matsuoka, et. al. 1989). The sulphonyl urea herbicide chlorimuron 
ethyl is metabolised by two inducible S. griseolus P450s, P450SU1 
(UYP 105; \ 1) and P450SU2 (CYP 105B 1) (O'Keefe et. al., 1988). S. griseus 
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contains a cytochrome P450 that is inducible by the isoflavenoid genistein 
present in soyaflour (Sariaslani & Kurtz 1986). Extracts of this organism, 
prepared from soya flour-induced cells and supplemented with spinach 
ferredoxin and ferredoxin-NADPH reductase are capable of aromatic benzylic, 
and alicyclic hydroxylation (Trower et. al., 1988). The ChoP gene of 
Slrepiomyce. s sp. SA-COO encodes a cholesterol oxidase cytochrome P450 
that has a high degree of homology with human and Pseudomonas P450s 
(Horii et. al., 1989). 
A plethora of 5treplomyces species have been widely reported as excellent 
steroid hydroxylators. C2 and C4 hydroxylation of the phenolic steroid 
oestradiol is known to be P450 catalysed (Trower et. al., 1988). Skeletal sites 
transformed in steroids include ý 1,2ß, 6ß, 7ß, 9a 11 a, 11 ß, 15a and 16a (for 
examples sec footnote') but unlike in the oestradiol bioconversion the nature 
of these other steroid hydroxylases is unknown. 
Mentioned above is the fact that Streptomyces species are a rich source of 
cytochromes P450 and that some Streptomyces species are steroid 
hydroxylators. Despite this, there is no evidence to date reported that any 
Streptomyces P450 is responsible for steroid hydroxylation (except for, Berrie 
et (il., 1999). However, by analogy with steroid hydroxylation in the bacterial 
species Bacillu cereus (Wilson et. al. 1966) and B. megaterium (Berg et. al. 
1976) a reasonable assumption is that these hydroxylases are site-selective 
cytochrome P450 monooxygenases. 
4.2 MATERIALS 
Materials were obtained from the sources previously described in chapter 3 
except that here, epoxy activated Sepharose 6B was purchased from 
¢' Collingsworth D. R. et. al. 1952 
Herzog If. L. et. al. 1957 
Nazaki Y. et. al. 1965 
Smith L. L. et. al. 1961 
Fried J. 1956 
McAleer W. J. et. al. 1958 
Shirasaka M. & Tsuruta M. 1960 
Vondrova 0. & Capek A. 1963 
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Pharmacia Biotech Ltd.. St. Albans, Herts., U. K.: MIMETIC Blue 1 
A6XL 
affinity resin was obtained from Affinity Chromatography 
Ltd.. Freeport, 
Ballasala, Isle of Man, U. K. and Cibacron Blue FG3A and 
NAD-Sepharose 
affinity gel from Sigma Chemical Co., Poole, Dorset, U. K. 
4.3 METHODS 
4.3.1 Preparation of Cell-Free Extract 
The description of the preparation of cell-free extracts is in chapter 2. along 
with a description of other methods attempted but not subsequently needed. 
The treatment and analysis of steroidal metabolites is also discussed in chapter 
4.3.2 The CO Binding Difference Spectrum 
In order to assay P450 purity at each attempted stage of purification, carbon 
monoxide binding difference spectra were obtained. Two cuvettes, containing 
either cell extract from any of the above stages, or pure protein in 
orthophosphate buffer, were placed in a double beam spectrophotometer and 
the absorbance range 390 nm - 520 nm (Ruckpaul, 1990) was scanned to set a 
base line. One cuvette remained in the spectrophotometer and to the second, a 
Ie wv granules of sodium dithionite were added. The cuvette contents were 
mixed by gently inverting five times. Carbon monoxide gas was then bubbled 
through the dithionite reduced sample for 1.5 min at a rate of one bubble/sec. 
This co-treated cuvette was placed back in the spectrophotometer and the 
absorbances read across the 390 - 520 nm range, against the sample blank 
(Omura & Sato. 1964 [1]). 
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The amounts of sodium dithionite added were varied and the concentration 
of 
protein sample in the cuvette was varied, until a satisfactory spectrum 
had 
been obtained. 
4.3.3 Sodium Periodate Dependent Progesterone Hydroxylation by 
Cytochrome P450 
Progesterone was added to a concentration of 4.0 mM to 1.0 ml crude cell-free 
extract incubations containing 0.5 ml of 0.1 M phosphate buffer. 
Sodium 
periodate was added to a concentration of 2.25 mM. Incubations were rotated 
at 20 rpm on a Gallencamp blood tube vertical rotator, at 25 °C for 10 h prior 
to steroidal metabolite extraction. 
4.3.4 Inhibition of Progesterone 2P, 16a-Hydroxylation by Ketoconazole 
Ketoconazole was added at 0.5 - 8.0 µg/ml to the cell free incubations 
described in 4.3.3 above and the steroidal metabolite profiles from each 
incubation were compared by TLC analysis. This profile comparison was 
repeated for both partially purified and purified progesterone hydroxylase 
preparations, also at concentrations of 0.5 - 8.0 µg / ml. Progesterone was 
added at 4.0 mM and sodium periodate ( Hrycay et al. 1975 ) at 2.25 mM. 
Incubations were carried out for 10 h before steroidal metabolites were 
extracted as described in chapter 2. Methanol dissolved metabolites were 
examined by TLC and analysed spectrophotometrically, using a Pye Unicam 
Pl. 1 8800 uv/vis spectrophotometer as described in chapter 2. 
4.3.5 Requirement for NADH or NADPH 
In the assays described above, Na104 removes the requirement for the natural 
electron donor. NAD(P)F1, the electron transfer proteins and molecular 
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oxygen. 'I o develop the assays with av iew to reconstituting the natural P450; 
the natural electron donor was identified. 
All natural cytochrome P450 systems have a requirement for either NADH or 
NADPJI. To the crude cell extracts prepared as described above, NADH or 
NADPH was added to a concentration of 0-0.5 mM. Crude cell-free 
incubations comprised 0.5 ml cell-free extract made up to 1.0 ml with 100 mM 
Na phosphate buffer, pH 7.2. To each incubation progesterone was added to a 
concentration of 0.32 mM (following optimisation of the progesterone 
requirement). The incubations placed on a vertical rotating platform was 
rotated for 10 h at 20 rpm prior to steroidal metabolite extraction and 
examination by TLC as described in chapter 2. 
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4.4 Purification of the Cytochrome P450 
Responsible for Progesterone 
Transformation in S. roseochromogenes 
4.4.1 DEAE-Cellulose Ion-Exchange Chromatography 
('cll breakage to obtain the S15 fraction, was carried out as described in 
section 4.3.1. DEAE-52 cation exchange chromatography was carried out as 
the first stage of purification. CM-32 Anion exchange chromatography was 
also attempted, but failed to separate the progesterone hydroxylase activity 
from other proteins as it was not retained on the column. Pre-swollen DE-52 
DFAE-cellulose was mixed with orthophosphate buffer (0.1 M K2HPO4 ,5 
mM EUTA, D TT 0.25 mM, 10 % glycerol, pH 7.2) and degassed under 
reduced pressure Ibr 1.5 h. The slurry was then poured into a glass column 
(25 cm x5 cnm) to give a bed volume of 100 ml. The column was thermally 
equilibrated at 4 °C and washed for 2h with the column buffer described 
above. S 15 fraction was applied to the column. Once the S 15 had permeated 
the column bed, the column was washed through with 2x bed volume of 
column buffer. Proteins were then eluted from the column with 100 ml each 
of 50mM, 100 mM, 150mM. 200mM, 250mM, 300mMand 350mMNaC1 
in the column buffer. Eluted protein fractions were examined by 
polyacrvlamide gel electrophoresis and assayed for progesterone hydroxylase 
activity', as described in chapter 2. 
4.4.2 Preparation of ha-Progesterone Sepharose 6B Affinity Columns 
6.0 g of freeze dried epoxy-activated Sepharose 6B was resuspended in 100 ml 
of distilled ý\ater and gently stirred for 5 min before being transferred to a 
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sintered glass funnel. The gel was washed for 1h with 1200 ml of 
distilled 
water added in 200 ml aliquots. 
After swelling and washing, the gel was coupled with 11 a- 
hydroxyprogesterone ( Vertblad 1976 ) by first resuspending 1.8 mg of this 
ligand in coupling buffer (100 ml dimethylformamide in 100 ml of 0.1 M 
potassium phosphate, pH 10). The gel was added to the ligand solution and 
this slurry was poured into a1L volumetric flask and mixed by swirling in an 
orbital incubator at 32 °C for 16 h. 
Following this incubation, any excess reactive groups on the Sepharose 6B 
were blocked (Fox & Hechemy 1978; Kagedal et al., 1978; Simons et 
a!.. 1977) by washing the gel in the phosphate buffer, then incubating the gel 
in 1 .0M ethanolamine at 
40 °C for 10 h. The coupled gel was then washed 
with coupling buffer as described above. The slurry was poured into a glass 
column and the gel washed for Ih with coupling buffer. The column was 
then washed alternately in buffers of high and low pH (0.1 M acetate - 0.1 M 
NaCI, pl1 4.0 and 0.1 M borate - 0.5 M NaCl, pH 8.0) ( Harvey et al., 1974 ). 
Each wash was for 20 min and the cycle repeated thrice. 
4.4.3 Steroid Affinity Chromatography 
II a-Hydroxyprogesterone was coupled to epoxy-activated Sepharose 6B as 
described in section 4.4.2. The resulting slurry was poured into a glass 
column (15 cm height x1 cm internal diameter) to give a bed volume of 11 
nil. The column was washed for Ih with the column buffer described in 
. section 4.4.1 and equilibrated at 4 °C. 
Active post DE-52 fractions were combined then dialysed in 400 ml column 
buffer and 10 % glycerol for 5 h, twice. The dialysed fraction was assayed for 
steroid hydroxvlase activity as described in chapter 2. Dialysed post DE-52 
fraction was then applied to the steroid affinity column and allowed to enter 
the matrix completely. The column was then washed with column buffer at 
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pl-1 7.2 until twice the bed volume had been collected. 
The fractions were 
assayed for progesterone hydroxylase activity :a negative result 
indicated 
hydroxylase-matrix binding. The column was then washed with buffer 
containing NaCI in the concentrations used in the DE-52 elution 
in section 
4.4.1. Column fractions were examined by polyacrylamide gel 
electrophoresis. 
When not in use, the column was stored in sodium azide (0.05 M) in 0.1 
M 
phosphate buffer at 4 °C, to prevent bacterial degradation and hydrolysis of 
the matrix ( f'ox ei al. 1978; Landt et al. 1978 ). 
4.4.4 MIMETIC Ligand Affinity Chromatography 
I'hese column matrices were purchased ready made. Each column resin was 
bound to a different coloured dye, as specified by the manufacturer, to identify 
it. When not in use the column resins were stored at 0-4 °C, in ethanol / 0.1 
M NaCl 25: 75 v/v. Column adsorbents used were MIMETIC ligand A6XL: 
Yellow 2, Blue 1, Blue 2, Red 2& Red 3. Pilot scale columns were prepared 
first to establish which resin bound the hydroxylase and provided the most 
effective protein separation of the dialysed post steroid-affinity active 
fractions. After identification of the most effective resin, it was used in large 
scale preparation of progesterone 2ß, 16a hydroxylase P450. A 15 ml bed 
volume column was prepared by degassing for 1h on ice then pouring into a 
glass column (2 cm x 30 cm ). The column was equilibrated and washed with 
the 0.1 M orthophosphate column buffer at 4 °C. Active post steroid-affinity 
fractions. which had been combined and dialysed, as in section 4.4.3, were 
applied to the column immediately followed by two bed volumes of column 
butler. Proteins were eluted from the column using column buffer containing 
50 mM, 100 mM. 1 50 mM, 200 mM & 250 mM NaCl. Fractions were 
assayed ihr progesterone 2 ß. 16a hydroxylase activity. as in section 4.4.3 then 
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combined prior to dialysis twice in 400 ml of 0.1 M orthophosphate buffer at 
4°C for 3 h. 
Column fractions were examined by polyacrylamide gel electrophoresis as 
described in chapter 2. 
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4.5 RESULTS 
4.5.1 Cell Breakage Techniques for the Disruption of Cells and the 
Retention of Cell-Free Progesterone 20,16a Hydroxylase Activity 
S. roseochromogenes cells were disrupted by homogenisation and by 
sonication as described in chapter 2, for the purpose of comparison in order to 
identify the most effective method of release of progesterone 2ß, l 6a 
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Figure 4.5.1a. Protein concentration of S. roseochromogenes obtained by 
homogenisation and sonication. 
The protein concentration obtained by homogenisation using an MSE blender. 
was greater than that by sonication. The optimum blending time, retaining 
progesterone 16a hydroxylase activity, was 5.0 min. The results in Figure 
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Figure 4.5.1b. The retention of progesterone hydroxylase 
activity with increasing homogenisation time. 
The results in Figure 4.5. la showed that increasing homogenisation time 
increased the release of protein, thus resulting in an increasing S15 protein 
concentration. However, Figure 4.5. lb showed S15 loosing progesterone 
hydroxylase activity after 3.0 min. homogenisation time. Three minutes was 
therefore the optimal homogenisation time. 
4.5.2 Homogenisation Times and Patterns and the Release of Protein 
from Whole Cells with the Retention of Hydroxylase Activity 
'Striking a Balance' 
Homogenising cells continuously for 3 minutes has a warming effect on the 
ice-cold cell slurry, through friction. Figure 4.5.2a indicates that this may be 
the case, because cooling at 30 second intervals gave rise to the retention of 
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Figure. 4.5.2a. Progesterone hydroxylase activity with 30 second cooling period 
on ice. Between each 30 second burst of homogenisation. 
Six, 30 second bursts of homogenisation with 30 seconds on ice between each 
burst of homogenisation, provided S15 which was capable of 11.2 % 
transformation of progesterone when incubated with 3.0 mM progesterone. 
4.5.3 The Effect of Protease Inhibitors During Cell Homogenisation 
8% Polyacrylamide gels were used to examine the proteins contained in S 15. 
S 15 samples were left for increasing periods of time before electrophoresis to 
reveal the presence of possible proteases. This was established by an increase 
in the number of bands appearing on an SDS-PAGE slab gel. To prevent 
degradation, a protease inhibitor, phenylmethylsulphonylfluoride (PMSF) was 
used during the preparation of cell free extracts ( Trower et al., 1989 ) at a 
concentration of 7.0 µM from a stock made up in 50: 50 water: methanol v/v. 
138 
4.5.4 The Effect of Cell Culture Age on Maximum Recovery of 
Progesterone 16a Hydroxylase Activity 
Figure 4.5.4a shows the optimum time for cell harvesting was after 35 h of 
growth. The figure also shows progesterone transformation by the respective 
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Figure 4.5.4a. The effect of cell culture age on metabolite production b\ 
cell-free preparations of the differint aged cultures. 
The data in Figure 4.5.4a show a decline in the transformation capability of 
cell free extracts after 40 h cell growth. Identical results were obtained for 
both metabolites for all incubation times. Also shown in the figure, is the total 
percentage transformation of substrate. 
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4.6 Characterisation of the Progesterone 
16a-Hydroxylase System of S. 
roseochromogenes 
4.6.1 The Effect of DTT Concentration on Progesterone 16a 
Hydroxylase Activity in Crude Cell Extracts (S15) 
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Figure 4.6.1a. Effect of incubation buffer DTT concentration on progesterone 
transformation by cell free extracts of S. roseochromogenes. 
When S15 was incubated with 4.0 mM progesterone, I mM EDTA at pH 7.2 
and 0.5 mM DTT, an increase in the production of the major metabolite of 
30% and 100% of the minor metabolite, was observed, compared with 
incubation in the absence of DTT or the presence of 1.0 mM DTT. 
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4.6.2 The Effect of EDTA Concentration on Hydroxylase Activity in 
Crude Cell Extract (S15) 
The cell-free incubation conditions described in section 4.6.1 were retained 
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Figure 4.6.2a. The effect of varying EDTA concentration in the 
incubation buffer on the transformation of progesterone by 
cell-free extracts. 
The data in Figure 4.6.2a show that 10 mM EDTA was the optimum 
concentration for maximum production of both major and minor metabolite 
and concentrations of EDTA above 20 mM were inhibitory to progesterone 
transformation by these cell-free extracts. Above 20 mM EDTA the minor 
dihydroxylated metabolite was undetectable and at 30 mM EDTA neither 
metabolite was detectable. 
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4.6.3 Effect of Glycerol Concentration on the Retention of Progesterone 
16a Hydroxylase Activity in Crude Cell Extracts (S15) 
Glycerol was added to buffers (Trower et a1., 1989) in order to stabilise the 
protein structure of the progesterone 16a hydroxylase, especially during 
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Figure 4.6.3a The effect of increasing glycerol concentration on the total 
transformation of progesterone by cell-free extracts in a 
3h incubation. 
The data in Figure 4.6.3a show that 10% glycerol was the optimum buffer 
proportion to use. Cells were also stored in 10 % glycerol at -70 °C. The 
presence of glycerol above 10% was of no advantage and increased the 
viscosity of samples thereby retarding their flow through column 
chromatography purification columns. 
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4.6.4 Sodium Periodate (Na104) Concentration in Phosphate 
Buffer for Maximum Progesterone Transformation 
Cytochrome P450 systems are multicomponent and require other proteins for 
transfer of electrons from NAD(P)H to the terminal P450. However, an 
oxidising agent can be used to obviate the requirement for electrons in a 
shortened form of the P450 catalytic cycle known as the peroxide shunt 











Concentration of sodium periodate 
Figure 4.6.4a Effect of varying the concentration of Na104 in 
incubation buffers, on the transformation of 
progesterone by cell-free extracts. 
The data in Figure 4.6.4a show that 2.5 mM sodium periodate was the 
optimum concentration for the production of both major and minor 
metabolites in cell-free incubations. Above a concentration of 3.0 mM. 
sodium periodate appeared to have an inhibitory effect upon the progesterone 
hydroxylase activity. From 0-1.5 mM Na104 there was a sharp increase in 
the rate of progesterone transformation attributable to the increasing 
concentration of oxidant. 
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4.6.5 pH Dependence of Cell-Free Transformation of progesterone 
S. roseochromogenes cell free extracts were incubated with progesterone. as 
described above at pH values from 6.4 to 8.6. The effects of this on the 
biotransformation of progesterone into both major and minor metabolites are 











6.4 6.6 6.8 7 7.2 7.4 7.6 7.8 8 8.2 8.4 8.6 
pH of inc baton 
p 2,16-dhydrogprogesterone -r 16-hydroxyprogesterone 
Figure 4.6.5a Effect of cell-free incubation pH on the production of both 
major and minor metabolites of progesterone 
transformation. 
The data show that a pH of 7.2, was the optimum cell-free pH for progesterone 
biotransformation assays. This was the same pH as was found to be optimum 
for the growth of S. roseochromogenes whole-cell cultures. 
A sharp decrease in the rate of production of the major metabolite was 
observed above pH 7.6 and a pH above 8.2 totally inhibited the production of 
both metabolites. A pH below 6.4 was not conducive to progesterone 
transformation. The data show that over this pH range, the minor metabolite 
follows a similar production profile as the major metabolite. 
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4.6.6 Effect of Progesterone Concentration on Hydroxylase Activity 
Equal concentrations of protein from cell extracts were incubated with 
increasing concentrations of progesterone to determine an effect on the 
hydroxylation of the substrate. The data for progesterone transformation are 
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Figure 4.6.6a The effect of progesterone concentration on metabolite 
production in 10 h cell-free incubations. 
Up to 4.0 mM progesterone, the increase in transformation was approximately 
linear. However, above this concentration, metabolite production was 
inhibited in that the greater the concentration of progesterone above 4.0 mM, 
the lower the percentage bioconversion. 
4.6.7 Effect of Protein Concentration on the Production of Progesterone 
Hydroxylase Metabolites 
An S 15 protein concentration of 6.25 mg/ml yielded the greatest progesterone 
transformation in cell-free incubations as described above. Increasing the 
protein concentration above this, may introduce a higher proportion of an 
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inhibitory factor. Figure 4.6.7a shows the effect of protein concentration on 
progesterone transformation. 
20 
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Figure 4.6.7a Effect of increasing the concentration of S 15 protein in the cell-free 
incubation on progesterone transformation. 
At this stage, it was not known what proportion of the protein fraction P450 
was. Above 6.25 mg/ml of S 15, the percentage transformation of progesterone 
began to fall. 
4.6.8 Varying the Incubation Time of Progesterone with 
Cell Extract (S15) 
Cell free assays were incubated for increasing lengths of time, to determine 
the time required for maximum transformation of the substrate. In Figure 
4.6.8a, the data show that a maximum of 12.4 % transformation was observed 
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Figure 4.6.8a Increasing incubation times for cell free assays. 
Incubation times above 3.0 h did not increase the production of metabolites. 
Transformation from 0-3.0 h was linear. 
4.6.9 Inhibition of Progesterone Hydroxylase activity by Ketoconazole 
Ketoconazole is a known P450 inhibitor and inhibitor of steroidogenesis. In 
porcine testicular microsomal P450, ketoconazole inhibits the P450 dependent 
cleavage of 17a-hydroxyprogesterone at the C17-20 bond (Nagai et al., 
1987) in a dose dependent fashion as to in yeast 14a demethylase inhibition 
by ketoconazole. The study of fungal P450 inhibition by azole antifungal 
agents has been extensive, for example Saccharomyces cerevisiae CYP61, 
sterol A22-desaturase (Kelly et al., 1997[ 1 ]) 
Ketoconazole and other azole P450 inhibitors are used in medicine and 
industry as antifungal agents, where the development of resistance to such 
agents is an important consideration at the genetic level. For example the 
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insertion of the 14a demethylase gene of Saccharomyce. s' cerevi. viae into azole 
resistant plasmids thereby forming azole resistant yeasts for industrial 
fermentation (Kelly et al., 1993 [1]). 
Figure 4.6.9a shows the result of the inhibitory effect of ketoconazole on 
progesterone transformation by S15 at 6.5 mg/ml protein incubated with 4.0 
mM progesterone. Incubation was with increasing concentrations of 
ketoconazo le. 
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Figure 4.6.9a. The inhibitory effect of ketoconazole on S. roseochromogenes progesterone 
hydroxylase activity. 
Figure 4.6.9a shows a dose dependent response to ketoconazole. 2 µg/ml 
ketoconazole totally inhibited the production of the minor metabolite, 2ß, 16a 
dihydroxyprogesterone but 0.22 µmol/mg protein/h of the major metabolite. 
16a hydroxyprogesterone, was produced at this concentration. The major 
metabolite was totally inhibited at a ketoconazole concentration of 4.0 µg/ml. 
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4.7 Purification of the Progesterone 16a- 
Hydroxylase Cytochrome P450 in S. 
roseochromogenes 
4.7.1 DEAE Cellulose Ion-Exchange Chromatography of 
S15 Cell-Free Extract 
S. roseochromogenes S15 cell free extract was prepared and applied to a 
DEAF 52 ion exchange column as described in section 4.4.1. The profile of 
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Figure 4.7.1a Elution profile of S 15 proteins from the DEAE 52 column. 
149 
In the profile in Figure 4.7.1 a above, the first peak contained unbound proteins 
eluting from the column in the wash buffer or 'follow-through'. The second 
peak is proteins eluted at 100 mM NaCl. and the third peak is proteins 't hich 
eluted at 200 mM NaCl. The active fractions eluted at 200 mM NaCl. 
4.7.2 Dithionite Reduced Carbon Monoxide Difference Spectrum of Post 
DEAE 52 Column progesterone Hydroxylase Containing Fractions 
Post DEAE column fractions, were tested for reduced CO difference spectra 
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Figure 4.7.2a Dithionite reduced CO difference spectrum for S. 
roseochromogenes progesterone hydroxylase. 
The spectrum in Figure 4.7.2a, has a peak at 450 nm indicative of the presence 
of native cytochrome P450, a trough at 430 nm and a peak at 420 nm 
corresponding to denatured P450 in the preparation. From this spectrum: a 
value of A450 =0.041 and A490 =0.035, were measured. Using a molar 
extinction coefficient of 91 cm 1mM-1 (Omura & Sato, 1964 [2]) these values 
correspond to a native P450 concentration of 65.9 nM. The total P450 
concentration in the fraction must be greater because it contains denatured 
P450. 
1 50 
4.7.3 Sepharose 6B - 11a-Progesterone Affiniti' Chromatography, of 
Active Post DEAE 52 Fractions 
Fractions from the 200 mM NaCI DEAE 52 eluate which displayed typical 
reduced CO spectra and progesterone hydroxylase activity were combined and 
dialysed as described in the methods section prior to application to the 
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Figure 4.7.3a Elution profile of proteins eluting from the steroid IIa 
progesterone affinity column described. These were 
active post 200mM DEAE S 15 protein fractions. 
In Figure 4.7.3a the double peak represents unbound eluting protein. No 
hydroxylase activity was detected in these fractions. The second peak eluted 
at 150 mM NaCl and this fraction contained the hydroxylase activity. The 
progesterone hydroxylase had affinity for the substrate affinity column 
(Weibel et al., 1972). Haemoprotein was detected by 417 nm absorbance. 
The 150 mM NaCl fraction contained all the 417 nm absorbance and 
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progesterone 16a hydroxylase activity. An encouraging sign here in terms of 
purification was the large haem peak which corresponded with the total 
protein peak containing the hydroxylase activity. 
4.7.4 MIMETIC Ligand Affinity Chromatography of Post Steroid 
Affinity Chromatography Active Progesterone 16a Hydroxylase 
Fractions 
This purification method followed the steroid affinity stage above, in the 
purification protocol. 
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Figure 4.7.4a MIMETIC Ligand Blue I affinity column chromatography of active 
post steroid affinity chromatography fractions. The protein elution 
profile. The upper profile is total protein, A, 80 and the lower 
profile is haem A417. 
In Figure. 4.7.4a, the first peak represents unbound protein eluted from the 
column. The second peak contained proteins eluted from the column at 120 
mM NaCl and these fractions contained the progesterone 16a hydroxv lase 
I2 
activity. The protein eluted between fractions 18 - 22 contained pure P450 as 
judged by SDS polyacrylamide gel electrophoresis. The P450 concentration 
of the 120 mM NaCl fraction determined by the method of Omura & Sato. 
1964, was 0.25 nmole. This represents a yield of 1.2 %. Total protein 
recovered, determined by the modified Bradford method, was 0.078 mg. Thus 
the specific content of the 120 mM NaCI MIMETIC Blue I column fraction 
was 3.21 nmol P450 / mg protein. 
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4.8 SDS PAGE of Proteins in Fractions 
from the above Chromatographic 
Stages of Purification 
4.8.1 Polyacrylamide Gel Electrophoresis of Post MIMETIC Blue 1 120 
mM NaCl Fractions 
Polyacrylamide gel electrophoresis was carried out as described in chapter 2 
and gave an Mr of 63 x 103 for the P450. A 15 % gel was run with size marker 
protein ladders and the result is shown in Figure 4.8.1a. From left to right, 
lanes I and 2 show the two electron transfer proteins required by this P450 for 
reconstituted activity in the absence of Na104. They are shown here for size 
comparison but their elucidation and purification are described in chapter 6. 
Figure 4.8.1a SDS-polyacrylamide gel of purified S. roseochrornogenes 2ß, 16a hydroxylase 
cytochrome P450, roseodoxin and roseoredoxin reductase. From left to right: Lane 1, roseoredoxin 
reductase (3.1 µg Mr 65 x 10'); lane 2, roseoredoxin (2.8 µg Mr 14 xl 0'), lane 3, progesterone 2ß, 16a- 
hydroxylase cytochrome P450 (4 p. g M, 63 x 103); lane 4, wide range protein size ladder Mr 205 x 10' - 
14.2 x 10'; lane 5, lower ranger protein size ladder M, 66 x 10' -14.2 x 10'; and lane 6, upper ranger 
protein size ladder Mr 45 x 10' -14.2 x 10'. Lanes 4-6 contained 35 . tg protein. 
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4.8.2 Haem Stain of the Progesterone 16a Hydroxylase P450 Post 
Polyacrylamide Gel Electrophoresis 
A single sample of the purified progesterone 16a hydroxylase (approximately 
5µg) was applied to a 10 % polyacrylamide gel prior to electrophoresis. 
i 
Figure 4.8.2a Photograph of a haem stained polyacrylamide gel. The spot indicates the 
staining of a single haem protein band in the gel, progesterone 16a 
hydroxylase P450 from S. roseochromogenes. 
The electrophoretogram was visualised by haem staining according to the 
method described in chapter 2. A photograph of the result is shown in Figure 
4.8.2a. The single band confirmed that the protein responsible for the Na104 
dependent transformation of progesterone, was a haem protein. 
4.8.3 Two-Dimensional Gel Electrophoresis of Pure Progesterone l6a 
Hydroxylase Cytochrome P450 
Two dimensional gel electrophoresis was employed in order to determine 
more precisely, the purity of the post MIMETIC Blue I. 1 ?0 mM NaCl 
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fraction progesterone 16a hydroxylase protein sample. Whereas SDS PAGE 
separates proteins on the basis of size, this procedure separates out any 
impurities on the basis of two parameters: isoelectric point and size, in the first 
and second dimensions respectively. The resulting 10 % slab gel was silver 




Figure 4.8.3a Photograph of a silver stained two dimensional polyacrylamide gel showing 
the progesterone hydroxylase cytochrome P450 of S. roseochromogenes has 
a pl of 6.6 and was highly pure. 
The presence of a single silver stained band indicated a high degree of protein 
purity as silver staining is an extremely sensitive technique. Measurement of 
the position of the band in the second dimension gave a pI of 6.6 for this 
protein. 
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4.8.4 Dithionite Reduced Carbon Monoxide Difference Spectra of 
Partially Purified P450 from DEAE, Steroid Affinity and 
MIMETIC Chromatography 
Co-ordinates were taken from each of the CO spectra obtained from the P450 
purification stages described above and plotted as shown in Figure 4.8.4a.. 
thereby superimposing the spectra. 
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Figure 4.8.4a Reduced CO difference spectra of the three post purification stage active 
2ß, l 6a hydroxylase fractions. The profiles show a decline in P450 
concentration with processing. 
CO-difference spectra were examined at the three stages of purification. 
Spectra were not recordable for pre-DEAE preparations as these fractions 
were too turbid and consequently failed to give defined peaks against a general 
protein absorbance background. The spectra in Figure. 4.8.4a, were used to 
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estimate the P450 concentration at successive stages of the purification. These 
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Figure 4.8.4b Dithionite reduced, carbon monoxide difference spectrum of the post 120 
mM NaCl MIMETIC Blue I affinity column fraction. 
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4.8.5 Summary of S. roseochromogenes' 16a Progesterone Hydroxylase 
Cytoch ro me P450 
The 16a hydroxylase P450 purification stages described above and their 
results are summarised in Table 4.8.5. 
Purification Stage Total P450 P450 Recovery Purification 
Protein (nmol) (nmoll (%) Factor 
(mg) mg protein) 
S 15 extract 1,050 21.01 0.019 100 1 
DEAE ion exchange 42.59 20.02 0.47 95.29 24.7 
(200 mM NaCl 
fraction) 
Dialysis 42.53 18.1 0.43 86.14 22.6 
Sepharose 6B 11 a- 2.8 3.3 1.18 15.71 62.1 
progesterone 
affinity column (150 
mM NaCl fraction) 
Dialysis 2.79 2.94 1.05 13.99 55.3 
MIMETIC Blue I 0.08 0.27 3.46 1.29 182.1 
affinity column (120 
mM NaC l fraction) 
Dialysis 0.08 0.25 3.21 1.2 168.9 
Table 4.8.5 Purification of S. roseochromogenes progesterone 2ß, 16a hydroxylase 
cytochrome P450. 
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4.9.1 Sephadex G2000 Gel Filtration of Pure Protein to Determine the 
Size of the Progesterone 16a Hydroxylase 
For confirmation of the 16a hydroxylase's molecular mass, gel filtration 
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Figure 4.9.1a Calibration of the Sephadex column for molecular weight 
determination of progesterone 16a hydroxylase. 
The standard curve in Figure 4.9.1a, shows the elution volumes from the 
Sephadex column of proteins in the range 13370 Da to 247500 Da. A sample 
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of purified steroid hydroxylase was applied to the calibrated column. The 
elution profile for the protein standards is shown in Figure. 4.9.1 b. with the 
P450 sample peak superimposed. The P450 sample peak is the smaller peak 
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Figure 4.9.1 b. Elution profile of proteins from the Sephadex column. 
The purified P450 eluted in a total volume of 114 ml. Using the calibration 
curve in Figure 4.9.1a, this corresponds to an Mr of 63000. This value 
confirmed the estimation made by polyacrylamide slab gel electrophoresis. 
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4.9.2 Elucidation of the Pathway of 16a Monohydroxv progesterone and 
20,16a Dihydroxyprogesterone Synthesis by S. roseochroinogenes 
Progesterone 20,16a Hydroxylase P450 
There are three possible pathways by which the major and minor metabolites 
could be synthesised from progesterone. 2ß monohydroxyprogesterone was 
never detected therefore removing the case for a fourth possibility. This 
evidence is described in chapter 5 along with the identification of metabolites 
by NMR analysis. The three possible pathways are : 
Possibility 1: Progesterone --* i 6a-hydroxyprogesterone 
Progesterone -+ 2ß, 16a-dihydroxyprogesterone 
Possibility 2: Progesterone 2ß, 16a-dihydroxyprogesterone - 16a- 
hydroxyprogesterone 
Possibility 3: Progesterone -> 16a-hydroxyprogesterone -+ 2ß, 16a- 
dihydroxyprogesterone 
[4-14C] Progesterone was incubated with purified progesterone 16a 
hydroxylase P450 to produce [4-14C] 16a-hydroxyprogesterone, which was 
separated by TLC. 69 nM P450 was incubated for 5h with the radiolabelled 
16a monohydroxylated product plus unlabelled progesterone each at 2mM. 
The 20,16a-dihydroxyprogesterone contained the majority of the radiolabelled 
material. This result supports possibility 3 above, 16a monohydroxv 
dependent 2ß hydroxylation of progesterone. as the pathway of 
biotransformation. 
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4.9.3 Reconstitution of the Progesterone 16a Hydroxylase P450 
Hydroxylase System 
Reconstitution of the 16a hydroxylase P450 was attempted with a view to 
determining the proteins required for restoration of catalytic competence. . -fis 
exemplified in many other cases of P450 activity such as the system from 
Pseudomonas putida (Sligar et al., 1974 and Gunsalus & Wagner, 1978), 
Streptomyces carbophilus (Matsuoka et al., 1989), Streptomyces griseus 
(Trower et al., 1989), Streptomyces griseolus (O'Keefe et al., 1991) also the 
microsomal example of Rhizopus nigricans (Breskvar, 1983). Pure 
progesterone 16a hydroxylase P450, was combined with different post 
chromatographic column eluates to determine whether NADH dependent 
hydroxylation of progesterone could be supported naturally i. e: could 
catalytic competence of the P450 be restored by ancillary proteins replacing 
the unnatural peroxide shunt pathway. It was found that the first DEAE 
column peak eluate, by itself, restored catalytic competence to the 
hydroxylase. Since this fraction was not capable of hydroxylation alone I 
concluded that this fraction must contain one or more factors responsible for 
the transfer of electrons to the P450. This aspect of the work is developed 
further in chapter 6. 
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4.10 DISCUSSION 
In chapter 3,16a-monohydroxy- and 2ß. 16a-dihydroxyprogesterone were 
identified as the transformation metabolites produced by S. roseochromogenes 
cytochrome P450 during incubation with exogenous progesterone. Reported 
here in chapter 4 is the purification to homogeneity of the cvtochrome P450 
responsible for in vitro progesterone 2ß, 16a- hydroxylation. 
Determination of P450 Concentration in Post MIMETIC Pure Protein 
Fractions 
The purification table (Table 4.8) in section 4.8, shows a loss in the amount of 
P450 from one stage to the next as expected but more importantly there is a 
loss in P450 amount during dialysis. This is attributable to the denaturation of 
the protein from P450 to P420. This is why the spectra in 4.8.4a show an 
increasing P420 peak and a decreasing P450 peak at subsequent stages of the 
purification. Purified P450 appears to be at a higher concentration when 
determined by the dye-binding method, than when determined 
spectrophotometrically. 
This thesis is the first report to identify unequivocally cytochrome P450 as a 
steroid hydroxylase enzyme in the Streptomyces genus. 
P450 mechanisms of oxidation for substrates seems to be very similar. 
Evidence has accumulated that the crystal structure of the soluble P450 101 
can be used as a guide for the elucidation of the active-site structure of 
membrane-bound cytochromes P450 (Koymans et al., 1993 [1]). 
Crystallisation of two other P450s is reported : P450terp & P450 102 
(P450BM3). P450 102 is catalytically self-sufficient, requiring only NADPH 
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and molecular 02 to catalyse the hydroxylation of long-chained fatty acids. 
The enzyme contains haem, FAD and FMN in an equimolar ratio. with the 
haem located at the amino terminal domain (haem domain) and the FAD/FMN 
at the carboxyl domain (flavin domain). Thus, P450 102 resembles 
microsomal P450s which require an FAD/FMN-containing reductase for 
activity. Sequence comparisons with other P450s indicate that the haem 
domain of P450 102 more closely resembles membrane-bound eukaryotic 
P450s from family 4 than it does P450 101 (P450cam)" Therefore, P450 10 
appears to be an excellent model for eukaryotic P450s with the distinct 
advantage that the enzyme is soluble and can be produced in large quantities 
in recombinant systems 
Steroidal products were identified in chapter 3 by 1-D 1H NMR. 2ß mono 
hydroxyprogesterone was not found to be present after any incubation. 
Polyacrylamide gel electrophoresis of the pure protein showed that the P450 
had an Mr of 63000. This was confirmed by Sephadex G2000 molecular sieve 
chromatography. Isoelectric focusing of the purified protein showed it to have 
a pI of 6.6. Bubbling CO through a solution of dithionite reduced P450 
solution gave a characteristic absorption peak at 450 nm. 
Cytochromes P450 (P450) are haem containing (Omura & Sato, 1962) 
monooxygenase proteins found in eukaryotes and in some prokaryotes 
(Lindenmayer & Smith, 1964, Smith et al., 1992). In all cases they form part 
of a multicomponent enzyme system which catalyses the reductive cleavage of 
molecular oxygen (Sariaslani, 1991). This results in the oxygenation of 
substrate and the reduction of the other atom of oxygen to water. The 
multicomponent system in prokaryotes comprises a ferredoxin reductase and 
ferredoxin. which transfer electrons from NADH to the P450. This results in 
the reduction of the Fe3+ of the haem moiety to Fe2+, thus allowing the 
binding of 02 to give Fei+. O2- (White & Coon. 1980). A complete amino 
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acid sequence was not available for the P450 in question here. So what is the 
situation in Streptomyces roseochromogenes ? 
It is interesting to note the reported purification of a P450 from a red alga. 
Where the first stage of purification was DEAF cellulose ion exchange 
chromatography as described here. Reconstitution was attempted as described 
here in section 4.9.3 and the approach used was very similar to that reported 
here in terms of the replacement of P450 with cvtochrome c. Oxygenase 
activity was resolved in to three fractions, from extracts of the unicellular red 
alga Cyanidium caldarium by serial column chromatography through D1: AE- 
cellulose, Reactive Blue 2-Sepharose and 2', 5'-ADP-agarose. In i1tro 
oxygenase activity required the presence of all three fractions, plus substrate, 
02, reduced pyridine nucleotide and another reductant. Fraction I has a visible 
absorption spectrum similar to that of ferredoxin and was bleached by 
dithionite reduction. Fraction I was replaceable by commercially available 
ferredoxin. Fraction III contained ferredoxin-linked cvtochrome c reductase 
activity and could be partially replaced by spinach ferredoxin-NADP+ 
oxidoreductase. None of the three cell fractions could be replaced by bovine 
spleen microsomal haem oxygenase or NADPH-cytochrome P450 reductase 
(Cornejo & Beale, 1988). The rationale for the elucidation of the system in S. 
roseochromogenes commences in chapter 6. 
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Chapter 5 
Spectrophotometric and Kinetic 
Analysis of Streptomyces 
roseochromogenes 2ß, 16a 
Hydroxylase Multicomponent 
Cytochrome P450 System 
5.1 INTRODUCTION 
Inhibitor and substrate induced spectral changes of characteristic reduced 
cytochrome P450 spectra were first observed by Remmer et al. in 1966. This 
work was carried out on hepatic microsomal P450s. 
Spectral changes due to inhibitor and substrate binding are now recognised as 
characteristics of all P450s and can be used to determine the relative extent of 
interaction between ligand and protein (Jefcoate, 1978). This has recently been 
exemplified by the production of P450 type I substrate binding spectra from the 
fungus Pleurotus pulmonarius, in order to determine the substrate affinity of 
benzo[a]pyrene, where a KS of 66 µM was obtained (Maspahy et al., 1999). 
Correlation has been made between the 'type', of spectrum and the spin state, or 
change in spin state of the Fe3+ ion of the P450s haem moiety. However, it is 
not always possible to predict the 'type' of spectrum a particular ligand will give 
rise to. Some ligands such as ketoconazole stabilise the haem moiety by N-co- 
ordination to the 6th ligand of the Fe3+ producing ferric iron. This would 
inhibit the electron accepting capability of P450 necessary to complete the 
catalytic cycle. This bonding replaces the loosely co-ordinated 6th ligand 
which is usually water (Malmström 1982). 
Collection of kinetic parameters such as ligand binding and modelling of 
steroid biotransformation based upon data gathered through spectrophotometric 
analysis is vital in terms of the development of pharmaceutical steroids and 
other products with therapeutic activity, such as antifungal agents (Lamb et al., 
1999). The kinetics of various aspects of such reactions are of great 
importance, such as the dissolution kinetics of steroids (Chen & Vey 1990). 
Also the fact that enzymatic processes are usuall` conducted in the aqueous 
environment means that their kinetics may be dictated by solubility of substrate 
or ligand. 
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Binding Spectra of Partially Purified P450 
It is a spectrophotometric property of cytochromes P450 that gives these 
enzymes their name. Reduced cytochrome P450, when exposed to carbon 
monoxide, gives a characteristic absorption maximum around 450 nm 
compared to non-treated reduced P450. This phenomenon was identified by 
Omura & Sato in 1963 while looking into the spectral properties of cytochrome 
b5, from rabbit liver. 
5.2 MATERIALS 
Materials were as previously described in chapter 2. 
5.3 METHODS 
5.3.1 Production of Reduced Cytochrome P450 Carbon Monoxide 
Difference Spectra and Determination of Cytochrome P450 
Concentration 
The cytochrome P450 concentrations of purification fractions were measured 
from difference spectra in a split beam Pye Unicam PU8800 spectrophotometer. 
Equal volumes of a P450-containing fraction were pipetted into two matched 
glass cuvettes. A few grains of solid sodium dithionite were added to both 
fractions to reduce the P450. The cuvettes were gently inverted until the 
dithionite had dissolved, after which they were simultaneously scanned 
between 390 to 520 nm to obtain a zero baseline. Carbon monoxide was 
bubbled for 1.5 min into the test cuvette at a rate of I bubble ̀ sec. The CO 
difference spectrum «-as then obtained by re-scanning between 390 to 520 nm. 
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To determine the concentration of cytochrome P450 in a particular fraction. the 
absorbance of that fraction was measured from the difference spectrum at 450 
and 490 nm. The values obtained were applied to the formula: 
P450 concentration = A450nm - A490nm 
Co 
Where so is the millimolar absorbance coefficient of P450450-ago and is 91 cm-' 
mM-' (Omura & Sato 1964[2]). 
5.3.2. CO Difference Spectroscopy for S. roseochromogenes Progesterone 
20,16a Hydroxylase 
As the degree or extent of P450 - CO binding interaction is used to determine 
the amount of P450 present in a sample, the CO difference spectra for the P450 
of S. roseochromogenes were examined for different in vitro conditions. 
To avoid repetition, the resulting spectra are shown in the result section along 
with the conditions under which the spectrum was obtained. This was carried 
out in order to attain optimum in vitro conditions for the purification of the 
progesterone 20,16a hydroxylase enzyme. 
5.3.3 Measurement of Substrate Binding with P450 by Optical Difference 
Spectroscopy 
S. roseochromogenes P450 at varying concentrations was placed into matched 
silica cuvettes as described above and a baseline measured from 200 - 600 nm. 
Varying concentrations of progesterone from 0-5.0 pmol in 1.0 ml of 0.1 
phosphate butler were added to the test cuvette with an equal volume of buffer 
simultaneously added to the reference cuvette. The P450 concentration N. was 3.0 
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pmol. The spectra were then rescanned. The chart record paper «as reversed to 
its original starting position prior to recording each assay. This «was to permit 
superimposition of the spectra for the purposes of comparison. Which ever 
P450 sample was under investigation, spectra were recorded at increasing 
substrate concentration until a saturation effect was observed. 
Spectral changes observed at ligand concentrations much higher than P450 
concentration are of doubtful value because P450 may be affected by changes 
in structure by substrate such as the effect of camphor binding with P450cam 
(Tsai et al., 1970) (and Jefcoate, 1978). 
5.3.4 Measurement of Inhibitor Binding with P450 by Optical Difference 
Spectroscopy 
This was performed in the same way as for substrate binding spectroscopy. In 
addition to this, assays which had been exposed to ketoconazole were then 
exposed to CO in the same way as described above to demonstrate the 
practically irreversible binding of ketoconazole to P450. 
5.3.5 Determination of Ligand-P450 Dissociation Constant, Kd for S. 
roseochromogenes Progesterone 20,16a Hydroxylase 
To determine the ligand-P450 Kd , (i) absolute & (ii) 
difference spectra were 
performed and data plotted versus concentration of substrate. Substrates give 
Type I spectra. Pyridines, amines and azoles such as ketoconazole give Type II 
spectra generally. These compounds bind to the oxidised form of P450. 
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5.3.6 Substrate and Inhibitor Binding Spectroscopy 
r/c=Kdn - Kdr .... equ. 
5a. 
Where r= no. of bound ligands, c= no. of free ligands, Kd = dissociation 
constant, n= no. of binding sites. 
Although a Lineweaver-Burke plot could be used to determine the binding 
constant, equation 5a, the Scatchard equation takes account of the number of 
binding sites. 
5.3.7 Effect of Ligand Structure on Binding to P450 
P450 inhibitors are usually classified according to the modification that they 
produce on the maximum absorption of the Soret band. Most compounds 
oxidised by P450 produce a blue shift of the maximum of the Soret absorption, 
stabilising the high-spin form, whereas compounds having donor groups 
capable of binding to the metal move the Soret absorption to the red region, 
shifting the spin equilibrium to low spin. 
X-ray structures have been reported for large numbers of adducts with non- 
natural substrates, for which different binding modes have been observed. The 
size, of the ligand molecule and its ability to interact with the protein residues 
determine the affinity. The nature, the size, and the steric crowding of the 
ligand determine also the displacement or the presence of the axial solvent 
ligand and its protonation state. The latter properties have been proposed to 
determine the spin state (low or high spin) of the iron (III) in the adducts. 
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5.4 RESULTS 
5.4.1 CO Difference Spectroscopy and Determination of S. 
roseochromogenes 2ß, 16a Progesterone Hydroxylase P450 
Concentrations 
When CO was used for the determination of P450 presence, where it was 
passed through purification fractions of 1.0 ml at a rate of 1 bubble per sec. 
The profile below in Figure 5.4.1a was used to determine the P450 
concentration in post MIMETIC Blue I affinity chromatography samples in the 
purification protocol for P450 described in chapter 4. 
= 0.023 AU 
Figure 5.4.1a CO difference spectra prepared as described above. The P450 concentration 
was 0.25 µM and spectrum A represents the profile after 2 minutes of bubbling CO, at 1 bubble 
per second, through a 1.0 ml solution of post MIMETIC Blue I eluate in the P450 purification 
protocol. Profile B represents the same sample after 5 min of bubbling CO through the sample. 
Profile C represents an identical sample treated with CO but with the addition of ketoconazole 
to 0.1 µM. The 450 nm peak is shortened. Where AU = absorbance units. 
173 
5.4.2 Substrate Binding Difference Spectroscope 
With progesterone as substrate, Figure. 5.4.2a was obtained with the component 
concentrations given in the legend. The P450 exhibited a typical set of type I 
substrate binding spectra with maxima at 384 nm. minima at 420 nm and an 
isosbestic point at 401 nm (Iba et al.. 1993). 
A 
Figure 5.4.2a. S. roseochromogenes cytochrome P450 progesterone substrate binding 
spectra. 
The amount of cytochrome P450 was 3.0 pmol in all incubations. Curve 1,0.1 pmol 
progesterone; curve 2,0.3 pmol progesterone; curve 3,0.5 pmol progesterone; curve 4.1.0 
pmol progesterone and curve 5,1.4 pmol progesterone. The assay volume was 1.0 ml in each 
case. 
Data collected from substrate binding were used in the following sections for 
the determination of Kd values. 
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5.4.3 Determination of the Dissociation Constant (Kd) for the S. 
roseochromogenes Progesterone 2ß, 16a Hydroxylase P450 from 
Substrate Binding 
According to Scatchard analysis as described in the introduction to this chapter. 
a Kd for progesterone of 1.95 x 10.8 M was obtained for this P450. The 








0246 AA X105 10 Is] 
Figure 5.4.3a Chart showing AA vs AA/[S] for the binding of the substrate progesterone 
with S. roseochromogenes 2p, 16a hydroxylase cytochrome P450. The 
gradient shown, gives a value for Kd of 1.95 x 10-8 M. 
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5.4.4 Determination of the Dissociation Constant (Kd) for the S 
roseochromogenes Progesterone 20,16a Hydroxylase P450 from 
Inhibitor Binding 
As in the previous section, according to Scatchard analysis a Kd for 
ketoconazole of 1.36 x 10-7 M was obtained for this P450. The gradient of the 
chart in Figure 5.4.4a, gave the Kd value for ketoconazole binding. 
Figure 5.4.4a Chart showing AA vs AA/[S] for the binding of the inhibitor ketoconazole 
with S. roseochromogenes 20,16a hydroxylase cytochrome P450. The 
gradient shown, gives a value for Kd of 1.36 x 10"' M. 
This Kd value must be greater than that for CO binding since bubbling CO 
through ketoconazole - saturated P450 did not remove the ketoconazole and no 
CO binding spectra were obtainable under such circumstances. 
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5.4.5 The S. roseochromogenes Progesterone 20,16a Hydroxylase P450 
Inhibitor Binding Spectra 
Solutions of purified progesterone 2ß, 16a hydroxylase were set up as described 
above at 3.0 pmol in each 1.0 ml incubation, to examine the effect of 
ketoconazole concentration on the inhibitor binding spectra. The resulting 









Figure 5.4.5a Ketoconazole binding spectra for the S. roseochromogenes cytochrome P450 
where AU = absorbance units. The amount of progesterone 20,16a 
hydroxylase was 3.0 pmol and ketoconazole amount was: spectrum 1,0.1 
pmol; spectrum 2,0.1 pmol; spectrum 3,0.3 pmol; spectrum 4,0.5 pmol. 
Points A, B and C in Figure 5.4.5a, where the spectra cross do not represent 
isosbestic points and the reason for the curves crossing at these points is 
unknown. These data gathered for ketoconazole binding did not allow for 
accurate Scatchard analysis. 
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5.4.6 Examination of the Kinetic Parameters of Models of Progesterone 
Biotransformation by Streptomyces roseochromogenes 
Taking the Lineweaver-Burk equation: 
V= Vmax[SS] 
.......... equ. 5b. Km + [S] 
A Lineweaver - Burk plot and the values for Vmax. and Kd , were obtained 
for 
each of the theoretical models for progesterone biotransformation, described 
below, where L-B = Lineweaver-Burk plot and RP = the roseoredoxin 
phenomenon, described in detail in chapter 7. When S. roseochromogenes cells 
were grown in the presence of progesterone and the roseoredoxin component 
purified from cells, it produced an altered product ratio when incubated in 
reconstitution assays. Namely the proportion of 2ß, l 6a hydroxyprogesterone 
to 16a hydroxyprogesterone increased in these incubations compared to 
counterpart reconstitution assays where the roseoredoxin was taken from cells 
which had not previously been pre exposed to progesterone. Therefore each 
model described below was examined in two ways. One with roseoredoxin 
taken from progesterone pre incubated cells and one where roseoredoxin was 
taken from non progesterone pre incubated cells. 
The theoretical models were examined using experimental data obtained. 
Model 1: 
Where the two transformation metabolites are treated as one, i. e. total 
transformation is considered, rather than the individual metabolites produced. 
The products in this case are therefore the 2ß, 16a hydroxyprogesterone plus the 
16a hydroxyprogesterone. 
L-B plot: The plot in figure 5.4.6a. shows the L-B plots as line 5 which is 
actually two lines. Table 5.1 shows this as the first and second rows of data in 
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the table. The kinetic parameters for this model are the same in the presence 
and absence of the roseoredoxin phenomenon. Theoretically this is because the 
overall production of metabolite is no different in either form of the model (+ or 
- RP) but the metabolite ratio is altered, a factor not considered in this model. 
Model 2: 
Where the two transformation metabolites are considered as separate reactions 
and as two alternative routes of transformation and hence analysed separately. 
The two transformation products are considered but the 16a 
hydroxyprogesterone is taken as the substrate for a second phase bioconversion 
to 2ß, 16a dihydroxyprogesterone i. e: 
Step 1: progesterone = 16a hydroxyprogesterone 
Step 2: 16a hydroxyprogesterone = 2ß, 16a dihydroxyprogesterone 
L-B plot: Line 4 in Figure 5.4.6a is very close to line 5. The kinetic parameters 
of the production of 16a hydroxyprogesterone in the absence of RP, are similar 
to those for the overall biotransformation of progesterone given by model I 
(line 5). It is the second phase bioconversion to 2ß, 16a dihydroxyprogesterone 
in the absence of RP which give rise to line 1. 
For the second phase, a greater proportion of the metabolites are dihydroxylated 
when the Vmax is increased and the Km is decreased (lines 1 and 2, Figure 
5.4.6a. ) as appears to be the case in the presence of RP. 
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Model Vmax 1 /Vmax Vmax/2 [S] at 1/[S] at Km Kcal/Km 
u (µm01 (p. mol (µm01 Vmax/2 Vmax/2 (mM) (sec-' \1-' ) 
min-') min) min') (mm) (mm-) 
I in the 
absence 0.015 67 0.0075 0.6 1.67 0.6 1.53 x 105 
of RP 
1 in the 



















in the 0.004 253 0.002 0.85 1.18 0.85 5.22 x10`' 
presence 
of RP 
Table 5.1 Kinetic parameters of the various model components of the in vitro 
reconstituted biotransformation system of progesterone by S. 
roseochromogenes according to the models described. At Vra, t/2, Km = 
[S] 
and -1 /[S] = -1/Kn, ; the 'x' intercept in Figure 5.4.6a. 
RP = 'roseoredoxin phenomenon' (see text for definition). 
Kit/KR, , Table 
5.1, column 8, is a measure of the enzymatic efficiency and is 
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Figure 5.4.6a. Lineweaver-Burke (L-B) plot of the reactions described in the above models. 
Where line 5 represents two lines : that for model I in the presence and in the 
absence of the roseoredoxin phenomenon. The L-B plots are theoretically the 
same as there is no increase in yield, simply an altered product ratio (RP). 
Model I considers total transformation rather than the separate routes of 
transformation. Lines 1,2,3 and 4 represent the two stages of bioconversion 
described by model 2, both in the presence and absence of RP. 
5.4.7 Absolute Spectrum for Purified S. roseochromogenes 2ß, 16a 
Hydroxylase, Roseoredoxin 
The absolute absorbance spectrum of oxidised roseoredoxin showed maxima at 
280 and 400 nm with a shoulder at 310 nm Fig. 5.4.5a The absorbance profile 
was mainly preserved after reduction of the roseoredoxin with a 15 fold excess 
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1I 
of dithionite. Thus, the 280 and 400 nm maxima "ere retained but not the 310 
nm shoulder. Reduction decreased the absolute absorbance above 300 nm. 
Figure 5.4.7a. Absorbance spectrum of S. roseochromogenes roseoredoxin. The solid line is 
the absorbance of 8.0 µM native oxidised roseoredoxin in 0.1 M K2HPO4 
buffer pH 7, the dotted line is the absorbance of the reduced form treated with 
a 15 fold excess of sodium dithionite. 
5.4.8 Absolute Spectrum for Purified S. roseochromogenes 2ß, 16a 
Hydroxylase, Roseoredoxin Reductase 
The absolute absorbance spectrum of oxidised roseoredoxin reductase showed 
maxima at 272 , 
374 and 446 nm Figure 5.4.6a. The absorbance profile was 
mainly preserved after reduction of the roseoredoxin with a 15 fold excess of 
dithionite. 
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Figure 5.4.8a. Absorbance spectrum of S. roseochromogenes roseoredoxin reductase. The 
solid line is the absorbance of A, 5.0 µM; B, 7.0 µM native roseoredoxin 
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Figure 5.4.8b. Absolute absorbance spectrum of S. roseochromogenes roseoredoxin 
reductase. 
The chart recording in Figure5.4.8b shows the 374 and the 446 nm peaks with 
the 374 peak as a shoulder of the 446 nm peak; these becoming separate 
artefacts upon reduction of the protein, as shown in Figure 5.4.8a. 
The purification and characterisation is described in more detail in chapter 6. 
The kinetic analysis presented in this chapter incorporates this protein as the in 
vitro reductase component of the multicomponent P450 system. This is not 
necessarily representative of the in vivo scenario as the protein has reductase, 
i. e. electron transfer ability but may not exclusively be a 'roseoredoxin' 
reductase rather, this protein may transfer electrons to other recipient proteins. 
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5.5 DISCUSSION 
5.5.1 The Importance of Kinetic Parameters 
The type of analysis presented in this chapter is significant in terms of 
rationales for drug design and the development of modified enzymes for the 
metabolism of new drugs. The consideration of kinetic parameters is vital in 
terms of the relationship between an enzyme's efficiency and the half-life of a 
drug for example. Vmax/Km is particularly important in established strategies 
for the in vitro drug metabolism predictions from in vitro metabolite kinetic 
data. These relationships are often well established for the rat. However it has 
been recently claimed that these models are not useful for prediction of kinetics 
of drug metabolic behaviour in human tissue, because the dominant human 
P450 (CYP) 3A4 does not show classic hyperbolic metabolism rate v substrate 
concentration consistent with Michaelis - Menten kinetics, as predicted 
(Houston & Kenworthy, 2000). The human CYP 3A4 P450 (along with 3A5) 
has been implicated in the 16a hydroxylation of oestrone (an oestrogen) to the 
putative carcinogen 16a hydroxyoestrone (Zeqi et al., 1998) . 
I6a 
hydroxylation of course being at the centre of the work presented here. The 
Vmax for P450 (CYP) 3A4 is not maintained at high substrate concentrations 
and does not have a valid human model, despite the dissolution kinetic model 
for steroid substrates at high concentrations in the aqueous environment, 
postulated by Chen & Wey in 1990. The hydroxylation of oestrone by human 
P4503A4 has a K,,, of 172 µM and by microsomes, a Km of 154 µM for 16a 
hydroxylation. This contrasts with the S. roseochromogenes 16a hydroxylation 
of progesterone, where in the absence of the roseoredoxin phenomenon, Kam, 
(reconstituted) = 0.0015 M and in the presence of the roseoredoxin 
phenomenon Km = 0.0007 M (Table 5.1) a difference of an order of magnitude 
of 102 . 
The human P450 (CYP) 3A4 has a Vmax of 0.238 mol min"' for 16a 
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hydroxylation of oestrone by microsomes and 1.05 mol min"' for the expressed 
P450 system (Zeqi et al., 1998). This is in contrast to the 16a hydroxylation 
presented here of an order of magnitude of 108 . 
It has been postulated that 
blocking the oestrone to 16a hydroxyoestrone pathway, could provide a 
therapeutic approach to diminishing the risk of oestrogen dependent breast 
cancer. Since, in the human system the rates are increased on average 6 fold in 
the presence of cytochrome b5 and Vmax is not maintained as substrate 
concentration increases; is it possible that the reconstituted 16a hydroxylase 
system of S. roseochromogenes, presented in this work, could play a role in the 
examination of steroid 16a hydroxylation and its kinetics, to this end ? 
5.5.2 The significance of the Substrate and Inhibitor Binding Spectra 
The concentration of substrate within an assay and the extent of binding of 
P450 to a substrate are inversely correlated with protein concentration. Any 
relation between Kd (dissociation constant) and Km ( Michaelis constant) is 
invalid unless exactly the same protein concentration is used in each assay. 
Other errors affecting kinetic modelling frequently found in the experimental 
design are: (i) excessive consumption of substrates for the measurements of 
rates at low substrate concentration or (ii) there may be failure to estimate a 
significant concentration of P450-bound substrate. The latter can be calculated 
from the spectral response if Ac for the difference spectrum is known (typically 
40-100 mM-1 cm 1 for P450s). Both problems are significant with high a nity 
substrates. Also distribution of a ligand between aqueous and non aqueous 
phases may require consideration in determining Kd and Km values (Chen & 
Wey, 1990). 
In titrations to calculate binding constants the extent of binding is generally 
quantified as AAbsorbance (peak to trough) and Kd is derived from 
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Lineweaver-Burk plots of 1/AA vs 1/[S]; Kd =1/intercept. . alternatively. 
Scatchard plot analysis of AA vs AA/[S] is plotted; Kd= slope. Scatchard 
analysis is better for calculation of dissociation constants because multiple 
binding sites and/or multiple P450s from dissociation curves can be detected 
and a wide range of substrates used. 
Insolubility of substrate affects spectra in two ways; (i) turbidity - baseline 
curves up towards the UV, (ii) binding curves will saturate prematurely so that 
in extreme cases Kd reflects solubility in the aqueous-microsome medium 
rather than binding to P450. The solubility enzyme kinetics of IIß steroid 
hydroxylation by Curvularia lunata were examined in order to gain a better 
understanding of the mechanism of enzymatic transformation of steroids at 
high substrate level (Chen & Wey, 1990). 
5.5.3 Measuring P450 Concentration using Spectra 
n-Octylamine produces essentially identical difference spectra as CO with P450 
so the spectra and calibration are applicable to octylamine-induced difference 
spectra (type IIa). The value AA (407-448nm) at saturation of octylamine also 
measures octylamine-bound P450 (Ac = 28cm-1 mM-1). This value can be 
compared with total P450 calculated from a reduced-CO difference spectrum 
(Ac 450-490nm = 91 cm I mM-1). This value is used throughout this work. 
AA 645-700nm can be used to measure P450 (Ac =4.5 cm -I mM- I) A 645nm 
absorbance peak is present only in the high-spin state; the response measures 
only the amount of high spin P450. It was relatively difficult to obtain this 
absorbance measurement and therefore this value was not used in this work. 
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5.5.4 Determination of Inhibitor and Substrate Kd s for S. 
roseochromogenes Progesterone Hydroxylase P450 
CO : P450 complexes show Soret peaks at 420-424nm suggesting interaction of 
haem iron and azole nitrogen. The binding of ketoconazole to lanosterol 14u 
demethylase P45014DM is very high, with an apparent Kd <0.01 mM for 
example (Vanden Bossche et al., 1993). Azoles also interact with the reduced 
form of P45014DM" Absorption spectra suggest that the azole nitrogen still 
interacts with haem iron (Turf & Loper 1992). 
Reduced P450: ketoconazole complexes are not readily converted to reduced 
P450: CO complexes suggesting the interaction of azole with P450 is strong in 
that the Kd is high for ketoconazole binding. 
Kd values have often been used in the determination of rate limiting steps of 
P450 reactions. For example product release has been found to be a rate 
limiting step for several P450 reactions. The examination of azole antifungal 
agents in terms of their effects upon P450 activity continues to be vitally 
important because so many P450 related products are based upon these azole 
antifungals. The appearance of drug resistant strains of pathogens is a 
legitimate concern. For example the pathogen Candida krusei has a P450 
which is inhibited by ketoconazole and itraconazole at lower concentrations 
than fluconazole but all three drugs interfered with the binding of CO to sterol 
14a demethylase P450, in direct proportion to their inhibitory effect upon 
ergosterol biosynthesis. The 'slightly' lower Kd of the fluconazole was only 
partially responsible for its poor inhibitory effect (Venkateswarlu et al., 1997). 
However, the sterol 14a demethylase P450 of a closely related organism, 
Candida albicans, was mutated in the haem binding domain by G464S, and the 
poor inhibitory effect of fluconazole was then purely attributable to a low Kd 
(Kelly el al., 1999). Comparisons of such reactions with mammalian 
counterparts may well be useful in terms of biochemical drug modelling since 
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this enzyme catalyses the oxidative removal of C32 methyl of lanosterol in the 
biosynthesis of the fungal sterol. ergosterol. Ergosterol is the fungal 
counterpart to mammalian cholesterol as the mammalian analogue catalyses the 
identical transformation in cholesterol biosynthesis (Yoshida & Kumaoka, 
1975). 
The extent of binding or Kd can determine, indirectly, the rate of a reaction. In 
the oxidation of ethanol to acetic acid by P450 2E1 the Kit/Km value is at least 
one order of magnitude higher than in the oxidation to acetaldehyde (Bell 
Parikh & Guengerich, 1999). Determinations of Kd values are important in the 
collection of modelling data for P450 systems. Another example of the 
significance of Kd in terms of the mechanism of P450 catalysis is in the house 
fly (Musca domestica), P450 epoxidation of heptachlor, where the affinity of 
the P450 reductase for NADPH is 10 times higher than for NADP+ (Kd of 0.31 
and 3.3 µM, respectively). Such an affinity change during catalysis could 
account for a +30 mV shift of the redox potential of FAD (Murataliev et al., 
1999). In this mechanism, oxidation of the NADPH is required, hence its 
higher affinity. The high affinity of the reductase, an FMN semiquinone and 
the P450 for each other in the formation of a catalytic intermediate has evolved 
an extremely efficient reaction. The rate of oxidation of the one molecule of 
NADPH is rapid but the rate of oxidation of a second is too slow to account for 
the rate of catalysis, this is explained by the formation of two semiquinones 
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Figure 5A....... Ketoconazole. 
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5.5.5 Determination of the Dissociation Constant (Kd) for the S. 
roseochromogenes P450 from Inhibitor Binding 
The usefulness of determining a ketoconazole Kd for this P450 is questionable 
in view of the binding spectra, points A, B and C, shown in Figure 5.4.5a 
above. 
However, the binding of ketoconazole to this P450 appeared to be much 
stronger than to progesterone as might be expected for an inhibitor. This was in 
view of the fact that bubbling CO through the enzyme inhibitor complex failed 
to displace ketoconazole in favour of CO. 
5.5.6 The Absolute Absorption Spectra of the Three Components of the 
2ß, 16a Hydroxylase System. 
One of the more characteristic spectral features of P450 is the large blue shift in 
the Soret visible absorption band from 419 - 390 nm when substrate is bound. 
Hence, from a P450 spectrum one can observe substrate free or substrate bound 
P450. The spectra here, of the P450 and of the reductase give little information 
except that the reductase spectrum showed the absorbance peaks associated 
with its FAD moiety. The P450 spectra do not represent a characteristic or 
particular type of spectra. The roseoredoxin spectrum however, does share 
characteristics with another known Streptomyces ferredoxin (Trower et al., 
1990), that of a 7Fe ferredoxin from Streptomyces griseus. The significance of 
this similarity is tenuous even though both proteins are from the same genus, 
because Fe/S redoxin spectra do not generally have common features and are 
always unique (Nicholls & Ferguson, 1992). Spectral characterisation would 
be better served by ESR or EPR. 
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5.5.7 The Two Models of Progesterone Biotransformation Presented in 
this Chapter 
Considering models I and 2 and Table 5.1; if the roseoredoxin phenomenon is 
due to a fundamental difference in the electron transfer efficiency then one 
would expect that P450 might be reduced in its catalytic cycle at a different rate 
by the different forms of the transfer protein. This would affect the second 
hydroxylation (2ß) in that the faster the reduction of P450 the greater the yield 
of the dihydroxy product. One would therefore expect Vmax to increase in this 
instance but not Km which is a measure of the binding affinity of the substrate. 
This should be unchanged in both scenarios because the P450 is unchanged. 
Kcat/Km should change as efficiency changes. Data lines 4 and 6 in Table 5.1 
show that the roseoredoxin phenomenon may be related to a change in reducing 
efficiency, Kit/Km are of the same order of magnitude and Vmax is much larger, 
0.004 µmol min-' in the presence of the roseoredoxin phenomenon compared to 
0.015 p. mol min-' in the absence of the phenomenon for the second 
hydroxylation. Km however changes from 1.5 mM to 0.85 mM in the presence 
of the roseoredoxin phenomenon for the second hydroxylation (lines 4 and 6, 
Table 5.1). 
Many drugs and xenobiotics combine with cytochrome P450 to produce a Type 
I difference spectrum characterised by maximum absorbancies at 390-395nm 
and minimum absorbancies at 416-420nm (Remmer et al., 1966; I mal & Sato 
1966; Schenkman et al., 1967). Most compounds that produce the type I 
spectra are substrates for cytochrome P450-mediated monooxygenase reactions. 
Other compounds, which are frequently not substrates produce a Type II 
spectrum. which has a maximum absorbance at 425-435nm and a minimum 
absorbance between 390-400nm. The rather broad range of maximum 
absorbance may be due to a contribution of a small increment of a type I 
difference spectrum elicited by certain type II compounds e. g. aniline 
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(Schenkman et al., 1972 & 1981). A binding spectrum with its maximum 
absorbance more narrowly defined at 418-420nm, referred to as "reverse Type 
I" difference spectrum (Schenkman et al., 1972, Kumaki et al.. 1978), is 
qualitatively the near mirror image of the Type I spectrum. 
The ferric form of P450 haem has five electrons in the d-orbital. Depending on 
the pairing of these electrons, P450 exists in either high-spin (five unpaired 
electrons, S=5/2) or low-spin (one unpaired electron, S=1/2) configuration. It is 
thought that high spin-P450 is penta-coordinated and low spin-P450 is hexa- 
coordinated. ESR studies have suggested that the Type I spectrum is generated 
when LS-P450 is converted to HS-P450. The Type II difference spectrum is a 
complex mixture of absorbance changes that involve the N atom in the haem of 
the P450 (Katagiri et al. 1968, Peterson, 1971; Waterman et al 1973. 
Schenkman et al 1981). 
A variety of difference spectra are generated when perturbations of P450 are 
produced by Types 1, II or reverse Type I compounds (Remmer et al., 1966, 
Imai & Sato 1966, Schenkman et al., 1967,1972, Kumaki et al 1978) by carbon 
monoxide (Omura & Sato, 1964) or ethyl isocyanide (Imai & Sato, 1966 [2]), 
by changing temperature (Cinti et al 1979) or by using linoleic acid 
hydroperoxide (LAHP) to bleach P450 (Nerland et al., 1981). With the 
exception of the difference spectrum produced when microsomes are bleached 
with LAHP, these spectra do not resemble the "absolute" spectra observed with 
purified, soluble P450, rather, the method is in contrast to others described as it 
applies exclusively to membrane bound P450s. Visualisation of the spectra 
obtained with LAHP is possible because, at certain concentrations I, AHP 
bleaches P450 but spares cytochrome b5, the only other haemoprotein present 
in carefully prepared microsomes (Nerland et al., 1981). This procedure allows 
visualisation of a number of membrane-bound forms of P450; reduced, reduced 
and complexed with CO, oxidised, and oxidised and complexed with 
compounds that produce Types I, II and reverse Type I difference spectra 
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(Nerland et al., 1981). These spectra closely resemble the "absolute" spectra 
observed with solubilised, purified P450. 
The LHAP method can be used to determine the relative amounts of high spin- 
and low spin-P450 bound in rat hepatic microsomes with and without the 
addition of Type I compounds. Advantage is taken of the temperature 
dependency of the spin state of P450 (Cinti et al., 1979) to determine the 
overall enthalpic and entropic changes for the spin equilibrium to generate 
computer-derived spectra of high spin (HS)- and low spin (LS)-form P450. and 
to construct a nomogram that allows direct estimation of the percentages of HS 
and LS forms of P450 at temperatures compatible with biochemical functions. 
The extent to which theoretical models can be examined is limited here, in 
respect of the fact that the most up to date methodologies for kinetic analysis 
were not available. However, the work does allow for appreciation of the fact 
that many avenues are left open for development of this work. The models 
presented here could form the basis of mechanistic investigation of this P450 
with more advanced techniques than spectrophotometric analysis. For example, 
Electron Paramagnetic Resonance (EPR) spectroscopy as used in the 
determination of single turnover kinetics of putidaredoxin (Brewer & Peterson, 
1988) and more recently 'designed' probes were used to detect the presence of 
human P450 of CYP2D6 in poor metabolising individuals of MDMA (Ecstasy). 
Michaelis-Menten kinetics were obtained for demethylenation to show that the 
absence of a low Km component for demethylenation by liver microsomes 
meant a lack of CYP2D6 (Kreth et al., 2000). 
The data presented in this chapter provide a basis for further work. Table 5.1 
shows the kinetic parameters for the reactions considered 
in this work. In 
particular the measure of enzymatic efficiency by Kcal/K, n, shows 
ho« much 
more efficient the secondary hydroxylation of progesterone 
is in the presence of 
the roseoredoxin phenomenon compared to in its absence. 
This aspect of the 
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work is considered in detail in chapter 7. Kcat/Km of 1.53 x 10' sec-' M"' for the 
overall bioconversion of progesterone to 2ß, 16a dihydroxyprogesterone (model 
1), is many times less efficient than the theoretical maximum efficiency. which 
would give an order of magnitude of 108 for K. c,, t/Krr, where this value is 
approaching the diffusion controlled association rate. The rate-limiting step 
was not determined here. 
As outlined above the problems of obtaining accurate human P450 kinetic 
models for drug design are widely reported and arise from making in vitro/in 
vivo comparisons. Models are valid but only when unique adjustments are 
accounted for in any model by the use of appropriate validation techniques, 
such as dose response studies (Yu et al., 1996). This year, in fact, the P450 
mentioned above in the first section of this discussion (5.5.1), from CYP3A4, 
has been predicted to be involved in the drug interaction between triazolam (a 
psychotropic drug) and erythromycin (an antibiotic drug). Prediction by the 
pharmacokinetic model of a mechanism based inhibition of CYP3A4 was 
successfully borne out in vivo as a result of in vitro examination of each drug's 




Reconstitution of the 213,16a 
Progesterone Hydroxylase 
Cytochrome P450 System from 
Streptomyces roseochromogenes 
6.1 INTRODUCTION 
In chapter 4, it was shown that a factor or factors in the initial eluate of the 
first stage of P450 purification, was responsible for the restoration of 
NADH-dependent catalytic competence to the S. roseochromogenes 
progesterone 2ß, 16a hydroxylase P450. Only this fraction was capable of 
restoring the self supported hydroxylation of progesterone. 
The genus Streptomyces is a rich source of cytochrome P450 
monooxygenase enzymes that are involved in a wide variety of biosynthetic 
and xenobiotic transformation reactions. In Streptomyces antibioticus, this 
enzyme is responsible for C-8 epoxidation of the lactone ring of the 
antibiotic oleandomycin (Rodriguez, et al., 1995). The DNA sequence of 
the S. antibioticus P450 is related to the eryF gene of S. erythraea 
(Saccharopolyspora erythraea) which codes for a soluble cytochrome P450 
(CYP 107) that stereospecifically 6-hydroxylates 6-deoxyerythronolide B to 
erythronolide B during erythromycin A biosynthesis (Shafiee & Hutchinson, 
1987). In S. carbophilus P450sca hydroxylates compactin to pravastatin, a 
tissue-selective inhibitor of 3-hydroxy-3-methylglutamyl-coenzyme A 
reductase (Matsuoka, et al., 1989). The sulphonyl urea herbicide 
chlorimuron ethyl is metabolised by two inducible S. griseolus P450s, 
P450SUI (CYP105A1) and P450SU2 (CYP105B1) (O'Keefe, et al., 1988). 
S. griseus contains a cytochrome P450 that is inducible by the isoflavenoid 
genistein present in soyaflour (Sariaslani & Kurtz, 1988). Extracts of this 
organism, prepared from soya flour-induced cells, and supplemented with 
spinach ferredoxin and ferredoxin-NADPH reductase are capable of 
aromatic benzylic, and alicyclic hydroxylation (Trower, et al., 1988). The 
ChoP gene of Streptomyces sp. SA-COO encodes a cholesterol oxidase 
cytochrome P450 that has a high degree of homology with human and 
Pseudomonas P450s (Horii. et al., 1989). 
Steroid hydroxylation by Streptomyces has been reported. C2 and C4 
hydroxylation of the phenolic steroid oestradiol is known to be P450 
catalysed (Trower, et al.. 1988). Skeletal sites transformed in non-phenolic 
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steroids include ", 1,2ß, 6ß, 7ß. 9a 11 a, 11 ß, 15a and 16a [for examples 
see Collingsworth et al. (1952), Fried (1956). Herzog et al. (1957). McAleer 
et al. (1958), Nazaki et al. (1965), Shirasaka & Tsuruta (1960), Smith et al. 
(1961), Vondrova & Capek (1963)]. Unlike in the oestradiol bioconversion 
the nature of these other steroid hydroxylases is unknown. 1-lowever, by 
analogy with steroid hydroxylation in the bacterial species Bacillus cercus 
(Wilson, et al., 1966) and B. megaterium (Berg, et al.. 1976), a reasonable 
assumption is that these hydroxylases are site-selective cytochrome P450 
monooxygenases; see chapter 4. 
In chapter 3 16a-monohydroxy and 2ß, 16a-dihydroxyprogesterone, were 
identified as the transformation metabolites produced by S. 
roseochromogenes during a 72 h incubation with exogenous progesterone. 
Also reported, in chapter 4, was the purification to homogeneity of the 
cytochrome P450 responsible for in vitro progesterone 2ß, 16a 
hydroxylation. The purification of the two endogenous electron transfer 
proteins, roseoredoxin and roseoredoxin reductase required to confer 
catalytic competence on progesterone 2ß, 16a hydroxylase P450, are 
discussed in this chapter. 
6.2 MATERIALS 
Materials were essentially as described in chapter 4. 
6.3 METHODS 
6.3.1 Development of the Cytochrome c Assay for Electron Transfer 
Determination. 
In order to conserve stock P450 and to obtain 'same-day' results on the 
transfer of reducing power from the electron transfer factor/s present in the 
DEAE 52 column wash; this assay was developed, in which cytochrome c 
replaced the P450 component of the assay described in chapter 4. l , lectron 
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transfer was observed from the factor/s in the DEAF 52 eluate. to 
cytochrome c rather than observing this transfer to P450 by the 
transformation of progesterone. Instead of the Na104 supported 
transformation of progesterone (as described in chapter 4). for the assay of 
P450 activity; this assay detects transfer of electrons from NADH. the 
natural electron donor, to cytochrome c. 
In the assay to be described in this chapter, changes to the 'background' 
transfer of electrons by the addition of different cellular fractions was used 
as a measure of the presence or absence of S. roseochromogenes electron 
transfer proteins. 
The advantages of developing a cytochrome c assay for the purification of 
the electron transfer factor/s from the DEAE 52 initial eluate, rather than 
using the purified P450 component of the hydroxylase system, are given in 
Table 6a. 
Factors to be 
considered -* Analysis Time Availability Expense 
Assay I 
Results are Several hours This P450 is not Expensive in 
1. Using analysed by for assay and overexpressed and time and the 
purified P450 
TLC post extraction is taken from the cost of 
steroidal followed by purification purification 
extraction running and protocol described materials 
from the assay drying of TLC in chapter 3, thus 
mixture plates not very available 
Results Many assays Commercially Less processing 
2. Using instantly may be available in large to obtain results 
Cytochrome c 
observable as repeated in quantities therefore less 
C an increase in one day expense. yt. c 
Assn with is comparatively 
reduction of inexpensive 
cyt. C. 
Table 6a. Table illustrating the advantages gained through development of this 
cytochrome c assay for the observation of electron transfer from 
roseoredoxin and roseoredoxin reductase. 
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6.3.2 Purification of Electron Transfer Proteins from S. 
roseochromogenes. 
The roseoredoxin reductase (ferredoxin reductase) was purified from the 
flow-through wash of the DE-52 DEAF-cellulose column obtained in the 
first stage of P450 purification. This fraction was directly loaded onto a 
Whatman DE-32 DEAE-cellulose column and eluted with a linear 0-300 
mM NaC1 gradient made up in buffer B and 10% glycerol. Fractions (5 ml) 
were collected and assayed for cytochrome c reductase activity at 550 nm 
and for NADH oxidation at 340 nm. Also, the spectrum of each fraction was 
recorded from 260 to 460 nm and compared to that of a standard of 
authentic FAD. 
Fractions which reduced cytochrome c, oxidised NADH, and contained 
FAD, were pooled and dialysed for 8h against buffer B before loading on to 
a Cibacron Blue FG3A column and eluted with a linear 0-200 mM NaCl 
gradient in buffer B. Fractions (2.0 ml) were collected and assayed as 
described above. Active fractions that contained roseoredoxin reductase 
were pooled, dialysed against buffer B+ 20% glycerol (buffer C), and 
stored at - 70 °C. 
The roseoredoxin reductase DE-32 cellulose column fractions obtained 
above were used to purify roseoredoxin (ferredoxin), the second electron 
transfer protein in the S. roseochromogenes progesterone 2ß, 16a 
hydroxylase cytochrome P450 pathway. Roseoredoxin activity was assayed 
by measuring the rate of cytochrome c reduction in the presence of NADH 
and purified roseoredoxin reductase (Cibacron Blue fraction). The 
stimulation of the basal rate of electron transfer, from roseoredoxin 
reductase directly to cytochrome c, was used to measure roseoredoxin 
activity. Active fractions were pooled and dialysed as described above and 
then applied to an NAD-Sepharose affinity column. Proteins were eluted 
with a linear 0-100 mM KCI gradient in buffer B. KCI buffers were required 
due to loss of electron transfer activity in NaCl. Fractions were assayed for 
cytochrome c reductase activity as described above and the absorbance of 
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these fractions was measured at 280 and 414nm. Active fractions containing 
the highest A414/A280 ratios were pooled, dialysed against buffer C and 
stored at -70°C. 
6.3.3 Measurement of S. roseochromogenes Roseoredoxin and 
Roseoredoxin Reductase Activity 
Roseoredoxin activity was measured in a final volume of 1 ml containing 
100 mM Na phosphate, 5.2 mM MgCl 2 
buffer pH 7.2,0.05 mM cytochrome 
c, 0.05 units roseoredoxin reductase and 0.2 mM NADH. (1 unit of 
roseoredoxin reductase is the amount of protein required to reduce 0.5 µmol 
of cytochrome c per min in the presence of excess roseoredoxin). The rate of 
cytochrome c reduction was measured at 550 nm against a control 
incubation without NADH. Cytochrome c reduction was measured to 
completion of the reaction at 25°C. The absolute amount reduced was 
calculated by measuring the absorbance difference between the test and 
control incubations at 550 nm. An absorbance coefficient of 29.9 MM-' cm -I 
was used to calculate reduced cytochrome c and 8.9 mM"' cm' for oxidised 
cytochrome c. 
Roseoredoxin reductase activity was measured as described above except 
that roseoredoxin was omitted from the incubations. 
6.3.4 Cytochrome P450 Dependent Progesterone Hydroxylation: 
Natural NADH Dependent Verses NaI04 Supported Reactions 
The progesterone 2ß, 16a-hydroxylase activity of purification fractions was 
determined using the NaIO4 method, in the absence of natural electron 
transfer proteins (Goodman & Smith, 1961). Progesterone (4 mM) and 
Na104 (1.5 mM) were added to 0.5 ml of fraction contained in metal capped 
Bijou bottles. Mixtures were made up to 1 nil with buffer B. Bottles were 
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fixed to a turn-table that was vertically rotated at 40 rpm for 2h at 25°C. 
Steroid metabolites were extracted from the incubations by shaking the 
mixtures with chloroform (1 ml) for 1 min. The chloroform layer was 
removed and evaporated at 60°C. The residue was dissolved in methanol (10 
µl) and spotted onto TLC plates. These were run and processed as described 
above. 
In the natural reconstituted system where, 1.5 mM Na104 was replaced by 2 
mM NADH, along with 0.3 p. M purified progesterone 2ß, 16a-hydroxylase 
cytochrome P450,0.05 U roseoredoxin and 0.1 U roseoredoxin reductase, 
hydroxylation was absolutely specific for NADH. NADPH did not 
substitute at any concentration tested. The NADH optimum for 
hydroxylation in these assays was 2 mM. 
Steroid metabolites synthesised in the above incubations were identified 
only by TLC because the tiny quantities of compound produced precluded 
structural determination by full chemical methods or by NMR. The TLC 
spots obtained co-chromatographed with spots of the authentic 16a 
monohydroxy- and 2ß, 16a dihydroxyprogesterone produced by intact S. 
roseochromogenes, even when the constituents of the solvent system were 
varied. 
6.3.5 Detection and Stoichiometry of the Flavin Prosthetic Group 
Fractions from the purification of roseoredoxin reductase, were examined 
for their FAD content. Only fractions which contained FAD were pooled 
prior to dialysis. 
FAD was detected post dissociation from its protein, although in the first 
instance, samples were selected by their typical flavin spectra (200-600nm) 
where peaks at 272 nm, 374 nm and 446 nm were observed as shown in 
Figure 6.4.2a. 
For the dissociation of FAD from protein, samples were boiled for 4 min in 
0.1 NI phosphate buffer. pH 7.2. The samples were cooled prior to 
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centrifugation in Centricon® concentrator tubes (Centricon- 10) at 10000 
rpm for 10 min. TLC was performed on the supernatant with 2% w/v 
Na2HPO4 in water, as solvent (Fazekas & Sandor, 1971). Flavin presence 
was detected as a yellow fluorescence when observed under u. v. light at 364 
nm. Protein concentrations were determined as described in chapter 2 in 
order to determine the FAD/protein stoichiometry for purified samples. 
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6.4 RESULTS 
6.4.1 The Detection of Reducing Power in S. roseochromogenes Cell - 
Free Extracts, Utilising the Cytochrome c Assay 
The spectra in Figure 6.4.1 a. show the changes induced in the cytochrome c 
spectra by roseoredoxin and roseoredoxin reductase. Different cellular 
fractions were added to the cytochrome c assay described during the 
purification of the electron transfer proteins for the purpose of locating them 
resulting in the assay containing purified roseoredoxin and roseoredoxin 
reductase. 
-- _- =1----'_-- -= Wavelength /nm 
1- --_l A 
1 4=T 
- --ýý- ý 
B=-- 1 550 
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10-3 -- 1.5 =: -=- -0- =-Y-. - 
Figure 6.4.1a Cytochrome c reduction profile, absorbance v wavelength, showing 
increasing absorbance at 550 nm with increasing reduction by S. roseochromogenes 
roseoredoxin and roseoredoxin reductase. 0.5pmol cytochrome c was present with 1.1 units 
of roseoredoxin reductase and excess roseoredoxin. The reaction was initiated by the 
addition of NADH to 0.2mM. The final volume was 1.0 ml. Where A= spectrum 30s 
post NADH addition and B= spectrum I min post NADH addition. 
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Roseoredoxin reductase activity was measured as described above except that 
roseoredoxin was omitted from the incubations. 
Curve B in Figure 6.4-l a represents 1.0 unit of cytochrome c reductase 
activity. 
Roseoredoxin within the cytochrome c assays accounted for a 'leakage 
reduction rate of 0.1 units of cytochrome c reductase activity which had to 
be subtracted from final rates of reduction. This leakage is illustrated in 
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Figure 6.4.1 b Cytochrome c reduction attributed to roseoredoxin in the absence of 
roseoredoxin reductase. This represents a leakage rate of 0.1 units of reductase activity. 
0.5pmol cytochrome c was present with excess roseoredoxin. The reaction was initiated by 
the addition of NADH to 0.2mM. The final volume was 1.0 ml. 
Figure 6.4. lb represents the maximum amount of electron transfer 
attributable to roseoredoxin. When cytochrome c was then replaced by S. 
roseochromogenes' cytochrome P450 and the components of the assay 
retained i. e. those illustrated in Figure 6.4.4a., progesterone hydroxylase 










Time / min 
Figure 6.4.1c. HPLC trace of 6.0 h progesterone transformation incubation by 
reconstituted S. roseochromogenes' cytochrome P450 multicomponent hydroxylase system. 
Peak 1,20,16a-dihydroxyprogesterone (retention time 20 min); Peak 2,16a-mono- 
hydroxyprogesterone (retention time 40 min) 
The product ratios were compared to those obtained for the sodium 
periodate mediated progesterone P450 hydroxylation described in methods 
section 6.3.4. Although the initial rates of hydroxylation were found to be 
different, the turnover numbers were vastly different as shown in Table 
6.4.1 a. 
Pathway Initial rate of progesterone 
transformation 
(mmol progesterone /mmol P450/h) 
Turnover 






Table 6.4. Ia. Comparison of progesterone metabolism catalysed by the reconstituted 
natural cytochrome P450 dependent hydroxylation pathway and the 
Nal04 dependent pathway. 
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Figure 6.4.2a Absorbance spectrum (200-600 nm) of FAD dissociated from 
roseoredoxin reductase. 
As discussed in section 6.3.5, such spectra as shown in Figure 6.4.2a were 
used to identify FAD during roseoredoxin reductase purification. U. V. 
visible analysis also revealed that the flavin and the flavoprotein gave the 
typical flavoprotein spectrum in the 350-500 nm range with peaks at 374 nm 
and 446 nm, with a trough at 400 nm. 
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6.4.3 TLC Analysis to Reveal the Nature of the Electron Transfer 
Protein's Prosthetic Group 
TLC analysis revealed by a yellow fluorescent spot, that the flavin from 
roseoredoxin reductase, co-migrated with standard authentic FAD. A 





Figure 6.4.3a Photograph of a chromatogram visualised under uv light. Migration was 
from left to right. Lane 1- standard authentic FAD, Lanes 2&3 are 
samples of the roseoredoxin reductase FAD, illustrating co-migration. 
6.4.4 Purification of the Progesterone 2ß, 16a-Hydroxylase 
Cytochrome P450 Electron Transfer Proteins Roseoredoxin 
Reductase and Roseoredoxin from S. roseochromogenes 
The DE-52 DEAE-cellulose column flow-through and wash, obtained from 
the first stage of P450 purification, as described in section 4.9.3., was used 
as starting material for the purification of the electron transfer proteins 
roseoredoxin reductase and roseoredoxin. A two step procedure was used to 
purify to homogeneity both proteins. The data for these methods are shown 
in Tables 6.4.4a. (roseoredoxin reductase) and 6.4.4b. (roseoredoxin) 
respectively. 
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In the case of roseoredoxin reductase, a second DEAE column, containing 
DE32 cellulose, followed by dye affinity chromatography on Cibacron Blue 
FG3A resulted in a 258 fold purification of this particular protein. 
Roseoredoxin co-eluted with the roseoredoxin reductase in the DE32 300 
mM NaCI fraction, but was separated from the latter protein by NAD- 
Sepharose affinity chromatography to give a final 163 fold purification. 
Both proteins gave single bands by SDS-PAGE. M, values of 14 x 103 and 
65 x 103 were determined from the SDS-PAGE gels for roseoredoxin and 






A*Wft -, 4* 401w 
NOW t-. 'All- 
Figure 6.4.4a SDS-polyacrylamide gel of purified S. roseochromogenes 2ß, 16a 
hydroxylase cytochrome P450, roseoredoxin and roseoredoxin reductase. 
Lane 1, roseoredoxin reductase (3.1 µg Mr 65 xl 03); lane 2, roseoredoxin (2.8 µg 
Mr 14 x 103); lane 3, progesterone 2ß. 16a-hydroxylase cytochrome P450 (4 µg Mr 
63 x 103); lane 4. wide range protein size ladder Mr 205 x 103 -14.2 x 103; lane 5, lower ranger protein size ladder M, 66 x 103 -14.2 x 103; and lane 5, upper ranger 
protein size ladder Mr 45 x l0i -14.2 x 10;. Lanes 4-6 contained 35 µg protein. 
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Table 6.4.4a. Purification of S. roseochromogenes roseoredoxin reductase 
Purification Total Total Yield Recovery Purification 
Stage Protein Roseoredoxin roseoredoxin Roseoredoxin factor 
reductase reductase Reductase (mg) 
(nmol) (nmoUmg (%) 
protein) 
S 15 Extract 1050 32 0.03 100 1 
DEAE52 800 30.5 0.04 95.31 1.3 
Column 
Flow-through 
DE 32 0-300 6.84 19.96 2.92 62.38 97.3 
mM NaCl 
Fraction 
Dialysis 6.84 18.44 2.70 57.63 90 




Dialysis 1.88 13.03 6.93 40.72 231 
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Table 6.4.4b. Purification of S. roseochromogenes roseoredoxin 
Purification Total Total Yield Recovery Purification 
factor 




S15 extract 1050 51 0.05 100 1 








Dialysis 6.84 17.77 2.60 34.80 52 












Streptomyces roseochromogenes, contains a cytochrome P450 (chapter 4) 
which. in conjunction with two indigenous electron transfer proteins. 
roseoredoxin and roseoredoxin reductase, hydroxylates exogenous 
progesterone firstly to 16a-hydroxyprogesterone and thereafter in a second 
phase bioconversion to 20,16a-dihydroxyprogesterone. The progesterone 
2ß, 16(x-hydroxylase P450 and the two electron transfer proteins have been 
purified to homogeneity. In this purification process, a cytochrome c assay 
was developed, for two major reasons ; 1) in order to conserve valuable 
stock purified cytochrome P450 and 2), for ease of detection of electron 
transfer activity. A fully reconstituted assay would be very time consuming 
because it would require time for steroid hydroxylation, significant time for 
steroid extraction and finally, a relatively long HPLC analysis for each 
metabolite assay. By contrast the spectrophotometric cytochrome c assay is 
rapid and can be used to analyse multiple incubations. 
Following this, the natural reconstituted incubation containing the three 
purified proteins (roseoredoxin reductase, roseoredoxin and cytochrome 
P450) and NADH, the natural electron donor, produced identical hydroxy- 
progesterone metabolites as produced by intact cells. 
Comparison of Progesterone Metabolism Catalysed by a Reconstituted 
Natural Cytochrome P450 Dependent Hydroxylation Pathway and an 
NaIO4 Dependent Peroxide Shunt Pathway 
The roscoredoxin, roseoredoxin reductase and NADH requirement in the 
natural progesterone 2ß, 16a hydroxylase cytochrome P450 hydroxylation 
pathway was replaceable by NaI04. Peroxy and hydroperoxy compounds 
(XOOH) act in a shortened form of the catalytic cycle known as the 
"peroxide shunt" by replacing the requirement for NADH, the electron 
transfer proteins and molecular 02, the terminal electron acceptor in the 
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natural pathway. When these two pathways were compared for 
progesterone transformation catalysed by highly purified S. 
roseochromogenes progesterone 2ß, 16a hydroxylase cytochrome P450 , 
it 
was found that the initial rate of hydroxylation was nearly 40% greater in 
the Na104 peroxide shunt pathway (1.62 mmol progesterone 
converted/mmol P450/h) than in the natural reconstituted pathway (1.18 
mmol progesterone converted/mmol P450/h). By contrast, the peroxide 
shunt pathway supported 13 fold fewer hydroxylation events per molecule 
of P450 (0.45 mol progesterone converted/mol P450) than the reconstituted 
pathway (6.0 mol progesterone converted/mol P450) (Table 6.4.1a. ). These 
yield data show that in the reconstituted natural pathway, progesterone 
2ß, 16a hydroxylase P450 supports multiple rounds of hydroxylation in 
contrast to a likely single round by a minority of P450s in the peroxide shunt 
pathway (Berrie et al., 1999). 
Examination of the Reconstitution of P450 Catalysis 
Development of assays such as the natural reconstitution assay described in 
this chapter are important in terms of cloning strategies for cytochromes 
P450. Since P450s are multicomponent there is a need for them to be co- 
expressed with their electron transfer proteins in host vectors or for the P450 
to become catalytically competent in combination with the hosts own 
reductase proteins. Alternatively, overexpressed P450 may be purified and 
detected by its addition to reconstitution assays as described in this chapter. 
An example of integration with host proteins upon reconstitution is in the 
case of cytochrome P450 NF a eukaryotic P450 expressed in eukaryotic host 
(a yeast). Cytochrome P450 NF, a member of the P450 IIIA subfamily, is 
the major contributor to the oxidation of the calcium-channel blocker, 
nifedipine in human liver microsomes. This drug is used in the treatment of 
hypertension. NF25 cDNA was expressed in Saccharomti cc. s cerevisiae 
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using an expression vector. The yeast endogenous NADPH-cytochrome 
P450 reductase coupled efficiently with the heterologous P450 NF25 though 
its concentration was far lower than that of its analogue in human liver. 
Addition of rabbit liver NADPH-cytochrome P450 reductase increased the 
oxidation rates. Rabbit liver cytochrome b5 also caused an enhancement of 
catalytic activity of this particular P450 in a reconstituted system involving 
the protein purified from human liver. Furthermore, the level of the yeast 
endogenous cytochrome P450 (lanosterol 14a-demethylase) was found to 
be negligible compared to the heterologously expressed cytochrome P450 
(30 times less). Therefore yeast microsomes containing P450 NF25 
constitute a good functional model for studying the binding capacities and 
catalytic activities of this form of human hepatic cytochrome P450 (Renaud 
et al., 1990). 
Yeast P450s are also expressed in other yeast expression vectors such as the 
two P450s : P450 52A3 (P450Cm1) and 52A4 (P450Cm2), from the fungus 
C'andida maltosa. Both the P450 proteins and the corresponding C. maltosa 
NADPH-cytochrome P450 reductase were separately produced by 
expressing their cDNAs in Saccharomyces cerevisiae. This reconstituted 
both active monooxygenase systems (Scheller et al., 1996). This is an 
example of the expressed P450s being co-expressed along with their own 
reductase gene rather than utilising the host reductase. For this purpose, a 
multicopy plasmid was constructed that contained two independent 
expression units controlled by the galactose-inducible GAL10 promoter 
(Zimmer et al., 1995). 
The multicomponent co-translation of P450 systems is exemplified by the 
catalytically self sufficient 118 kDa, fatty acid oxygenase P450 from 
Bacillus megaterium. Even though the enzyme system is an exception to 
other P450s by being self sufficient its domains are nevertheless co- 
translated, each requiring the others for catalytic competence, just as in 
other P450s. A 4-base pair sequence (AAAG) is found to have a regulatory 
role in the expression of the BM-1 gene in B. megaterium. This sequence is 
found in all eukaryotic and prokaryotic systems which contain barbiturate 
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inducible proteins and is known as a Barbie box. This sequence would 
therefore necessarily need to be included or mutated to enable constitutive 
expression of this P450. 
The above examples are of co-expression to restore catalytic competence to 
a P450, where reductase elements and regulatory factors are expressed with 
the P450 itself, thereby negating the need for a separate assay to establish 
the success of P450 cloning. Purification and characterisation of NADPH- 
cytochrome P450 reductase from the filamentous fungus Rhizopus nigricans 
was observed initially by its cytochrome c reductase activity, rather than 
utilising valuable purified P450 and observing 1la steroid hydroxylation 
(Makovec & Breskvar 1998). This meant the development of a cytochrome 
c assay such as the assay described in this chapter. Purified reductase 
contained approximately equimolar quantities of flavin adenine dinucleotide 
(FAD) and flavin mononucleotide (FMN) per mole of the enzyme as would 
be expected from such a eukaryotic P450 reductase. Not all cytochrome c 
(P450) reductase proteins transfer electrons to all P450s. Therefore there is a 
theoretical danger from obtaining false negative results of successful P450 
expression. For example, the reductase in this example, from R. nigricans, 
was unable to replace the adrenodoxin reductase from the 11$3 steroid 
hydroxylase P450 from adrenal mitochondria (Makovec & Breskvar 1998). 
As mentioned above, the 14a demethylation reaction in the biosynthesis of 
fungal sterols is important and the subject of many studies; Ustilago maydis 
(Lamb et al., 1998) and the grass, Sorghum bicolor (Bak et al., 1997) as is the 
benzopyrene hydroxylase system from Pleurotus pulmonarius (Maspahy et 
al., 1999). However, the P450 system from Candida albicans, was used in 
the generation of a soluble and catalytically active sterol 14ademethylase 
reductase complex. The associated NADPH dependent reductase is also 
bound to the endoplasmic reticulum. A diglycine linker recognition site was 
used to remove the hydrophobic N terminal membrane anchor of 33 amino 
acids. Reconstitution of the soluble enzyme with yeast reductase and 
treatment with the suitable protease for the diglycine linker, resulted in a 
functional, soluble eukaryotic P450 14DM system. The purpose of this 
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reconstitution was to show that the membrane anchor serves to localise 
P450 14DM to the endoplasmic reticulum where the substrate is located but 
that the anchor is not essential in demethylase activity (Lamb et al.. 1999 
[2]). Also a genetically engineered fused enzyme between rat cytochrome 
P4501A1 and yeast NADPH-P450 reductase was created by the formation 
of three expression plasmids, pAMC1 for rat P4501 A 1, pAMR2 for 
P4501A1 and yeast NADPH-P450 reductase. pAFCRI was for a fused 
enzyme between P4501 Al and the reductase. After construction each was 
introduced into Saccharomyces cerevisiae AH22 cells for the purpose of 
comparing kinetic parameters of the zoxazolamine 6-hydroxylase reaction 
by the fused enzyme and reconstituted assay reactions. By dual-wavelength 
stopped-flow spectrophotometry, it was found that electrons were rapidly 
transferred from NADPH through FAD and FMN to the heme iron of the 
fused enzyme (Sakaki et al., 1994). 
A third type of 'artificial' P450 has been created where FAD or 1~ MN were 
covalently bound to cytochrome P450 2B4. The most catalytically active 
was the conjugate of cytochrome P450 with FMN. This artificial single 
protein hydroxylase was able to initiate the demethylation of 
dimethylaniline and aminopyrine. It also initiated the p-hydroxylation of 
aniline. The conjugate of cytochrome P450 2B4 with FAD oxidised these 
substrates at a much slower rate (Uvarov et al., 1994). 
Most characterised P450 systems are eukaryotic. The most obvious physical 
difference between prokaryotic and eukaryotic systems is solubility. 
Bacterial P450s are soluble whereas the microsomal and mitochondrial 
11450s are membrane-associated proteins. In bacteria the three-component 
arrangement is most common but two component systems have been 
identified but are very rare. For example, in contrast to Streptomyces 
ro. sc'ochromogc'nes, P450 from Streptomyces carbophilus catalyses the 
hydroxylation of mevastatin to pravastatin as a two rather than three 
component P450 monooxygenase. The NADH-cytochrome P450 reductase 
was purified from S. carbophilus as a single polypeptide with a molecular 
weight of 51 kDa. This alone reconstituted the in vitro hydroxylation with 
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cytochrome P450, NADH and 02. This protein contained an FAD and FMN 
molecule. The FMN molecule was easily dissociated from the reductase 
(Serizawa & Matsuoka 1991). In contrast, P450, am putidaredoxin reductase 
contains only FAD and is specific for NADH and the P450meg megaredoxin 
reductase as discussed above in terms of reconstitution, contains only FMN 
and is specific for NADPH. The catalytically self-sufficient P450BM-3 is 
currently the only single-component P450-dependent monooxygenase 
known, other than those manufactured (for example, Lamb et al., 1999 [2] 
and Sakaki et al., 1994). It is a paradox that P450BM-3 is structurally more 
analogous to the P450 systems of liver microsomes than to bacterial P450 
monooxygenases. Another difference between prokaryotic and eukaryotic 
P450s is function. Most known bacterial P450-dependent systems initiate 
the oxidation of recalcitrant carbon compounds so that the hosts can utilise 
them as sole carbon sources for growth (Fulco, 1991). Eukaryotic P450s are 
more associated with the removal of xenobiotics and biosynthesis. 
P450cam, described above is an exception to the prokaryotic P450s. In terms 
of other, prokaryotic P450 systems; ferredoxin electron transfer proteins 
have also been purified from Streptomyces griseolus which was found to 
contain two 7 kDa isoforms, designated Fd-1 and Fd-2. These proteins have 
52% identity and both contain single [3Fe-4S] clusters (O'Keefe et al., 
1991). Both ferredoxins are active in reconstituted cell-free systems 
containing the SUI P450 isoform, although Fd-2 is more effective. The 
genes for the ferredoxins and the sulfonylurea P450 monooxygenases are 
virtually contiguous. Thus P450SUI and the downstream Fd-1 form a 
closed spaced pair, similarly P450SU2 and Fd-2. In Streptomyces griseus 
only a single ferredoxin encoded by SOY B has been putatively identified. 
The situation in S. roseochromogenes remains to be resolved. 
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Chapter 7 
Preincubation of Streptomyces 
roseochromogenes with 
Progesterone, Induces a Post 
Translational Modification in the 
Electron Transfer Protein, 
Roseoredoxin 
The Roseoredoxin Phenomenon 
7.1 INTRODUCTION 
There is now a wealth of compelling evidence identifying cytochrome P450 as 
responsible for steroid hydroxylation reactions in both bacteria and filamentous 
fungi e. g. in bacteria - 60 in Bacillus thermoglucosidasius (Sideso et al., 1998) 
and 15ß in Bacillus megaterium (Berg et al., 1976): in filamentous fungi - 7a in 
Phycomyces blakesleeanus (Ahmed et al., 1995); 1 la in Aspergillus fumigatus 
(Smith et al., 1994), Aspergillus ochraceus (Samanta & Ghosh, 1987), Neciria 
haematococca (Ahmed et al., 1996) and Rhizopus nigricans (Breskvar et al., 
1987); 11 ß in Cochliobolus lunatus (Janig et al., 1992); and 15a in Penicillium 
raistrickii (Irrgang et al., 1997). 
Bacterial cytochromes P450 are the terminal proteins in a soluble three 
component system (Type I system) that transfer electrons to acceptor molecular 
dioxygen. P450 catalyses the reductive cleavage of the dioxygen producing 
H2O and an -OH group which is ultimately covalently bonded to enzyme-bound 
substrate by the P450 apoprotein. The stereochemistry of the hydroxylation is 
determined by the particular structural architecture of the catalytic active centre 
of the apoprotein. The electrons that drive the hydroxylation originate from 
NADH passing to P450 via intermediate redox proteins. In Type-I systems 
these proteins are, a low molecular weight ferredoxin-like redoxin that directly 
interacts with the P450 and a larger flavin-containing redoxin reductase that is a 
one electron transducer positioned between NADH and the redoxin. This 
soluble three component system has been identified in the P450SOy system of S. 
griseus (Trower et al., 1992) and in the sulfonylurea herbicide P450 
monooxygenase system in Streptomyces griseolus (O'Keefe et al., 1991) where 
the component proteins have been purified. 
A cytochrome P450 was purified from Streptomyces roseochromogenes strain 
10984 (chapter 4) which catalyses progesterone 16c hydroxylation and a 
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second phase 2ß hydroxylation (Berrie et al., 1999). the basis of this chapter. 
Indeed the subsequent publication is based upon the phenomenon (designated, 
the 'roseoredoxin phenomenon') described in this chapter. 
Two other proteins, a redoxin and a redoxin reductase together with the electron 
donor NADH were absolutely required for these hydroxylations (Berrie et al.. 
1999). Further to the reconstitution in chapter 6; it is shown here that the ratio 
of 16a-monohydroxyprogesterone to 2ß, 16a-dihydroxyprogesterone produced 
in a reconstituted cell-free system, containing all three highly purified protein 
components, depends on the growth history of the S. roseochromogenes and 
that the change in metabolite ratio is manifested by the roseoredoxin rather than 
the roseoredoxin reductase or progesterone 2ß, 16a-hydroxylase cytochrome 
P450. 
7.2 MATERIALS 
Streptomyces roseochromogenes strain 10984 was purchased from the National 
Collection of Industrial and Marine Bacteria (NCIB) Ltd., Aberdeen, Scotland. 
Media and general chemicals were purchased from the sources previously 
described in chapter 2. Cibacron Blue FG3A and NAD-Sepharose affinity gel 
were obtained from Sigma Chemical Co., Poole, Dorset, U. K. 
7.3 METHODS 
7.3.1 Media, Culture Maintenance and Cultivation of Streptomyces 
roseochromogenes 
These were as previously described in chapter 2. 
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7.3.2 Determination of Progesterone Metabolite Yields Produced by 
Streptomyces roseochromogenes 
This was as previously described in chapter 4. 
7.3.3 Purification of Progesterone 2ß, 16a -Hydroxylase Cytoch rome P450 
from Streptomyces roseochromogenes 
This was as previously described in chapter 4. 
7.3.4 In vitro Cytochrome P450 Dependent Progesterone Hydroxylation 
The progesterone 2ß, 16a-hydroxylase activity was determined using 4 mM 
progesterone and 2 mM NADH, 0.3µM progesterone 2ß, 16a-hydroxylase 
cytochrome P450,0.05 units of roseoredoxin and 0.1 unit of roseoredoxin 
reductase made up to 1 ml with 0.1 M Na phosphate, 5 mM EDTA, 0.25mM 
DTT (buffer A) and 10% glycerol in Bijou bottles. Bottles were fixed to a turn- 
table that was vertically rotated at 40 rpm for 2h at 25°C. Steroid metabolites 
were extracted from the incubations by shaking the mixtures with 1 ml 
chloroform for I min. The chloroform layer was removed and evaporated to 
dryness at 60°C. The residue was dissolved in 10 µl methanol and separated on 
HPLC as described in chapter 2. 
7.3.5 Purification of Roseoredoxin & Roseoredoxin Reductase Electron 
Transfer Proteins from Streptomyces roseochromogenes 
A detailed description of the purification of these two proteins is given in 
chapter 6. Fractions which reduced cytochrome c. oxidised NADH and 
contained FAD, were pooled in this protocol for the purification of the two 
electron transfer proteins. 
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7.3.6 Effect of Cell Growth - History on Progesterone Metabolite 
Synthesis in in vitro Reconstituted Incubations 
Cultures of S. roseochromogenes were incubated in the normal way prior to 
harvesting and the purification of the three progesterone hydroxylase cellular 
components, as previously described. Progesterone metabolite synthesis was 
compared between assays comprising the hydroxylase components from cells 
grown in the presence of 0.32 mM progesterone for 8h prior to harvesting and 
assays comprising cellular components from cells grown in the absence of an 8 
h pre-incubation with progesterone. Metabolite yields were determined 
essentially by I-PLC analysis as described in chapter 2. 
7.3.7 Separation of the Two Isoforms of Streptomyces roseochromogenes 
Roseoredoxin 
A qualitative comparison was made between the protein components of the 
hydroxylase system in progesterone pre-incubated and control cells by two 
dimensional polyacrylamide gel electrophoresis. 
Results are shown in Figures 7.4.6a, 7.4.6b and 7.4.6c. 
The roseoredoxin obtained from the NAD-Sepharose affinity purification step 
was separated into two activity fractions on Whatman CM-52 cellulose by 
stepwise elution between 50-100mM KCl and 240-280mM KCI. The isoforms 
co-migrated in 10% SDS-PAGE (Figure 7.4.7a. ). 
7.3.8 Isoelectric Focussing of the Isoforms of Streptomyces 
roseoch romogenes 
An identical two-dimensional gel electrophoresis procedure for analysis of the 
roseoredoxin, was used, as described in the general analytical procedures 
section in chapter 2. 
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7.3.9 Measurement of Streptomyces roseochromogenes Roseoredoxin and 
Roseoredoxin Reductase Activity 
Roseoredoxin activity and roseoredoxin activity were measured according to 
the procedure described in section 6.3.3. 
7.3.10 SDS Polyacrylamide Gel Electrophoresis and Protein 
Concentration Determination 
These were performed as previously described in the general analytical 
procedures section, in chapter 2. 
7.3.11 To determine whether the difference between the two forms of 
roseoredoxin was attributable to a genetic change induced by the 
progesterone in the growth medium ? 
It was deduced that there must be more than one form of the roseoredoxin, as 
shown below in section 7.4. Cells were cultured in the normal way in YMG 
medium, as described previously. To mature cell cultures cycloheximide was 
added to a concentration of 100 µg/ml. Incubation was continued for a further 
8.0 h, after which progesterone was added to a concentration of 0.32 mM. The 
incubation was continued for a further 8.0 h prior to cell harvesting as described 
previously. To a second stationary phase culture, progesterone was added to a 
concentration of 0.32 mM but no cycloheximide was added to this second 
culture. The third culture contained 100 pg/m1 cycloheximide and the fourth 
culture was incubated identically as above but with no additions. 
Table 7.3a summarises these growth conditions. 
ýýý ýýý 
Culture Growth conditions 
I Cycloheximide followed by the addition of progesterone 
2 Progesterone alone 
3 Cycloheximide alone 
4 No progesterone & no cycloheximide 
Table 7.3a. Summary of the growth conditions described. 
Cells were harvested as described previously. From these harvested cells, 
roseoredoxin, roseoredoxin reductase and cytochrome P450, were all purified 
to homogeneity. 
7.3.12 Examination of Reconstitution Assays Comprising the Components 
Purified From Progesterone Pre-incubated and Control Cells 
Reconstituted assays were performed as described in section 7.3.6. Assays 
were terminated after 40.0 min (the optimum incubation time determined in 
chapter 6). The steroidal metabolites were extracted and analysed by HPLC as 
described in chapter 2. Retention times and peak areas were compared. 
Protein composition of reconstitution assays : 
1. Roseoredoxin(a) + Roseoredoxin reductase(a) + P450(a) 
2. Roseoredoxin(a) + Roseoredoxin reductase(a) + P450(p) 
3. Roseoredoxin(a) + Roseoredoxin reductase(p) + P450(p) 
4. Roseoredoxin(a) + Roseoredoxin reductase(p) + P450(a) 
5. Roseoredoxin(p) + Roseoredoxin reductase(p) + P450(p) 
6. Roseoredoxin(p) + Roseoredoxin reductase(p) + P450(a) 
7. Roseoredoxin(p) + Roseoredoxin reductase(a) + P450(p) 
8. Roseoredoxin(p) + Roseoredoxin reductase(a) + P450(a) 
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Where (a) represents component purified from cells grown in the absence of 
progesterone and (p) represents component purified from cells grown in the 
presence of progesterone. The same assays were established where 
components were purified from cells grown in the presence of progesterone but 
where cycloheximide had been added to cultures 8h prior to the addition of 
progesterone. The components were also substituted for counterparts purified 
from cells grown in the presence of cycloheximide but in the absence of 
progesterone. 
7.3.13 Time course of reconstitution assays comprising components 
purified from cells grown in the presence and absence of 
progesterone 
Assays containing all three of the cellular factors (Figures. 7.4.1 b. & 7.4.8. ) 
were run incubated for 40 min. The assays were established as described in 
chapter 6 but each component substituted for its counterpart purified from cells 
pre-incubated with 0.32 mM progesterone. The assay compositions are listed in 





Metabolite Production by Intact S. 
The HPLC trace of the hydroxyprogesterone metabolites produced in a 25 h 
whole cell transformation of progesterone by S. roseochromogenes is shown in 
Figure 7.4.1 a. Two metabolites were identified. The minor peak 1 (retention 
time 14 min) was 2ß, 16a-dihydroxyprogesterone and the major peak 2 
(retention time 27 min) was 16a-monohydroxyprogesterone. Peak 3 is 
untransformed substrate progesterone. The NMR identifying features of these 
compounds have been published, Smith et al. (1989) and Kirk et al. (1990). 
Ketention time, min 
Figure 7.4.1a. HPLC of 25 h progesterone transformation incubation by S. roseochromogenes. 
From left to right, peak 1,16a-dihydroxyprogesterone (retention time 14 min); 
Peak 2,16a-monohydroxyprogesterone (retention time 27 min); Peak 3, 
progesterone (retention time 89 min) 
Ratios of 16a-monohydroxyprogesterone to 2ß, 16a-dihydroxyprogesterone 
produced during this 25 h incubation are given in chapter 6. From 8h onward 
in whole cell biotransformations, 2ß, 16a-dihydroxyprogesterone also 
accumulated. The ratio of 16a-monohydroxyprogesterone to 2ß, 16a- 
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dihydroxyprogesterone gradually declined from an initial value of 61 at 8h to a 
final value of 3.6 from 21 h onward. This change in metabolite ratio reflected 
dihydroxylated metabolite enrichment consequent on second phase 2ß- 
hydroxylation. 
Assay after 40 min. 20,16a-DHP % total l6a-HP % total Ratio of l6a-HP 
transformation products transformation products to 20,16a-DHP 
1 Roseoredoxin(a) + 9.03 90.97 10.1 
Roseoredoxin 
reductase(a) + P450(a) 
2 Roseoredoxin(a) + 8.81 91.19 10.4 
Roseoredoxin 
reductase(a) + P450(p) 
3 Roseoredoxin(a) + 9.65 90.35 9.4 
Roseoredoxi n 
reductase(p) + P450(p) 
4 Roseoredoxin(a) + 8.95 91.05 10.2 
Roseoredoxin 
reductase(p) + P450(a) 
5. Roseoredoxin(p) + 25.97 74.03 2.9 
Roseoredoxin 
reductase(p) + P450(p) 
6 Roseoredoxin(p) + 26.03 73.97 2.8 
Roseoredox in 
reductase(p) + P450(a) 
7 Roseoredoxin(p) + 25.9 74.1 2.9 
Roseoredoxin 
reductase(a) + P450(p) 
8 Roseoredoxin(p) + 26.36 73.64 2.8 
Roseoredoxin 
reductase(a) + P450(a) 
Minor Major 








Figure 7.4.1 b SDS-15% polyacrylamide gel of purified S. roseochromogenes ' r, ( ,- 
hydroxylase cytochrome P-450, roseoredoxin and roseoredoxin reductaý, c 
From left to right, lane 1, roseoredoxin reductase (3.1 µg M, 65 x 103): I', ne 
2, roseoredoxin (2.8 . tg M, 14 x 103); lane 3, progesterone 16a-hydroxylase 
cytochrome P450 (4 µg M, 63 x 103); lane 4, wide range protein size ladder 
Mr 205 x 103 - 14.2 x 103; lane 5, lower range protein size ladder M, 66 x 10' 
- 14.2 x 10'; and lane 6, upper range protein size ladder M, 265 x 10' - 45 
103. Lanes 4-6 contained 35 µg total protein. 
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7.4.2 Hydroxyprogesterone Metabolite Production in Reconstituted 
Progesterone Hydroxylation Cell-Free Systems 
The two progesterone metabolites produced in whole cell transformations were 
also produced in reconstituted cell-free incubations containing highly purified 
progesterone hydroxylase cytochrome P450, roseoredoxin and roseoredoxin 
reductase. When all three proteins were from control i. e. non progesterone pre- 
incubated cells, a value of 10.1 was calculated for the relative synthesis of 16a- 
monohydroxyprogesterone to 2ß, 16a-dihydroxyprogesterone in a 40 min 
incubation (Table 7.4a, line 1). 
7.4.3 Results of Steroidal Metabolite Analysis by HPLC 
Each assay was initiated by the addition of NADH to a concentration of 0.2 
mM in 0.1 M potassium phosphate buffer following addition of progesterone. 
Reaction times were initially varied from 0- 40 min and reactions were 
quenched by the addition of 0.5 ml chloroform. 
Table 7.4a. shows the results of reconstituted cell-free progesterone incubations 
containing purified roseoredoxin, roseoredoxin reductase and cytochrome P450. 
In Table 7.4a., the first column is the assay and the subsequent columns 
describe the HPLC result. The assays are represented thus : 
(a) represents component purified from cells grown in the absence of 
progesterone and (p) represents component purified from cells grown in the 
presence of progesterone. 
Table 7.4a. shows that assays 1,2,3 and 4 produced an approximate product 
ratio of 10 :1 for 16a hydroxyprogesterone to 2ß, 16a dihydroxyprogesterone. 
respectively. Assays 5,6,7 &8 produced an approximate product ratio of 3: 1 
for the same respective metabolites. 
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7.4.4. Effect of an 8h Progesterone Pre-incubation on the Relative 
Synthesis of 16a-Monohydroxyprogesterone and 20,16a- 
Dihydroxyprogesterone in Reconstituted Progesterone Hydroxylase 
Cell-Free Systems 
The growth history of the cells was immaterial to the ultimate relative synthesis 
of the two hydroxylated progesterone metabolites only if the cell-free 
incubations contained either progesterone hydroxylase cytochrome P450 or 
roseoredoxin reductase (or both) from control or 8h progesterone pre-incubated 
cells (Table 7.4a., lines 2,3&4). Thus relative synthesis ratios of 10.35,10.17 
and 9.36 respectively were obtained when the P450 and the roseoredoxin 
reductase originated from progesterone pre-incubated or control cells but only 
the roseoredoxin was from control cells. By contrast the relative synthesis of 
16a-monohydroxyprogesterone to 213,16a-dihyd. roxyprogesterone was 2.79 
when the roseoredoxin originated from progesterone pre-incubated cells but the 
P450 and roseoredoxin reductase were from control or progesterone pre- 
incubated cells. No substantive difference in the product ratio produced (2.85) 
was noted if all the cell-free protein components were derived from 
progesterone pre-incubated S. roseochromogenes (Table 7.4a., line 5). 
Incubation time was not a factor in the roseoredoxin effect. Thus, although the 
absolute amount of both metabolites increased in incubations lasting from 2 to 
40 min, the same metabolite ratios shown in Table 7.4a. were always obtained. 
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7.4.5 Effect of Cycloheximide Pre-Incubation on the Relative Synthesis of 
l6a-Monohydroxyprogesterone and 2ß, 16a-Dihvdroxyprogesterone 
in Reconstituted S. roseochromogenes Progesterone Hydroxylation 
Cell-Free Systems Containing Control and Progesterone Pre- 
Incubated Roseoredoxin 
The data in Table 7.4a. clearly show that the roseoredoxin component of the 
P450 electron transfer chain modulates the relative synthesis of 16a- 
monohydroxyprogesterone and 2ß, 16a-dihydroxyprogesterone. We examined 
whether progesterone pre-incubation induced de novo synthesis of a 
roseoredoxin isoform or whether a post-translational modification of the 
protein had occurred. Gene expression was inhibited in 8h progesterone pre- 
incubated cells by blocking protein synthesis with 0.335 mm cycloheximide, a 
concentration in excess of that required to inhibit totally, cell growth. The 
progesterone hydroxylation profile of the reconstituted cell-free incubations 
containing roseoredoxin purified from these cycloheximide and progesterone 
pre-treated cells (16a-monohydroxyprogesterone to 213,16(x- 
dihydroxyprogesterone ratio 2.8) was identical to the progesterone only pre- 
incubated counterpart (ratio 2.8) contrasting the 10: 1 ratio in the non pre- 
incubated cell-free assays (chapter 4). These results are consistent with post- 
translational modification of the roseoredoxin rather than there being multiple 
roseoredoxin genes. 
7.4.6. Identification of Two Isoforms of S. roseochromogenes 
Roseoredoxin in Progesterone Pre-incubated Cells 
The roseoredoxin from the NAD-Sepharose purification stage from control and 
progesterone pre-incubated cells was analysed by isoelectric focussing (IEF). 
Control, non progesterone pre-incubated cells, contained only the pI 7.45 
roseoredoxin isoform (Figure 7.4.6a). By contrast the pl 5.6 isoform 
predominated in 8h progesterone pre-incubated cells and only a minor pI 7.45 
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band was observed (Figure 7.4.6. b). Interestingly, both isoforms were present 
in approximately equal amounts in 4h progesterone pre-incubated cells (Figure 
7.4.6c). The two roseoredoxin isoforms were separable by CM-52 cellulose 
ion exchange chromatography (Table 7.4.7a. ). Figure 7.4.7a in the next 
section, shows the two isoforms of roseoredoxin. 5.0 µg of roseoredoxin was 
loaded on each IEF gel in Figures 7.4.6a, 7.4.6b and 7.4.6c, prior to 
electrophoresis in the first dimension. These photographs show the isoforms 





Figure 7.4.6a Roscuredoyin purified fro th control cell:. 
ý'ýl 
Figure 7.4.6a shows the form of pI 7.45 present alone. Here there was no pre- 
incubation of the S. roseochromogenes cells with progesterone prior to 




Figure 7.4.6b. Roseoredoxin purified from 8h progesterone pre-incubated 
cells. 
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Figure 7.4.6b, shows a photograph of the second dimension. The spot 
corresponding to pI 5.6, of much greater intensity than that corresponding to pI 
7.45. This shows that the roseoredoxin isoform of pI 5.6 is the predominant 








Figure 7.4.6c. Roseoredoxin purified from 4h progesterone pre-incubated 
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The photograph in Figure 7.4.6c shows the two spots in the second dimension 
corresponding to pI 7.45 and p15.6, to be of relatively equal intensity and 
therefore appear to be present in equal amounts. 
7.4.7. Isoforms of Roseoredoxin 
The two isoforms of roseoredoxin were separated by CM-52 ion exchange 
















CM 79.2 39.6 55.4 
cellulose 
50-100 mM 
KC1 fraction 2.0 
CM 63.7 31.85 44.6 
cellulose 
240 - 280 
mm 
KC1 fraction 
Table 7.4.7a. Separation two isoforms of S. roseochromogenes roseoredoxin by CM-52 
cellulose ion exchange chromatography as described in section 7.3.6 and 
7.3.7. 
The photograph in Figure 7.4.7a. shows the two isoforms of roseoredoxin from 
separate fractional ranges from the CM 52 column. They were 





Tyr sý. ý- ar''". 
. -: "eý 
Figure 7.4.7a. 10 % polyacrylamide gel of S. roseochromogenes' roseoredoxin isoforms. 
Lane 1,50-100 mM KCI roseoredoxin isoform fraction from CM 52 (2.8 pg M, 14 x 10') 
Lane 2,240-280 mM KCI roseoredoxin isoform fraction from CM 52 (2.8 µg Mr 14 x10') 
Lane 3, protein ladder (35 µg total protein, M, 66 x 103 - 14.2 x 103 (Mr x 103 from the 
top of the gel to bottom: 66, BSA; 45, chicken egg ovalbumin; 36, rabbit muscle 
glyceraldehyde-3-phosphate dehydrogenase; 29, bovine erythrocyte carbonic anhydrase; 
24, bovine pancreas trypsinogen; 20, soybean trypsin inhibitor and 14.2, bovine milk a- 
lactalbumin. 
7.4.8. Isoelectric Focussing of the Isoforms of Streptomyces 
roseochromogenes' Roseoredoxin 
The same procedure for two-dimensional gel electrophoresis was used here, as 
described in the general analytical procedures section in chapter 2. The two 
cellular components were separated from each other by two dimensional 
polyacrylamide gel electrophoresis. In the first dimension they were separated 
on the basis of their pl. The second dimension did not separate the two 
components but showed that they were of the same relative molecular mass. 
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14000Da as they had co-electromigrated. The three photographs. Figures 
7.4.6a, 7.4.6b & 7.4.6c, show the two isoforms separable by 2D-IEF. These 
results indicate that the longer the pre-incubation period of cells with 
progesterone, the greater the conversion of the constitutive roseoredoxin to the 
modified pI 5.6 isoform. 
Figure 7.4.8 illustrates the two-dimensional electrophoresis of the whole 213 and 
16a hydroxylase system from S. roseochromogenes. 
Roseoredoxin reductase, pl 6.9 16a-hydroxylase cytochrome 
P-450, pl 6.6 
986.5 54 
/ 
: a: ,. 
Figure 7.4.8 2-D, IEF gel of S. roseochromogenes roseoredoxin, roseoredoxin reductase 
and 2ß, 16a-hydroxylase cytochrome P-450 : 
roseoredoxin reductase pl 6.9,16a-hydroxylase cytochrome P-450 pl 6.6, ß-lactoglobulin pI 5.2 




Isoelectric focussing of the two proteins, roseoredoxin and roseoredoxin 
reductase in the work presented here, revealed that the roseoredoxin is 
separable into two fractions. One having a pI of 7.45 and the other 5.6, initially 
raising doubts over its purity. However, the presence of two spots, only on a 
two-dimensional electrophoretogram lead to the conclusion of the presence of 
two forms of roseoredoxin. Does the more acidic roseoredoxin allow for 
growth of S. roseochromogenes in more acidic conditions or is its presence 
mechanistic? The phenomenon of differing progesterone metabolite ratios by 
the two isoforms and elucidation of its nature, is discussed here. 
Roseoredoxin was the common cellular factor which according to its history, 
provided the phenomenon of an altered progesterone metabolite ratio. More 
than one form of the same protein meant that the progesterone either initiated 
the production of another protein i. e.: an inducible protein thereby the 
phenomenon being genetic in nature. Or a change to the expressed protein was 
initiated i. e.: a post translation modification. 
7.5.1 Is the difference between the two forms of roseoredoxin attributable 
to a post translation modification, induced by the progesterone in 
the growth medium? 
The demonstration of the fact that two forms of a cellular factor co-exist by 
virtue of a post-translation modification rather than a genetic change, has been 
shown here by an experiment designed initially around a simple mathematical 
evaluation of probability. To simplify the whole experiment one can envisage 
three positions, say. A, B & C. Any one position can be filled with either of two 
possibilities, say, position A could be Al or A2 etc. There are therefore 23 =8 
possible incubations of progesterone preincubated and non pre-incubated P450, 
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roseoredoxin and roseoredoxin reductase. This is how the roseoredoxin was 
found to be responsible for the observed metabolite ratio change from whole 
cell ratios obtained from cells grown in the absence of progesterone. 
No other cellular factor effected this change. Hence the term 'the roseoredoxin 
phenomenon'. 
7.5.2 Why should there be an increase in the number of hydroxylation 
events occurring per unit time for the hydroxylase system pre 
exposed to progesterone? 
Clearly, the number of hydroxylation events increases in reconstitution assays 
(Berrie el al., 1999) due to the post translation modification described above. 
However, the reason why this should occur is unclear. The fact that 
cytochromes P450 are generally regarded as xenobiotic metabolisers 
(Sariaslani, 1991), (Taylor ei al., 1999), (Trower ei al., 1988) may point to a 
possible role for this phenomenon. In this example progesterone is not a 
substrate S. roseochromogenes would normally encounter in its natural 
environment and increasing the hydroxylase ability of this P450 system, may, 
from an evolutionary point of view be one mechanism employed to deal with 
such xenobiotics. 
7.5.3 Why should there be a difference between roseoredoxin from cells 
grown in the presence of progesterone and roseoredoxin from cells 
grown in the absence of progesterone? 
In contrast with that discussed above, electron transfer protein isoforms can 
exist as constitutive and distinct genetically different cellular factors, probably 
serving a multifunctional role. In the case of S. griseolus (Omer et. al., 1990) 
two 7 kDa ferredoxin isoforms co-exist, designated Fd-1 and Fd-2. These 
proteins have 52% mutual identity and both contain single [3Fe-4S] clusters 
(Nagy et. al., 1995). Both ferredoxins function in reconstituted cell-free 
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systems containing the SU1 isoform of P450 although Fd-2 is the more active 
protein. The genes for the ferredoxins and the sulfonylurea P450 
monooxygenases are virtually contiguous. Thus P450SU I and the downstream 
Fd-1 form a closed-spaced pair, similarly P450SU2 and Fd-2. This is in 
contrast to the findings presented here because in S. roseochromogene. s, only 
one of the roseoredoxin isoforms is constitutive. The fact that a second isoform 
exists is dependent upon the environmental history of the cells and is a post 
translation modification of the same protein, not a genetic change. 
Ferredoxin-like iron sulphur containing proteins required for cytochrome P450 
monooxygenase activity have been identified in a wide variety of bacteria e. g. 
Bacillus megaterium ATCC 13368 (Rauschenbach et. al., 1993), 
Bradyrhizobium japonicum (Tully et. al., 1998), Pseudomonas incognita 
(Peterson et. al., 1992), Pseudomonas putida (Koga et. al., 1989), Rhodococcus 
SP strain NI86/21 (Nagy et. al., 1995), Saccharopolyspora erythraea, CA340 
(Shafiee & Hutchinson, 1988), Streptomyces griseolus (O'Keefe et. al., 1991), 
Streptomyces griseus (Trower et. al., 1993), Xanthobacter sp., (Trickett et. al., 
1991). Where sequence analysis has been performed, the ferredoxin-like 
protein genes seem to be constituents of operons containing respectively the 
P450 gene and the redoxin reductase gene (the significance of this was 
discussed in chapter 6). However, in this case for S. roseochromogenes, we do 
not know this. 
Less in known about the situation in S. griseus where only a single ferredoxin 
encoded by SOY B has been putatively identified (Trower et. al., 1993). 
Results here suggest that a novel system for ferredoxin-like protein expression, 
namely post-translational modification, probably operates in Streptomivices. In 
control cells grown in a standard medium a single, mildly basic and soluble 
form of roseoredoxin (pl 7.45) is present. This protein. like its published 
bacterial counterparts forms the middle component of a natural c`lochrome 
P450 electron transfer chain. In 14tro, this S. roseochromogenes system 
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predominantly catalyses 16a monohydroxylation of progesterone and as a 
rather minor secondary reaction 2ß hydroxylation of the primary product. By 
contrast, pre-incubating the organism with progesterone results in the 
appearance of a second but more acidic, soluble form of roseoredoxin (PI 5.6). 
This modified form increases the 20 hydroxylation capability of the cytochrome 
P450, evinced by a greater hydroxylation turnover number (Berrie ei al., 1999) 
of the P450 resulting in a decline in the 16a-monohydroxy to 2(3,16a- 
dihydroxprogesterone ratio. That a supra optimal growth inhibitory dose of 
cycloheximide added to the cells for 8h prior to the progesterone pre- 
incubation had no effect on the appearance of the pI 5.6 isoform is strongly 
consistent with a progesterone dependent post translational modification of the 
roseoredoxin rather than for transcriptional activation of a second gene. There 
is no literature precedent for the regulation of ferredoxin activity by post- 
translational modification. 
Bacterial responses to changes in their environment are largely controlled by 
signal transduction systems that contain two central enzymatic components, a 
protein kinase that uses adenosine triphosphate to phosphorylate itself at a 
histidine residue and a response regulator that accepts phosphoryl groups from 
the kinase. This conserved phosphotransfer chemistry operates in diverse 
systems to provide different regulatory outputs (Stock et al., 1989). What is the 
nature of the post-translational modification in roseoredoxin from S. 
roseochromogenes and how does it modulate the activity of the P450? The 
covalent attachment of an acidic group such as phosphate is an obvious 
candidate to account for the 1.85 pH unit decrease of the roseoredoxin pI value. 
This enhanced 2ß hydroxylation capacity of the P450 directed by the modified 
roseoredoxin isoform must be a consequence of a change in the efficiency of 
electron transfer from NADH to the P450. 
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Chapter 8 
Structural Analysis of the S. 
roseochromogenes Progesterone 
213,16a Hydroxylase P450 and 
Ancillary Electron Transfer 
Proteins 
8.1 INTRODUCTION 
8.1.1 Crystallisation by Vapour Diffusion 
This is the most commonly used technique for crystallisation and was first 













Figure 8.1a Representation of the hanging drop set up for vapour diffusion. 
Each well in a Linbro box has a capacity of 2 ml and an internal diameter 
of 16 mm. 
The principle of vapour diffusion crystallisation is indicated in Figure 8. l a. 
A droplet containing the macromolecule to be crystallised, buffer, 
crystallising agent and additives, is equilibrated against a reservoir 
containing a solution of crystallising agent at a higher concentration than the 
droplet. If equilibration occurs by diffusion of water from the hanging drop 
then all components of the drop become more concentrated with species 
possessing a vapour pressure higher than water, exchange occurs from the 
reservoir to the drop. In this case the drop volume will increase and the 
constituents become less concentrated. 
The aim in any type of crystallisation trial is to achieve a supersaturated 
solution, which will nucleate and give rise to crystals which are as large as 
possible (Stura & Wilson, 1990). 
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8.1.2 Protein Crystals 
A protein crystal tends to be a rather open three-dimensional lattice with 30 
- 90 % of the crystal volume occupied by water molecules. Relatively little 
protein surface area is involved in protein - protein contact. Rather, each 
protein molecule is surrounded by a very ordered arrangement of water 
molecules by virtue of their hydrogen bonding networks. The types of 
interactions involved in crystal formation are like those which stabilise 
protein structure i. e. hydrogen bonding, ion pairs, hydrophobic interactions 
and even metal co-ordination. With membrane proteins, the crystal lattice 
also has protein - detergent and detergent - detergent micelle like 
interactions. As a result all protein crystals are soft and sensitive to 
environmental factors such as humidity. 
8.1.3 The use of Crystal ScreenTM. 
On examination of Table 8a. it can be seen that a range of 50 relatively 
broad conditions were used in this method known as sparse matrix sampling 
(Jancarik & Kim, 1991). If crystals are obtained in any one of the trials, the 
conditions within that trial can be varied to attempt to increase the size or 
number of crystals. Two variables can be chosen, such as pH and PEG 
concentration, then new trials are set up with these two components which 
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It has been noted in general but not exclusively. that relatively long 
equilibration times give better quality crystals in that they are more robust§. 
Any crystals observed may potentially be just salt crystals. This can be 
avoided by using low concentration phosphate buffer for example. A 
destructive method to test for salt crystals is to use a needle to press a 
crystal. A salt crystal will be resistant and maintain its structure but a 
protein crystal will easily crumble. A non destructive method would be to 
use a protein stain. 
Prior to being able to observe an X-ray diffraction pattern, the crystals 
should be examined for birefringence. Polarising lenses are placed in the 
microscope above and below the plane of the crystal sample and turned 
relative to each other while observing the crystals through the upper 
polarising lens. If the crystals have two refractive indices they will change 
colour as the polarising lens is rotated. 
birefringent. 
8.1.4 The Phase Diagram 
The crystals are said to be 
The solubility of a protein depends upon various factors as mentioned. The 
saturated macromolecule solution is in equilibrium with the crystallised 







M solubility curve 
Figure 8.1.4a Solubility diagram for a crystallising protein. 
0 Personal communication from Professor R. W. Pickersgill of QMNA'. 
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macromolecule, adding crystal macromolecule would not dissolve the 
protein whereas adding reservoir solution would dissolve the crystals. In 
Figure 8.1.4a, below the solubility curve, the solution is undersaturated. No 
crystallisation will occur. Above the solubility curve effectively excess 
macromolecule will appear as a solid phase. Zones of nucleation within the 
hanging drop are required to form as the centres of crystal growth (Ries- 
Kautt & Ducruix, 1999). 
The purpose of obtaining crystals is to gain knowledge of the protein 
structure through analysis of the X-ray diffraction pattern obtained when an 
X-ray beam is focussed on a crystal. This in conjunction with the protein's 
amino acid sequence can be used to gain an understanding of the quaternary 
structure of the proteins and possibly how they interact with each other as 
well as binding of substrates and ligands. These lines of research have been 
pursued extensively with the first P450 crystal structure to be mapped, that 
of P450 can, from Pseudomonas putida. This has been developed by the high 
resolution crystal structure of P450cam (Poulos et al., 1987). In crystal 
structural studies, binding of the substrate, camphor to the type I binding 
site without its binding to the type II binding site of P450cam was 
elucidated (Poulos et al., 1985). Binding of 5-exo-hydroxycamphor to both 
P450. binding sites forming binary complexes have also been observed 
through this methodology (Narasimhulu et al., 1998). 
8.1.5 X-Ray Analysis 
Crystal quality is hugely important. Quality in this case is judged by the 
ability to diffract. Crystals may degenerate in the X-ray beam; they may be 
unstable or not diffract or have a large unit cell dimension. In these cases the 
crystals may not be suitable for full structural determination. X-rays are 
used because of the wavelength of this type of radiation, ca. 1.5 A. By 
comparing diffraction distances from varying angles of incident X-ray 
beams, a pattern of electron density can be derived. Regions of high 
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electron density within a protein structure, correspond to the areas where the 
atoms are located. These areas will diffract the X-rays through a greater 
angle than X-rays incident upon an area of low electron density. This 
scattering is not random and can be explained mathematically, by Bragg's 
law. 
8.2 MATERIALS 
Molykote Silicone grease was obtained from Dow Corning, Munich, 
Germany. Linbro boxesN, were obtained from Flow Laboratories, Virginia, 
USA. Pre-siliconised glass coverslips, and Crystal Screen Kit were from 
Hampton Research, California, USA. 
8.3 METHODS 
8.3.1 Setting up Vapour Diffusion Trials 
Silicon grease was applied to the full circumference of each of 50 Linbro 
box well rims. To each of the wells, 1.0 ml of the corresponding crystal 
screen solution was added, in turn from solution 1 to solution 50. The 
formulation of each of the 50 solutions is shown in Table 8a. 
To each of 50 pre-siliconised glass coverslips, 20 µl of the protein solution 
was added ( concentration = 5mg/ml) in the centre. To each of these drops, 
20 µl of the corresponding crystal screen solution was added, thereby 
doubling the volume of the drop. This process was carried out six drops at a 
time rather than all 50 at once to reduce evaporation of the protein drops. 
Once the 40 pl drop was prepared, the coverslip was placed over its 
corresponding Linbro box well, containing the correct Crystal Screen 
solution. Thus the drop in the centre of the coverslip was hanging over the 
Commercially available Linbro boxes are normally used for tissue culture but with a 
slight modification they are ideal for crystal trials. See methods. 
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reservoir solution in an airtight environment created by the silicon grease 
seal around the rim. 
Once all 50 wells were sealed with their corresponding hanging drops, the 
lids to the Linbro boxes were prepared. To each inner corner of each of the 
lids, a small rolled-up piece of parafilm was firmly lodged. The lids were 
then placed on the Linbro boxes thereby creating space for the glass 
coverslips by virtue of the elevation by the parafilm. 
The crystal trials were then placed in a thermostatically controlled 
environment at 17° C and left with minimum agitation while checking the 
drops every few days. 
Once broad parameters have been set for the crystallisation of a protein, it is 
then desirable to narrow down the matrix components in order to find the 
optimum conditions for crystallisation. This may be performed on 
successively finer grids. This systematic screening of conditions was used 
to show that most proteins crystallise over a range of 1.5 to 2 pH units and 
20 % saturation of ammonium sulphate solutions (Weber, 1990). 
8.4 RESULTS 
8.4.1 On careful inspection through a microscope after I month, the first 
set of trials had not given rise to any sign of crystallisation. The trials were 
repeated using protein samples twice as concentrated as the original trials 
i. e. 5.0 mg/ml instead of 2.5 mg/ml. 
8.4.2 The fresh trials were left at 17° C for one month and crystals 
appeared in trials 14 and 15 of the roseoredoxin samples. Photographs of 
these are shown in Figure 8.4.2a and Figure 8.4.2b. In trial 6 of the 
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cytochrome P450 trials, successful crystallisation was achieved. This result 
is shown in Figure 8.4.2c. 
In both samples that crystallised, the crystals were isomorphous. Neither 
crystal sample was birefringent. 
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Figure 8.4.2a A photograph of crystals from trial 14 of table 8a. These crystals arc of 




Figure 8.4.2b A photograph of crystals from trial 15 of table 8a. These crystals are of 
the roseoredoxin protein purified from S. roseochromogenes. The 
crystals produced here were not as clear as in trial 14, shown in Figure 
8.4.2a. 
I 
Figure 8.4.2c A photograph of a crystal from trial 6 of table 8a. This crystal is 
cytochrome P450 purified from S. roseochromogcnc. ". 
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8.5 Molecular Sequence Analysis of S. 
roseochromogenes Roseoredoxin 
Reductase, Roseoredoxin and Cytochrome 
P450 
Amino acid sequencing was performed by Dr. A. Came of The Institute of 
Cancer Research, Fulham, London, on an automated sequenator. The amino 
acid residues were automatically analysed by HPLC. 
8.5.1 Streptomyces roseochromogenes 
Roseoredoxin Reductase 
No sequence was obtained for this component of the hydroxylase system. 
Upon re-examination of the protein post sequence analysis by SIDS-PAGE, 
there was a lack of a distinct band indicating degradation of the sample. In 
these circumstances accurate sequence analysis was not possible due to the 
presence of artefactual small peptides contaminating the HPLC analysis. 
8.5.2 Streptomyces roseochromogenes Roseoredoxin 
The longest sequence obtained for this protein was: 
X-N-L-E-F-P-E-R-I-K-M-L-K-D-Y-E-X-V-A- 
E-G-L-....... 
8.5.3 S. roseochromogenes Progesterone 2ß, 16a Hydroxylase 
Cytochrome P450 




8.5.4 Using Amino Acid Sequence Databases Accessible on the 
Internet to Determine the Uniqueness of Amino Acid Sequences 
Obtained 
The European Bioinformatics Institute (EBI) maintains and distributes the 
European Molecular Biology Laboratory (EMBL) Sequence database. 
Europe's primary sequence data resource. The EBI also maintains and 
distributes the SWISS-PROT Protein Sequence database (Rodriguez Tome 
ei al., 1996). The EBI network services include database searching and 
sequence similarity searching facilities accessible via the EBI website. 
Searches performed for each sequence obtained were BLAST and SWISS- 
PROT. 
The 'PDBFinder' (Protein Databank) database was also used to search for 
similar sequences to those obtained from sequencing here (swift. embl- 
heidelberg. de). 
The amino acid sequences for the roseoredoxin and the progesterone 2ß, 16a 
hydroxylase P450 were entered into database searches as described in the 
methods section of this chapter. The cytochrome P450 sequence received 
zero matches and is therefore unique. 
8.6 DISCUSSION 
Crystal Structure 
The current crystals are too small for X-ray analysis but it is anticipated that 
further refinement of the crystallisation conditions will give crystals large 
enough for diffraction trials. In addition to the single protein crystals, it is 
anticipated that combinations of the proteins may be co - crystallised in 
order to gain some insight into the way the structures interact in the 
hydroxylase system. Full amino acid sequences would greatly facilitate this 
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work in order that residues may be identified from X-ray diffraction 
patterns. 
Cytochrome P450 haemoproteins comprise a large gene superfamily that 
catalyse monooxygenase reactions in the presence of a redox partner. 
Mammalian members are membrane bound and therefore have resisted 
structure-function analysis by means of X-ray crystallographic methods. 
However, soluble P450s from bacteria have been used to build a model of 
the P450arom, which catalyses the conversion C19 steroids to oestrogens. 
This is a complex and poorly understood aromatisation (Graham-Lorence et 
al., 1995). The 3-D model was based upon the structures of P450cam, 
P450terp and P450BM_3. From this model a redox partner binding site was 
postulated. 
Detailed structural information is available for P450cam and its X-ray 
structure determined to a resolution of 1.63 A (Poulos et al., 1987). Two 
highly conserved regions are found between P450 101 (P450.,, ) and 
eukaryotic P450s. In modelling, conserved mammalian P450 sequences are 
aligned with conserved sequences from P450 101 (Koymans et al., 1993 
[2]). This method is ambiguous and imprecise as a result of the assumption 
of tertiary structures of eukaryote P450s being similar and the presence of a 
membrane binding segment at their amino termini. The most highly 
conserved region between prokaryote and eukaryote P450s, is the haem 
binding domain. The second most conserved being the helix I region; the 
oxygen binding site which constitutes part of the substrate binding site 
(Koymans et al., 1993[2]). 
The Sequences Presented in this Chapter 
The sequences presented in this chapter are too short for any type of 
structural analysis to be performed. This is because a peptide. when part of 
a large protein will take on a different shape due to non local factors within 
the protein influencing the factors which may exist within the peptide 
thereby invalidating any structural analysis of the peptide. Existing 
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approaches to protein secondary structure prediction from the amino acid 
sequence usually rely on local 
residue interactions and the secondary structural state of the central residue. 
An attempt has been made to produce an algorithm for secondary structure 
prediction based on recognition of potentially hydrogen-bonded residues in 
a single amino acid sequence. The unique feature of this approach involves 
database-derived statistics on residue type occurrences in different classes of 
ß-bridges to delineate interacting ß-strands. The a-helical structures are 
also recognised on the basis of amino acid occurrences in hydrogen-bonded 
pairs. The algorithm has a prediction accuracy of 68% in three structural 
stages and relies only on a single protein sequence as input (Frishman & 
Argos, 1996). 
The Significance of Physical Modelling of Cytochromes P450 Based 
upon their Amino Acid Sequences 
P450s all appear to take on a similar structural fold even though they 
frequently have less than 20 % sequence identity and catalyse different 
classes of reaction upon binding a diverse range of substrates. Therefore the 
regions within P450 sequences which do not have sequence identity (80 %) 
must share some other common factor or factors. 
The Haem Binding Site 
0 
It is now universally accepted that a cysteinyl residue at alignment position 
564 (Nelson & Strobel, 1989) corresponding to 'C' -357 in P450 101 (the 
P450caR, ) provides the fifth axial haem ligand in all P450s. The cysteinyl 
residue is part of a polypeptide chain that contains some other highly 
conserved and invariant residues ('F'-557, 'G'-560, and 'G'-566). In 
® Amino acid letter designations are given in the following footnotes -* 
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eukaryotic P450s the P450 101 residues 'H'-355 and 'L'-358 (Aligned 
positions 562 & 565) are changed into the functionally conservative 
residues 'R' and 'I'/'V' respectively. 0 
'H'-355 of P450 101 is in a position to either hydrogen bond or interact 
ionically with one of the haem proprionic acids (Poulos et al., 1987). 
Highly conserved 'R'-562 may have a similar function in all eukaryotic 
P450s. The 3-d structure surrounding the fifth haem ligand 'C' may be very 
similar in all eukaryotic P450s. The conservation in tertiary structure 
almost certainly relates to the critical role played by the Fe-S bond in the 
catalytic mechanism of all cytochromes P450. 
Site-directed mutagenesis has been used to investigate the functional role of 
amino acid residues around the haem binding domain. These experiments 
performed on rat liver P450 1A2 confirmed that the Cysteine-thiolate 
bonding to the haem iron atom ('C'-456 = Aligned position 564 of P450 
101) (Shimizu et al., 1989) and that 'R'-454 (Aligned position 562) interacts 
with the haem proprionate side chain similarly to 'H'-355 in P450 101. 
Hydrophobic residues such as 'F'-449, 'L'-451, 'G'-452, 'I'-457 and 'G'-458 of 
P450 1A2 (Aligned positions 557,559,560,565 and 566) are located next 
to the axial thiolate ligand to hold the haem in the active site (Shimizu et al., 
1988). 
The Molecular Oxygen Binding Site 
This highly conserved domain occurs at the central region of helix I that 
forms the 02 binding pocket in P450 101 (Nelson & Strobel, 1987.1988 & 
1989). Highly conserved amino acid residues are found at alignment 
positions 396 ('A'/'G') and 400 ('T'). Also, amino acid residues at positions 
393,394,395 and 405 are all hydrophobic in character, whereas a 
negatively charged amino acid ('E' or 'D'), a hydroxy amino acid ('T' or 'S') 
® A, Alanine C, Cysteine D, Aspartic acid 
F, Phenylalanine G, Glysine H, Histidine 
I.. L. eucine 
E. Glutamic acid 
1, Isoleucine K, Lysine 
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and an aromatic residue ('F', 'Y' or 'W') are conserved at positions 399.403 
and 407 respectively. 0 
In P450 101 a localised distortion and widening of the distal helix I between 
'G'-248 and 'T'-252 (Aligned positions 396 & 400) provide a pocket for 
molecular 02. Thus, high sequence homology around 'T'-252 residue in 
P450 101 and the corresponding 'T' at alignment position 400 in eukaryotic 
P450s indicates a similar 02 binding domain in this latter group of proteins. 
It has been suggested that some of the residues around the 02 binding site 
might form part of the substrate binding site, influencing the binding and 
orientation of the substrates. Residues `N'-310 to 'F'-325 of P450 I A2 
(Alignment positions 391-406) have been mutated (Shimizu et al.. 1989). 
CO-difference spectra were strongly influenced by these mutations agreeing 
with the proposal (Shimizu et al., 1989) that the region N'-391 to 'F'-406 
forms part of the substrate binding site in this particular P450. The catalytic 
activities of these mutants toward benzphetamine, 7-ethoxycoumarin and 
testosterone are dependent on the nature of the mutation (Furuya el al., 
1989[2] and Hiroya et al., 1991). 
Threonine 301 of P450,.. 
Substitution of the nearly invariant 'T' at alignment position 400 by 'A' in 
P450 I A2 yielded a mutant enzyme without activity toward benzphetamine 
but enhanced activity toward 7-ethoxycoumarin and testosterone. 
Substitution of invariant 'G' at alignment position 397 for 'E' enhanced 
activity for both benzphetamine and 7-ethoxycoumarin (Furuya et al., 
1989[l]). These data are unexpected because both 'T'-319 and 'G'-316 of 
P450 1A2 stabilise the oxygen binding pocket (Poulos, 1986). Substitution 
of these residues for functionally different amino acid 'E' or 'A' would 
be 
expected to result in catalytically inactive or weakly active mutants. 
® M, Methionine 
ArginineS, Serine 
Tryptophan 
N, Asparagine P, Proline 
T, Threonine 
Y, Tyrosine. 
Q, Glutamine R, 
' V, Valine N.
259 
This is significant because if one looks at the model of P450arom discussed 
above, which was built based on a "core structure" identified from the 
structures of the soluble, bacterial P450s (P450cam. P450terp, and P45OBN, _1) 
rather than by molecular replacement. From this model it was postulated by 
Graham-Lorence et al (1995) that a membrane-associated hydrophobic 
region of aliphatic and aromatic residues is involved in substrate recognition 
and a redox-partner binding region that may be unique compared to other 
P450s, as well as residues involved in active site orientation of substrates 
and inhibitor of P450arom, (vorozole). From this model it was proposed that 
a scheme for the reaction mechanism involves a "threonine switch" 
determining whether oxygen insertion into the substrate molecule involves 
an oxygen radical or a peroxide intermediate (Graham-Lorence el al., 1995). 
Changing the invariant 'T'-301 (Aligned position 400) of P450 2C2 into 'H', 
'V' 'I', 'L', 'Q, 'C' or 'N' diminished or abolished the hydroxylase activity of 
P450 2C2 toward substrates laurate and caproate (Imai & Nakamura, 1988 
& 1989)(Imai, el al., 1989 & 1990). Substituting 'T'-301 for 'S' diminished 
laurate co-1 hydroxylase activity in P450 2C2, whereas the corresponding 
caproate activity was higher than in the wild-type enzyme (Imai, el al., 1989 
& 1990). A double mutant 'T'-301 to 'S' and 'T'-302 to 'V' resulted in laurate 
co-hydroxylase activity, which was not detectable in the wild-type P450 
(Imai, et al., 1989 & 1990). Thus, 'T'-301 & -302 of P450 2C2 (Aligned 
positions 400 & 401) may play an important role in determining substrate 
specificities and recognising fatty acid substrate chain length, resulting in 
hydroxylation either at the co or 0)-1 position or both. 
The 16a steroid hydroxylation reaction (the reaction investigated in this 
work) has also been investigated by mutation. Mutants of P450 2C 14 
(testosterone 16-a hydroxylase) have been constructed in which 'T'-301 
(Aligned position 400) is replaced by 'S', 'V' or 'H'. The 'V' & 'H' mutants 
have diminished or no hydroxylase activity towards progesterone or 
ds testosterone, whereas the 'S' mutant has 50% less activity towar 
testosterone and slightly increased activity toward progesterone (Imai &: 
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Nakamura 1989). These studies taken with the data on P450 2C2 point to a 
hydroxyl group ('T' or 'S') as being necessary for efficient catalysis. 
Changing 'T'-252 (Aligned position 400) of P450 101 for 'A', 'V', 'C', 'P' or 
'G' uncoupled catalytic activity and resulted in H202 production. suggesting 
that the nearly invariant 'T' at alignment position 400 might have different 
functions in different P450s (Furuya et al., 1989[2]). 
As discussed above, for these reasons of ambiguity and a membrane binding 
domain in eukaryotic P450s, it seems that this type of modelling has only 
limited uses. It appears that comparison of primary sequences is the only 
accurate stage in this modelling approach. The problem of the prokaryote 
and eukaryote comparative model is important if modelling techniques are 
to be developed for the purpose of drug design. For example, the 
aromatase, P450arom catalyses the conversion of androgens to oestrogens in a 
variety of cells such as ovarian granulosa, testes, placenta, adipose tissue 
and various centres of the brain. The extragonadal synthesis of oestrogens 
has a major role in the pathophysiology of various breast carcinomas and 
endometrial adenocarcinoma (VandenBossche et al., 1994). This catalysis 
is in conjunction with an NADH P450arom reductase. Misalignment in the 
eukaryote modelling approach may prevent 1/. Active site determination and 
2/. Reductase binding site elucidation because P450arom has an endoplasmic 
reticulum binding domain. The development of P450arom inhibitors would 
reduce the need to prescribe steroidal P450 inhibitors in the treatment of 
some carcinomas. 
The Aromatic Region 
The amino acid primary sequences of membrane-bound P450s have a 
highly 
conserved region which is not shared by P450 101 (Ouzounis 
& Melvin, 
1991). This domain is called the "aromatic region" because it is 
characterised by its peculiar amino acid sequence from alignment position 
513-525 (Nelson & Strobel, 1989). The sequence is expressed as A 1-X-X- 
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P-X-X-A2-X-P-X-B-A3, where Al=an aromatic amino acid, P=Proline. 
B=either'R' or 'H', X= a weakly conserved amino acid. 
Three P450 1A2 mutants have been constructed to elucidate the function of 
this aromatic region and the individual amino acids it comprises (Furuv'a et 
al., 1989[2]). Residues 'F'-425, 'P'-427 and 'F'--430 (Aligned positions 520. 
522 and 525 respectively) were all changed into 'L' and their effect on 
catalytic activity of P450 I A2 toward benzphetamine and ethoxycournarin 
was examined. Benzphetamine activity accounted for only 7% of wild-type. 
ethoxycoumarin activity, this was increased to 2.5 fold with the 'L' 
replacement mutation (Furuya et al., 1989[2]). 
Mutants in which amino acid 'W'-419, 'P'-422 and 'R'-429 (Aligned 
positions 513,516 & 524 respectively) were changed to 'L' resulted in 
failure of haem to bind to the apoprotein., suggesting that the aromatic 
region indirectly contributes to the haem binding at least in P450 I A2 
(Furuya et al., 1989[l]). ESR spectra of mutants F425L and P427L support 
this suggestion as they displayed different g values compared to wild-type 
P450 I A2 (Sotokawa et al., 1990). This aromatic region seems to be a 
characteristic of membrane-bound P450s because this sequence is not 
readily apparent in P450 101. As the sequence is not apparent in the soluble 
P450cam, this region might therefore help to orientate the haem toward the 
membrane surface with the substrate binding site facing the membrane 
surface but in the absence of a suitable eukaryotic model these points cannot 
easily be resolved. Problems with alignment based modelling are not 
limited to the differences between prokaryotic and eukaryotic sequences. 
There are differences between microsomal and mitochondrial P450s. At the 
beginning of the L helix, all mitochondrial P450s contain two positively 
charged residues, usually 'R' (Peterson & Graham, 1998) 
The functions of the amino acid residues, which fall into other conserved 
regions, are largely unknown. these include the 'P'-'G'-'P' region at the N- 
terminus, almost invariant 'G' at alignment positions 110 & 118, and a 
highly conserved W-X-X-X-B region at positions 177-181 where 
W=trvptophan. X=a weakly conserved residue, and B=Arginine or I. ý'sine 
262 
(Gonzales, et al., 1989). Using nanosecond fluorometry , 
it has been shown 
that 'W'-121 of P450 2B2 (Aligned position 177) is not situated in the 
vicinity of the substrate binding site. The highly conserved region from 
alignment positions 177-181 is probably not part of the active site in 
membrane-bound P450s. It has been suggested that this sequence might be 
involved in the interaction with redox proteins (Aoyama et al., 1989). 
Despite these 'best-fit' scenarios in various domains of eukaryotic P450s, 
there are examples of minor changes having a large impact on selectivity 
and therefore limitations in modelling substrate interaction and transition 
state in eukaryotes, on P450 101 (P450. m) (Linberg & Negishi , 
1989) 
(Aoyama et al., 1989) (Johnson et al., 1992). However, such modelling 
may be useful in discerning more general structural features and should 
provide insight into aspects of electron transfer protein binding and oxygen 
activation (Guengerich, 1992). 
A method for attributing a measure of reliability to a residue pair in an 
optimal alignment of two protein sequences has been proposed (Mevissen & 
Vingron, 1996). Validation techniques are based on a database of 
structurally correct sequence alignments (Pascarella & Argos, 1992) and 
shows that correctly aligned parts of sequence alignments systematically 
receive high scores by this measure. The higher the sequence similarity 
between two sequences, the larger the fraction found of the correct parts of 
the alignment. These observations were used to design a program that 
draws a reliability curve along an optimal alignment indicating the chances 
for each residue pair to be aligned correctly (Mevissen & Vingron, 1996). 
Again, this method has its limitations as the reliability curve only gives a 
probability of alignment. Eukaryotic P450 structural determinations based 
upon amino acid sequences are still being modelled on the 3-D crystal 
structure of P450BMP. the haem domain of P450BM-3. For example, the 
construction of a three-dimensional model of human CYP2E 1 based on 
CYP 102. Interactive docking of a number of human CYP2E 1 substrates 
was found to be consistent with their known metabolism. For example the 
production of N-acetyl-p-benzoquinone imine, a hepatotoxin from 
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acetaminophen (paracetamol) at high concentrations due to its high Km. 
(Tonge et al., 1998). Site directed mutagenesis has also been employed as 
detailed above to examine substrate regioselectivity and active site 
composition along with the functions of hydrogen bonding within the active 
site of CYP2E 1 (Lewis et al., 2000). 
P450 3D Modelling - The way Forward 
Discussed above are the problems associated with amino acid sequence 
alignment. The fundamental issue is not the alignment but the absence of a 
eukaryotic model other than one derived from P450BM-3 and P450C. m. 
This situation however is currently under review. The development of a 
structurally determined microsomal P450 has been reported (Graham & 
Peterson, 1999). 
A variant of microsomal P4502C3 (progesterone 21 hydroxylase) has been 
constructed which lacks the problematic membrane binding segment of its 
N-terminus residues 3-20. This variant was designated P4502C3d and 
expressed at high levels in E. coli. Also contained in this variant was the 
substitution of alanine for 'D' at position 2. Also serine was substituted for 
'H'24 and 'G'25 to introduce a restriction site. These modifications are likely 
to facilitate attempts to crystallise the catalytic domains of microsomal 
P450s (von Wachenfeldt et al., 1997). Deletion of the N-terminal 
membrane-spanning domain from microsomal P450s 2C3 and then also 2C5 
generated the enzymes, 2C5dH and 2C3dH. The two proteins are tetramers 
and dimers, respectively. Each of four substitutions, N202H, 1207L, 
S209G, and S210T, diminished the aggregation of P450 2C5dH and 
produced a monomeric enzyme. The N202H and 1207L mutations also 
diminished the stimulation of catalytic activity by phospholipid and reduced 
the binding of P450 2C5dH to phospholipid vesicles. The modified enzymes 
exhibit rates of progesterone 21-hydroxylation that are similar to that of 
P450 2C5dH. These P450s are suitable for crystallisation and structural 
determination by x-ray diffraction studies (Cosme & Johnson. 2000). 
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For the amino acid sequencing of the proteins presented in this work, there 
is some sequence alignment with a protein. P xylanase for the roseoredoxin 
protein suggesting a hypothetical link but no such structural, even primary. 
comparisons, as discussed above can be made here. The P450 matched no 





There is now a wealth of compelling evidence identifying cytochrome P450 
as responsible for steroid hydroxylation reactions in both bacteria and 
filamentous fungi e. g. in bacteria - 6ß in Bacillus thermoglucosidusius 
(Sideso et al., 1998) and 15ß in Bacillus megaterium (Berg et al.. 1976). in 
filamentous fungi - 7a in Phycomyces blakesleeanus (Ahmed et al.. 199-5). 
11 cc in Aspergillus fumigatus (Smith et al.. 1994), Aspergillus ochraceus 
(Samanta & Ghosh, 1987), Nectria haematococca (Ahmed et al., 1996). 
and Rhizopus nigricans (Breskvar et al., 1987): 11 ß in C'ochl iohol us 
lunatus (Janig et al., 1992); and 15a in Penicillium raistrickii (Irrgang cl 
al., 1997). Despite the long history and extensive literature on microbial 
steroid hydroxylation no such role has so far been indisputably assigned to 
P450 for this reaction in Streptomyces species. Therefore, this work is the 
first report to identify unequivocally cytochrome P450 as a steroid 
hydroxylase enzyme in the Streptomyces genus. 
D 
Oil 
Figure 9.1 16a hydroxyprogesterone, the first product of the progesterone 
hydroxylase. The 166' carbon position of the 
perhydrocyclopentanophenanthrene ring system is 
hydroxylated as 
determined by NMR. 
Steroid 16u hydroxylation was first identified 40 years ago during the 
search for micro-organisms capable of efficient and mild stereospecific 
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access of the 16 site of the steroid nucleus (Thoma et al.. 1957) (Goodman 
& Smith, 1961). Microbial access of this site was eventually employed for 
the synthesis of a new generation of highly potent, synthetic. anti- 
inflammatory pharmaceuticals exemplified by triamcinalone (9a-luoro- 
11 ß, 16a, 17(x, 21-tetrahydroxy-pregna-1,4-diene-3.20-dione) developed to 
replace natural corticosteroids found to cause mineralocorticoid 
contraindicat ions. 
Here, the results of incubations with radio labelled 16a hvdroxv progesterone 
showed that the monohydroxyprogesterone (Figure. 9. I) is substrate for the 
production of the dihydroxyprogesterone (Figure. 9.2). 'ß 
hydroxyprogesterone was never identified as a product of this enzyme 
system. 
When two solutions of purified protein were reduced with sodium dithionite 
and CO bubbled through one and the absorbances of each compared, a 
characteristic P450 spectrum was obtained with the absorption peak at 450 
nm. When ketoconazole, a known P450 inhibitor, was added to incubations, 
no hydroxylase activity was observed. The results obtained show that this 
steroid hydroxylase is a cytochrome P450. 
0 
OH 
Figure 9.2 20,16a dihydroxyprogesterone, the second product of the progesterone 
hydroxylase. The molecule is hydroxylated at opposite ends. 
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When the progesterone molecule is reversed and capsized, as shown in 
Figure 9.3 (1800 horizontally and 180° vertically), one can see that the two 
0 
16 
Figure 9.3 View of progesterone turned through 1800 horizontally and 1800 
vertically (reverse capsized). One can see how the two replaceable 
protons become virtually spatially coincident 
replaceable protons, 20 and 16a, become virtually spacially coincident. This 
P450 from S. roseochromogenes is capable of hydroxylating progesterone in 
those two orientations. The amount of dihydroxyprogesterone present is 
greater than that expected were mono- hydroxylation entirely random. 
From this it appears that the P450 has a greater affinity for the 




substrate specificity and catalytic activity, is characteristic of cytochromes 
P450. This may confer upon micro-organisms which express them, a 
selective advantage in terms of the production of secondary metabolites 
from recalcitrant carbon compounds and in the case of Slreplomy'cc. s 
species, the production of antibiotic compounds. 
S. roseochromogenes 10984 possesses strong progesterone 2P and 16a 
hydroxylation activities. The time course of progesterone transformation 
showed 16a hydroxylation to be the primary event and 2ß hydroxylation to 
be a second phase reaction using 16(x monohydroxyprogesterone as 
substrate. Thus, 16a monohydroxyprogesterone was first detected in the 
culture medium after 6h of incubation and 2ß, 16a-dihydroxyprogesterone 
appeared 2h thereafter at 8 h. That this is the true route of progesterone 
bioconversion was shown when S. roseochromogenes transformed 
exogenous 16a-hydroxyprogesterone to 2ß, 16a-dihydroxyprogesterone. 
Moreover, free 20-monohydroxyprogesterone was never detected in this 
system even in transformation incubations containing 20 mg of progesterone 
and a metabolite detection threshold of under 0.1 mg of steroid (Berrie et 
al., 1999). 
With the purified P450 protein, reconstitution of the system was attempted. 
Purified P450 protein in combination with DEAE column peak 1 eluate 
(chapter 4), was capable of NADH dependent hydroxylation of 
progesterone, yielding the same products as in Figures 9.1 and 9.2, although 
less efficiently than in assays containing all three purified proteins found in 
the natural system. 
A turnover number of ca 0.02/min was calculated for S. roseochromogene: s 
P450 catalysed progesterone hydroxylation in the reconstituted pathway and 
a comparable value of ca 0.03/min for the Na104 dependent pathway. Both 
numbers are now the lowest reported for a purified P450 being an 
approximate order of magnitude lower than the previous bottom of the table 
turnover numbers of 0.6/min reported for the steroid 153-hydroxylase 
cytochrome P450 (P450meg) of Bacillus megaterium (Berg A. et al.. 
1979) 
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and of 1.8/min and 2.1 /min reported for procene-II and 7-ethox` coumarin 
hydroxylation respectively catalysed by a crude fraction of S. griseu. s P450 
(Trower et al., 1988). The reason for this catalytic inefficiency is unclear 
but it may be connected with the fact that progesterone is almost certainly 
not the physiological substrate for the S. roseochromogenes P450. Due to 
this paradox, a meaningful comparison of the true efficiency of this enzyme 
with its bacterial counterparts cannot be made until a natural substrate is 
identified. However, these data show that in the natural pathway highly 
pure S. roseochromogenes P450 catalyses multiple cycles of hydroxylation 
even with the unnatural steroid substrate. 
The major monohydroxylated metabolite, 16a-hydroxyprogesterone was 
produced in 3.6 fold excess to the minor metabolite 23.16a- 
dihydroxyprogesterone. In a reconstituted system containing highly purified 
progesterone 2ß, 16a-hydroxylase cytochrome P450 and electron transfer 
proteins, ferredoxin-like redoxin (roseoredoxin) and redoxin reductase 
(roseoredoxin reductase), both metabolites were produced but in a 10: 1 
ratio. When S. roseochromogenes was pre-incubated for 8h with 0.32mM 
progesterone and the purified components of the hydroxylase system 
incubated as before, the ratio of 16a-hydroxyprogesterone to 2ß, 16a- 
dihydroxyprogesterone produced, decreased to 2.8 : 1, virtually identical to 
the ratio in whole cell transformations. Reconstitution assays containing all 
possible combinations of hydroxylase proteins purified from progesterone 
pre-incubated and control cells showed that the roseoredoxin was solely 
responsible for the observed changes in in vitro metabolite ratios. The fact 
that the lower 16a-hydroxyprogesterone to 20,16a-dihydroxyprogesterone 
ratio was also obtained when S. roseochromogenes was exposed to 0.335 
mM cycloheximide for 8h prior to the progesterone pre-incubation, pointed 
to post translation modification of the roseoredoxin. Separation of two 
isoforms of roseoredoxin by isoelectric focusing supported this proposition. 
In contrast to steroid hydroxylation, cytochrome P450 has been identified in 
several Streptom 'ces pathways of secondary metabolism. Thus, this enzyme 
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participates in oleandomycin biosynthesis in StreptomyCL's-antibioticw 
(Rodriguez et al., 1995), the hydroxylation of compactin to pravastatin by 
Streptomyces carbophilus (Matsuoka et al., 1989), and in aN Aide variety of 
xenobiotic transformations in Streptomyces griseus (Sariaslani ei al., 1986, 
Trower et al., 1988). 
Cytochrome P450 genes have been cloned from Streptomyces species, S. 
griseolus and S. griseus. In S. griseolus, genes for the herbicide-inducible 
cytochromes P450, P450SUI and P450SU2, have been sequenced and the 
amino acid sequence of segments of the encoded proteins deduced. Thcse 
proteins were found to possess high sequence identity to the Pseudomonas 
putida camphor hydroxylase P450 (P450 101, P450, ýam) particularly in the 
haem binding domain (Omer et al., 1990). A DNA segment carrying the 
structural gene encoding P450,. y (soyC), has been cloned from S. griseus. It 
is noteworthy that this cytochrome P450 also has high sequence 
conservation with P450cam in the haem binding region (Trower et al., 1992). 
Ferredoxin electron transfer proteins have also been purified from the above 
two Streptomyces species. S. griseolus was found to contain two 7 kDa 
isoforms, designated Fd-1 and Fd-2. These proteins have 52% identity and 
both contain single [3Fe-4S] clusters (O'Keefe et al., 1991). In S. griseolus 
only a single ferredoxin encoded by SOY B has been putatively identified. 
The situation in S. roseochromogenes remains to be resolved. 
Ferredoxin-like iron sulphur containing proteins required for cytochrome 
P450 monooxygenase activity have been identified in a wide variety of 
bacteria e. g. Bacillus megaterium ATCC 13368 (Rauschenbach ei al., 
1993), Bradyrhizobium japonicum (Tully et al., 1998), Pseudomonas 
incognita (Peterson et al., 1992), Pseudomonas putida (Koga et al., 1989). 
Rhodococcus Sp strain N186/21 (Nagy et al., 1995), Saccharopol y. spora 
eryihraea, CA340 (Shafiee & Hutchinson, 1988), Streptom}ce. s' griseolus 
(O'Keefe et al., 1991), Streptomyces griseus (Trower et al., 1993). 
Xanthobacter sp., (Trickett et al., 1991). Where sequence analysis has been 
performed, these ferredoxin-like genes seem to be constituents of operons 
containing also the P450 and the redoxin reductase gene. 
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In the case of S. griseolus' Fd-l and Fd-2 (O'Keefe et al.. 1991). Both 
ferredoxins function in reconstituted cell-free systems containing the SUI 
isoform of P450 although Fd-2 is the more active protein. The genes for the 
ferredoxins and the sulfonylurea P450 monooxygenases are virtually 
contiguous. Thus P450SUI and the downstream Fd-1 form a closed-spaced 
pair; similarly P450SU2 and Fd-2 pair. 
Results here for S. roseochromogenes suggest that a novel system for 
ferredoxin-like protein expression, namely post-translational modification, 
may well operate in Streptomyces. In control cells grown in a standard 
medium a single, mildly basic and soluble form of roseoredoxin (pl 7.45) 
was present. This protein, like its published bacterial counterparts forms the 
middle component of a natural cytochrome P450 electron transfer chain. In 
vitro this S. roseochromogenes system predominantly catalyses 16a 
monohydroxylation of progesterone and as a rather minor secondary 
reaction, 2ß hydroxylation of the primary product. By contrast, pre- 
incubating the organism with progesterone results in the appearance of 
different, second, more acidic, soluble form of roseoredoxin (pI 5.6). This 
modified form increases the 2ß hydroxylation capability of the cytochrome 
P450. This is achieved by increasing the hydroxylation turnover number of 
the P450 thereby increasing the number of 2ß hydroxylation events. The 
result is seen as a decline in the 16a-monohydroxy to 2ß, 16a- 
dihydroxprogesterone ratio. That a growth inhibitory dose of cycloheximide 
added to the cells for 8h prior to the progesterone pre-incubation had no 
effect on the appearance of the pl 5.6 isoform is strongly consistent with a 
progesterone dependent post translational modification of the roseoredoxin 
rather than for transcriptional activation of a second gene. 
Transcriptional regulation of the P450 per se is a more usual regulator`' 
P450 process. Regulation of P450 catalysis ultimately by post translational 
modification of a P450 reductase, is a unique mechanism 
in P450 
regulation. There is no literature precedent for the regulation of 
ferredoxin 
activity by post-translational modification. 
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What is the nature of the post-translational modification of roseoredoxin and 
how does it modulate the activity of the P450? The covalent attachment of 
an acidic group such as phosphate is an obvious candidate to account for the 
1.85 pH unit decrease in the pI value of the roseoredoxin. This enhanced 2'ß 
hydroxylation capacity of the P450 stimulated by the modified roseoredoxin 
isoform could be accounted for by increased electron shuttling from the 
roseoredoxin reductase to the P450. This improved shuttling could result 
from enhanced interaction of the roseoredoxin with its adjacent electron 
transfer protein partners or an inherently superior electron transfer velocity 
of the modified roseoredoxin. The results of NMR experiments involving 
cytochrome P450,,, m (CYP 101) and its Fe2S2 ferredoxin electron transfer 
partner, putidaredoxin, indicate that conformational gating of the electron 
transfer complex between these two proteins may be important in their 
redox reactions (Pochapsky et al., 1996). For example, the enzymatic 
removal or modification of the C-terminal tryptophan of putidaredoxin is 
known to cause a much reduced rate of enzymatic activity in the 
reconstituted camphor hydroxylase system (Sligar et al., 1974) and (Davies 
& Sligar, 1992). 
Comparison of the properties of microsomal NADPH-P450 reductase and 
the flavoprotein domain of P450BM-3 (BMR) has revealed a significant 
difference in the mechanism of reduction of the haemoprotein P450 by these 
flavoproteins (Sevrioukova & Peterson, 1995). Microsomal NADPH-P450 
reductase transfers electrons to the haemoprotein by shuttling between 
hydroquinone and semiquinone forms of the FMN, delivering one electron 
per cycle. Since the microsomal NADPH-P450 reductase has evolved as 
part of a multi-enzyme system, this type of mechanism may permit 
regulation of the steps of the P450 reaction via variation in the affinity of the 
reductase for different P450s. This may provide a clue as to the possible 
role of the post translational modification of the P450 reductase presented in 
this work. Is the post translational modification involved in an altered 
reductase / P450 affinity? Thereby altering electron transfer efficiency and 
ultimately the rate of progesterone hydroxylation. The reductase domain 
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has evolved along with a haem domain. This enzyme was found to utilise 
the fastest and simplest way to reduce the haem iron. with the FM's moiety 
of BMR shuttling between the semiquinone and oxidised states. There are 
differences in the intermediates involved in the reduction of P450s by these 
two enzymes but the domain structures and mode of interaction between the 
reductase and P450s has been maintained over evolutionary time 
(Sevrioukova & Peterson, 1995). 
Most P450 systems which have been characterised in terms of their full 
multicomponent nature have been NADPH dependent and mammalian such 
as rat hepatic P450s. Elucidation of the mechanism of catalysis 
incorporating the three proteins purified here, has been limited by 
procedures available. However, a huge potential for further work has been 
released. Indeed, crystallisation trials and sequence analysis have already 
been initiated for this enzyme system - see chapter 8. Mechanistic 
investigation in terms of molecular changes in the protein interactions would 
require access to procedures such as magnetic circular dichroism 
(Andersson ei al., 1997) or pulse radiolysis (Kobayashi K. el al., 1990). 
These investigations for S. roseochromogenes' progesterone hydroxylase, 
remain as potential for further investigation. Amino acid sequences for the 
two proteins most discussed in this work; P450 and roseoredoxin. were 
obtained. These were short sequences but long enough to design a probe for 
a DNA library for the purpose of gene identification. Once the P450 gene 
has been identified, overexpression through cloning will enable further 
investigation of this complex enzyme system to progress. The cloning 
vector of choice may need to express the roseoredoxin and the reductase in 
order to support hydroxylation by the P450. This issue was discussed in 
chapter 6. 
It appears that the roseoredoxin here is primarily the P450 reductase 
in view 
of the evidence that its isoform had such a significant effect upon catalysis 
of the progesterone 2ß hydroxylase efficiency. The three proteins presented 
here are therefore probably the three proteins which constitute the 2ß, 16a 
7ý 1 
hydroxylase system of S. roseochromogenes in vivo. The roseoredoxin 
phenomenon would probably not have been identified if the roseoredoxin 
had been a non specific reductase. 
Considering the initial aims of this work as set out in chapter 1. the points 
have been addressed progressively chapter by chapter as the nature of this 
2P and 16a progesterone hydroxylase P450 system was revealed. For 
example, P450 in Streptomyces in chapter 3, cell-free biotransformation in 
chapter 4, P450 enzymatic modelling in chapter 6 and approaches to 
multicomponent reconstitution and P450 regulation in chapters 6 and 7. The 
potential for cloning strategy development and three-dimensional structural 
analysis was alluded to in chapter 8. It has been the intention b` discussion 
at the end of each chapter to contextualise the findings presented, thereby 
prompting routes for further investigation. 
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Abstract 
Slreptom}yces roseochromogenes, NCIB 10984, contains a cytochrome P450 which, in conjunction with two indigenous electron 
transfer proteins, roseoredoxin and roseoredoxin reductase, hydroxylates exogenous progesterone firstly to l6a- 
hydroxyprogesterone and thereafter in a second phase bioconversion to 2ß, 16a-dihydroxyprogesterone. The progesterone 16a- 
hydroxylase P450 and the two electron transfer proteins have been purified to homogeneity. A reconstituted incubation 
containing these three purified proteins and NADH, the natural electron donor, produced identical hydroxy-progesterone 
metabolites as in intact cells. 
Peroxy and hydroperoxy compounds act in a shortened form of the cycle known as the `peroxide shunt' by replacing the 
natural pathway requirement for the electron donor NADH, the electron transfer proteins and molecular O,, the terminal 
electron acceptor. In an NaI04 supported incubation, the initial rate of progesterone hydroxylation was marginally higher (1.62 
mmol progesterone/mmol P-450/h) than in the reconstituted natural incubation (1.18 mmol progesterone/mmol P-450/h) but the 
product yield was significantly lower, 0.45 mol hydroxyprogesterone produced/mol P-450 compared to 6.0 mol 
hydroxyprogesterone produced/mol P-450. These yield data show that in the reconstituted natural pathway, progesterone 160C- 
hydroxylase P450 supports multiple rounds of hydroxylation in contrast to a likely single oxygenation by a minority of P450s in 
the peroxide shunt pathway. © 2000 Elsevier Science Ltd. All rights reserved. 
Keywords: Streptomyes roseochromogenes; Progesterone 16x-hydroxylation; Cytochrome P450; Cytochrome P450 electron transfer proteins 
1. Introduction 
The genus Streptonryces is a rich source of cyto- 
chrome P450 monoxygenase enzymes that are involved 
in a wide variety of biosynthetic and xenobiotic trans- 
formation reactions. In Streptomyces antibioticus, this 
enzyme is responsible for C-8 epoxidation of the lac- 
tone ring of the antibiotic oleandomycin [1]. The DNA 
sequence of the S. antibioticus P450 is related to the 
eryF gene of S. erythraea (Saccharopolyspora c y- 
thraea) which codes for a soluble cytochrome P450 
Abbreviations: PAGE; polyacrylamide gel electrophoresis; P450; 
cytochrome P450. 
* Corresponding author. Fax: +44-181-983-0531. 
(CYP107) that stereospecifically 6-hydroxylates 6-deox- 
yerythronolide B to erythronolide B during erythromy- 
cin A biosynthesis [2]. In S. carbophilus P450Sc 
hydroxylates compactin to pravastatin, a tissue-selec- 
tive inhibitor of 3-hydroxy-3-methylglutamyl-coenzyme 
A reductase [3]. The sulphonyl urea herbicide chlori- 
muron ethyl is metabolised by two inducible S. griseo- 
/us P450s, P450su1 (CYP105A1) and P450su2 
(CYP105B1) [4]. S. griseus contains a cytochrome 
P450 that is inducible by the isoflavenoid genistein pre- 
sent in soyaflour [5]. Extracts of this organism, pre- 
pared from soya flour-induced cells and supplemented 
with spinach ferridoxin and ferridoxin-NADPH re- 
ductase are capable of aromatic benzylic and alicyclic 
hydroxylation [6]. The ChoP gene of Sireptomyces sp. 
0960-0760/00/S - see front matter Q, 2000 Elsevier Science Ltd. All rights reserved. 
P11: S0960-0760(99)00132-6 
154 J. R. Berrie et a!. / Journal of Steroid Biochemistry & Molecular Biology 71 (1999) 153-165 
SA-COO encodes a cholesterol oxidase cytochrome 
P450 that has a high degree of homology with human 
and Pseudomonas P450s [7]. 
A plethora of Streptoinyces species have been widely 
reported as excellent steroid hydroxylators. C2 and C4 
hydroxylation of the phenolic steroid oestradiol is 
known to be P450 catalysed [6]. Skeletal sites trans- 
formed in non-phenolic steroids include 41,2ß, 6ß, 7ß, 
9a lla, 11ß, 15a and 16a [for examples [8-15]] but 
unlike in the oestradiol bioconversion the nature of 
these other steroid hydroxylases is unknown. However 
by analogy with steroid hydroxylation in the bacterial 
species Bacillus cereus [16] and B. megateriuni [17] a 
reasonable assumption is that these hydroxylases are 
site-selective cytochrome P450 monooxygenases. 
In this paper we identify 16a-monohydroxy and 
2ß, 16a-dihydroxyprogesterone as the transformation 
metabolites produced by S. roseochroinogenes during a 
72 h incubation with exogenous progesterone. We also 
report the purification to homogeneity of the cyto- 
chrome P450 responsible for in vitro progesterone 16a 
hydroxylation and the two endogenous electron trans- 
fer proteins, roseoredoxin and roseoredoxin reductase. 
2. Methods 
2.1. Materials 
Streplonzyces roseochromogenes strain 10984 was 
purchased from the National Collection of Industrial 
and Marine Bacteria (NCIB) Ltd., Aberdeen, 
Scotland. 
Media and general chemicals were purchased from 
the sources previously described [18]. Epoxy activated 
Sepharose 6B was purchased from Pharmacia Biotech 
Ltd., St. Albans, Herts., UK; MIMETIC Blue 1 A6XL 
affinity resin was obtained from Affinity 
Chromatography Ltd., Freeport, Ballasala, Isle of 
Man, UK and Cibacron Blue FG3A and NAD- 
Sepharose affinity gel from Sigma Chemical Co., 
Poole, Dorset, UK. 
2.2. Media, culture maintenance and cultivation of S 
roseoclu"omogenes strain 10,984 
S. roseoclu"omogenes was grown at 25°C on yeast 
extract-malt extract-glucose (YMG) agar slopes and 
plates. YMG agar contained yeast extract (4 g), malt 
extract (10 g), glucose (4 g) and agar (15 g)/l of de- 
ionised H2O and pH 7.2. The organism was stored at 
4°C and sub-cultured every three months. The agar 
was omitted from liquid YMG. 
2.3. Steroid transformation by S. roseochromogenes 
strain 10,984 
Steroid transformations were performed essentially 
as previously described for filamentous fungi [18]. For 
small-scale analytical experiments, cells were grown at 
25°C for 48 h with continuous shaking (100 rpm in an 
orbital incubator) in 50 ml YMG in 500 ml conical 
flasks containing coiled wires to aid aeration and dis- 
persal of biomass. After an initial 24 h of growth, pro- 
gesterone (0.25 ml of a 20 mg/ml stock solution in 
ethanol) was added to each culture flask. After a 
further 24 h, cells were harvested by centrifugation in 
an 8x 50 ml angle rotor spun for 30 min at 8000 rpm 
and 4°C in a Sorvall 5B centrifuge. The supernatant 
was decanted and extracted with two equal volumes of 
chloroform. The organic layers were collected, com- 
bined and evaporated to dryness. 
To obtain sufficient pure metabolites for structure 
determination, progesterone transformation incu. 
bations were increased fourfold. 
2.4. Determination of progesterone metabolite yields 
produced by S. roseochromogenes strain 10,984 
Yields of progesterone metabolites produced by S. 
roseochromogenes were determined by TLC and 
HPLC. In the TLC method exactly 5 mg of progester- 
one was added to each incubation and dried trans- 
formation products were dissolved in exactly 100 µl 
HPLC-grade methanol. Equal A242 absorbance units 
of sample contained in ca 5 µl were spotted onto fluor- 
escent high-performance Kieselgel 60 F254 TLC plates, 
which were developed in an ethyl acetate/ether/toluene 
(4: 3: 3 by volume) solvent system. Steroids were viewed 
under UV light and plates were photographed. 
Individual spots were scraped from the TLC plate and 
eluted in HPLC-grade methanol. Dried steroids were 
re-dissolved in exactly 1 ml of methanol and the UV 
absorbance at 242 nm was measured. The absolute 
amount of steroid present was determined by reference 
to a calibration curve. 
In the HPLC method, progesterone metabolites were 
separated in 60% aqueous methanol on an analytical 
reverse-phase Whatman Partisil PXS 5/25 ODS col- 
umn. Column effluent was passed through an Pye 
Unicam PU 4020 UV detector set at 254 nm, 
Metabolite concentrations were calculated from the 
areas of the individual peaks eluting from the co1um11 
measured on a Hewlett Packard Integrator. 
2.5. Purification and structure determination of 
progesterone metabolites produced by S. 
roseochromogenes strain 10,984 
Metabolites for structure determination were puri- 
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fled as described above from scaled-up incubations. 
Analyses were by 1H NMR spectroscopy on a Bruker 
WH400 MHz spectrometer as previously described 
[18]. 16a-Hydroxyprogesterone was identified by the 
`fingerprint' method [18], which involved superimpos- 
ing spectra of authentic monohydroxy steroid stan- 
dards on the spectrum of putative 16a 
hydroxyprogesterone. This assignment was confirmed 
by measuring chemical shifts of key substituent pro- 
tons of 16cc-hydroxyprogesterone and comparing these 
values with those in authentic monohydroxyprogester- 
ones [19]. A full range of dihydroxyprogesterone spec- 
tra was not available to permit identification of 
20,16a-dihydroxyprogesterone by fingerprinting. The 
structure of this metabolite was assigned by the chemi- 
cal shift calculation method described above for 16a- 
hydroxyprogesterone and by a full 2-D 1H COSY 
spectrum analysis (homonuclear correlation spec- 
troscopy) [18]. 
2.6. Purification of progesterone 16a-Irydroxylase 
cytochrome P450 frone S. roseochrornogenes strain 
10,984 
S. roseochronzogenes was grown in 200 ml batches as 
described above. Cell pellets were resuspended in buf- 
fer A (0.1 M Na phosphate, 10 mM EDTA, pH 7.2) 
containing 10% glycerol. Washed cells were harvested 
and the pellets obtained were pressed between several 
sheets of Whatman 3MM chromatography paper to 
remove excess moisture and the resulting cake was 
stored at -70°C. 
Cells were disrupted by adding an equal mass of 
acid-washed sand to partially thawed biomass and the 
mixture was suspended in 1.5 ml ice-cold buffer 
A+ 10% glycerol/g cell biomass. The mixture was 
blended at full speed in an ice-cold MSE propeller 
style homogeniser in six bursts of 30 sec duration. The 
slurry was centrifuged at 15,000 rpm for 30 min at 4°C 
to remove particulate matter. The supernatant (S15) 
was decanted and stored at -70°C. 
All purification procedures were performed at 0- 
4°C. S15 fraction (10 ml) was loaded onto a Whatman 
DE52 DEAE-cellulose anion exchange column (100 
ml) previously washed and equilibrated in buffer B 
(0.1 M Na phosphate, 5 mM EDTA, 0.25 mM DTT 
and 10% glycerol). The column was washed with 2 
bed volumes of buffer B before proteins were eluted 
stepwise in buffer B containing 100,200 and 300 mM 
NaCl. Each fraction was assayed for progesterone 16a- 
hydroxylase activity as described below. 
The 200 mM DE-52 fraction, containing progester- 
one 16c -hydroxylase activity, was dialysed overnight 
against two changes of buffer B. This fraction was 
then loaded onto an lla-hydroxyprogesterone coupled 
Sepharose 6B affinity column (11 ml) which was 
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washed and equilibrated in buffer B. Unbound protein 
was washed from the column in two bed volumes of 
buffer B. Bound proteins were eluted in three separate 
fractions of buffer B containing 100,150 and 200 mM 
NaCl. The 150 mM NaCl fraction contained the hy- 
droxylase activity. This fraction was dialysed as 
described above. 
The dialysed progesterone affinity fraction was 
loaded onto a MIMETIC Blue 1 A6XL column (15 
ml). This column was washed with buffer B followed 
by buffer B containing 100 mM NaCl to remove all 
non-specifically bound protein. Progesterone 16c -hy- 
droxylase activity was eluted with 120 mM NaCl in 
buffer B. 
2.7. Cytochronie P450-dependent progesterone 
hydroxylation 
The progesterone 16a-hydroxylase activity of purifi- 
cation fractions was determined using the NaIO4 
method as previously described [23-25]. Progesterone 
(4 mM) and NaIO4 (1.5 mM) were added to 0.5 ml of 
fraction contained in metal capped Bijou bottles. 
Mixtures were made up to 1 ml with buffer B. Bottles 
were fixed to a turn-table that was vertically rotated at 
40 rpm for 2h at 25°C. Steroid metabolites were 
extracted from the incubations by shaking the mixtures 
with chloroform (1 ml) for I min. The chloroform 
layer was removed and evaporated at 60°C. The resi- 
due was dissolved in methanol (10 µl) and spotted 
onto TLC plates. These were run and processed as 
described above. 
In the natural reconstituted system in which the 
Na104 was replaced by NADH, purified progesterone 
16a-hydroxylase cytochrome P450, roseoredoxin and 
roseoredoxin reductase (e. g. Table 6), hydroxylation 
was absolutely specific for NADH. NADPH did not 
substitute at any concentration tested. The NADH op- 
timum for hydroxylation in these assays was 2 mM. 
Steroid metabolites synthesised in the above incu- 
bations were identified only by TLC because the tiny 
quantities of compound produced precluded full 
chemical or NMR structural analysis. The TLC spots 
obtained co-chromatographed with spots of the auth- 
entic 16a-monohydroxy- and 20,16a-dihydroxyproges- 
terone produced by intact S. roseochroniogenes. 
2.8. Production of reduced cytochrome P450 carbon 
monoxide difference spectra and determination of 
cytochrome P450 concentration 
The cytochrome P450 concentrations of purification 
fractions were measured from difference spectra in a 
split beam Pye Unicam PU8800 spectrophotometer. 
Equal volumes of a P450-containing fraction were 
pipetted into two matched glass cuvettes. A few grains 
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of solid sodium dithionite were added to both fractions 
to reduce the P450. The cuvettes were gently inverted 
until the dithionite had dissolved, after which they 
were simultaneously scanned between 390 to 520 nm 
to obtain a zero baseline. Carbon monoxide was 
bubbled for 1.5 min into the test cuvette at a rate of I 
bubble/s. The CO difference spectrum was then 
obtained by re-scanning between 390 to 520 nm. 
To determine the concentration of cytochrome P450 
in a particular fraction, the absorbance of that fraction 
was measured from the difference spectrum at 450 and 
490 nm. The values obtained were applied to the for- 
mula: 
P450 concentration = 
A450, m - A490nm 
Eo 
where Eo is the millimolar absorbance coefficient of 
P450450-490 and is 91 cm-'/mM-1. 
2.9. Purification of electron transfer proteins from S 
roseochromogenes strain 10,984 
The roseoredoxin reductase (ferredoxin reductase) 
was purified from the flow-through wash of the DE-52 
DEAE-cellulose column obtained in the first stage of 
P450 purification. This fraction was directly loaded 
onto a Whatman DE-32 DEAE-cellulose column and 
eluted with a linear 0-300 mM NaCl gradient made 
up in buffer B and 10% glycerol. Fractions (5 ml) 
were collected and assayed for cytochrome c reductase 
activity at 550 nm and for NADH oxidation at 340 
nm. Also, the spectrum of each fraction was recorded 
from 260 to 460 nm and compared to that of a stan- 
dard of authentic FAD. 
Fractions which reduced cytochrome c, oxidised 
NADH and contained FAD, were pooled and dialysed 
for 8h against buffer B before loading on to a 
Cibacron Blue FG3A column and eluted with a linear 
0-200 mM NaCl gradient in buffer B. Fractions (2.0 
ml) were collected and assayed as described above. 
Active fractions that contained roseoredoxin reductase 
were pooled, dialysed against buffer B+20% glycerol 
(buffer C) and stored at -70°C. 
The roseoredoxin reductase DE-32 cellulose column 
fractions obtained above were used to purify roseore- 
doxin (ferredoxin), the second electron transfer protein 
in the S. roseochromogenes progesterone 16a-hydroxyl- 
ase cytochrome P450 pathway. Roseoredoxin activity 
was assayed by measuring the rate of cytochrome c re- 
duction in the presence of NADH and purified roseor- 
edoxin reductase (Cibacron Blue fraction). The 
stimulation of the basal rate of electron transfer, from 
roseoredoxin reductase directly to cytochrome c, was 
used to measure roseoredoxin activity. Active fractions 
were pooled and dialysed as described above and then 
applied to an NAD-Sepharose affinity column. 
Proteins were eluted with a linear 0-100 mM KCl gra- 
dient in buffer B. KCl buffers were required due to 
loss of electron transfer activity in NaCl. Fractions 
were assayed for cytochrome c reductase activity as 
described above and the absorbance of these fractions 
was measured at 280 and 414 nm. Active fractions 
containing the highest A414/A280 ratios were pooled 
dialysed against buffer C and stored at -70°C. 
2.10. Measurement of S. roseochromogenes 
roseoredoxin and roseoredoxin reductase activity 
Roseoredoxin activity was measured in a final 
volume of 1 ml containing 100 mM Na phosphate, 5.2 
mM MgCl2 buffer pH 7.2,0.05 mM cytochrome c 
0.05 units roseoredoxin reductase and 0.2 mM NADH: 
(1 unit of roseoredoxin reductase is the amount of pro_ 
tein required to reduce 0.5 µmol of cytochrome c per 
min in the presence of excess roseoredoxin). The rate 
of cytochrome c reduction was measured at 550 1111 
against a control incubation without NADH 
Cytochrome c reduction was measured to completion 
of the reaction at 25°C. The absolute amount reduced 
was calculated by measuring the absorbance difference 
between the test and control incubations at 550 nnl. 
An absorbance coefficient of 29.9 mM/cm was used to 
calculate reduced cytochrome c and 8.9 mM/cm for 
oxidised cytochrome c. 
Roseoredoxin reductase activity was measured as described above except that roseoredoxin was omitted 
from the incubations. 
2.11. SDS-polyaciylamide gel electrophoresis 
SDS-PAGE (15% by wt) was performed according 
to the method of Laemmli [20] except that the running 
buffer contained glycerol (10% by volume). Gels were 
run at 125 V for 3 h, stained with Coomassie Brilliant 
Blue and. if appropriate, over-stained with silver [21]. 
2.12. Protein determinations 
Protein concentrations were determined using a 13i. - Rad Protein Assay Kit (Bio-Rad Laboratories, Hemel 
Hempstead, Herts., UK). 
2.13. Coupling of 11 a-Irydroxyp"ogesterone to Sepharose 
6B 
Freeze dried epoxy-activated Sepharose 6B (1 g) was 
swollen by suspending in distilled water (100 ml) and 
gently stirring for 5 min. The gel was harvested by fil- 
tration onto a scintered glass funnel under vacuum. 
The gel was then washed for 1h with distilled water 
(1200 ml) before coupling to l la-hydroxyprogesterotie. 
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Fig. 1. HPLC of 25 h progesterone transformation incubation by S. roseochroinogenes. From left to right, peak 1,20,16x-dihydroxyprogesterone 
(retention time 14 min); Peak 2,16a-mono-hydroxyprogesterone (retention time 27 min); Peak 3, progesterone (retention time 89 min). 
The coupling was performed by adding Sepharose 
6B to 1.8 mg of lla-hydroxyprogesterone dissolved 
in coupling buffer containing 100 ml dimethylforma- 
mide+ 100 ml 0.1 M Na phosphate buffer pH10. 
The suspension was incubated for 16 h at 32°C. 
After washing the coupled gel with copious phos- 
phate buffer, unreacted epoxy groups were blocked 
by incubation in 1.0 M ethanolamine at 40°C for 10 
h. The gel was again washed with phosphate buffer 
and the slurry poured into a glass column. The col- 
umn was washed in turn with three bed volumes of 
0.1 M acetate, 0.1 M NaCI buffer pH 4.0,0.1 M 
borate, 0.5 M NaCl buffer pH 8.0 and finally with 
buffer B. 
Table I 
Progesterone and its 2D and 16a-hydroxylated derivatives and HPLC peak I progesterone metabolite' 
Compound 4-H 17a-H 18-H 19-H 21-H CHOH 
Progesterone 5.73 2.54 0.67 1.20 2.13 
2(3-Hydroxy-progesterone 5.82 (0.09) 2.54 (0.00) 0.67 (0.00) 1.18 (-0.02) 2.13 (0.00) 4.20 (2(x-H) (1.85) 
16: c-Hydroxy-progesterone 5.75 (0.02) 2.54 (0.00) 0.68 (0.01) 1.19 (-0.01) 2.18 (0.05) 4.86 (160-H) (2.67) 
2(1,161-Dihydroxy-progesterone° 5.84 (0.11) 2.546 (0.00) 0.68 (0.01) 1.17 (-0.03) 2.18 (0.05) 4.20 (2a-H) (1.85) 
4.86 (160-H) (2.67) 
HPLC peak 1 
5.83 (0.10) 2.54b (0.00) 0.67 (0.00) 1.18 (-0.02) 2.18 (0.05) 4.19 (2a-H) (1.84) 
4.88 (16(3-H) (2.69) 
ä, Relative to Me4Si. Increments relative to progesterone in parentheses. bS calculated from the summed individual group increments, relative to progesterone. `doublet. 
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3. Results 
3.1. Identification of progesterone metabolites produced 
by S. rosechromogenes strain 10,984 
Two metabolites were purified from a 25 h pro- 
gesterone transformation incubation and are shown in 
the HPLC trace in Fig. 1. These metabolites were 
identified by 1H NMR spectroscopy as 2ß, 16a-dihy- 
droxyprogesterone (Fig. I peak 1, retention time 14 
min) and 16c -monohydroxyprogesterone (Fig. I peak 
2, retention time 27 min). The NMR identifying fea- 
tures of 16c-hydroxyprogesterone have been described 
previously [22]. 
3.2. NMR data for 2ß, 16a-dlhydrosyprogesterone 
The 'H NMR spectrum of 20,16a-dihydroxyproges- 
terone has not been previously published. Therefore, 
we identified this compound by matching the measured 
values for the chemical shifts of key identifying signals 
of peak 1 metabolite to theoretical values calculated 
for 20,16a-dihydroxyprogesterone (Table 1). The cal- 
culations involved summing the published values of 
the key identifying protons in 2ß- and 16a-monohy- 
droxyprogesterone [19]. 2D COSY analysis confirmed 
the structure. The features of structural significance of 
20,16a-dihydroxyprogesterone are summarised below. 
Peak I retained the fundamental signals of the pro- 
gesterone skeleton, i. e. 4-H (s', 6 5.83), 18-H3 (s, S 
0.67), 19-H3 (s, S 1.18), 21-H3 (s, 6 2.18) and displayed 
the features of dihydroxylation with two clearly separ- 
ated mid-field multiplets between 6 4.9 and S 4.2 at- 
tributable to methine protons of secondary 
hydroxylated carbon atoms. The shape and spectral 
position of these peaks was consistent with 20,16a- 
dihydroxylation. This transformation was confirmed 
by the following spectral data. The characteristic tri- 
plet of l7a-H in progesterone was coincident with a 
predicted doublet (ö 2.54), consequent on splitting by 
the 160-H. 16a-Hydroxylation was confirmed by the 
strong correlation of the 17-H in the COSY with the 
distinctive mid-field multiplet (2.69 ppm) at S 4.88 
extant at lower field than any other CHOH proton of 
a hydroxyprogesterone as a result of the proximity of 
the 160-H to the 20-oxo group. Correlation of COSY 
cross peaks of the mid-field multiplet CHOH signal at 6 4.19 with la-H at S 2.4, which was significantly 
shifted to low field (0.71 ppm) relative to progesterone 
and to 1 ß-H (S 1.56) and unusually shifted to high field (-0.48 ppm) relative to progesterone, confirmed 2f-hydroxylation. 
S, singlet; m, multiplet. 
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3.3. Time course of progesterone transformation by S. 
roseochromogenes strain 10,984 
16c -Hydroxyprogesterone, the major metabolite of 
progesterone transformation, first appeared in the cul- 
ture medium after 6h of incubation (Table 2). This 
metabolite was actively produced throughout the entire 
24 h incubation but the rate of production significantly 
slowed after 22 h. A second phase metabolite, 2ß, 16a- 
dihydroxyprogesterone, was first detected in the cul- 
ture medium 2h after the first appearance of 16a. -hy- 
droxyprogesterone. This compound steadily 
accumulated during the next 13 h of transformation 
but at less than half the rate of synthesis of 16a-hy- 
droxyprogesterone. Production also virtually ceased at 
21 h. 20-Hydroxyprogesterone, the counterpart mono- 
hydroxy metabolite to 16a-hydroxyprogesterone, was 
not observed at any time during the 24 h transform- 
ation period. At the end of transformation, 25% of 
substrate progesterone had been converted into hy- 
droxylated products of which ca 72% was 16a-hy- 
droxyprogesterone and ca 28% was 2ß, 16a- 
dihydroxyprogesterone. 
3.4. Optimisation of progesterone hydroxylation by S1S 
homogenates of S. roseochromogenes strain 10,984 
The conditions summarised below were established 
for optimal periodate hydroxylation of progesterone 
by S. roseochromogenes S15 supernatants (data not 
shown). The most active extracts were obtained from 
mature cultures grown for about 35 h and from cells 
disrupted by blending for 3 min with an equal mass of 
sand in bursts of 30 s, interspersed with 30 s resting on 
ice. Protease inhibitors in the blending buffer had no 
significant effect on hydroxylation, whereas the ad- 
dition of 10% glycerol stimulated hydroxylation nearly 
3-fold. EDTA concentrations to 10 mM were slightly 
stimulatory (30%) but were strongly inhibitory at 
higher concentrations. At 30 mM EDTA, hydroxyl- 
ation was totally inhibited. A similar effect was 
observed with DTT. The optimum concentration that 
gave 50% stimulation was 0.5 mM and 3 mM DTT 
inhibited hydroxylation by 50%. The pH activity pro- 
file was extremely sharp, the optimum being pH 7.2. 
Hydroxylation was severely inhibited either side of this 
value (30% respectively at pH 7.0 and 7.6). In contrast 
the Na104 oxidant optimum was broad and flat from 
1.5 mM to 5 mM. A true optimum for progesterone 
concentration could not be determined due its poor 
solubility in incubation buffer. 
Thus, varying the concentration from 0.5 to 7.5 mM 
(beyond the solubility limit) had virtually no effect on 
metabolite production. 
Using these optimal conditions, hydroxylation was 
linear for up to 18 minutes at 25°C and was pro- 
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Fig. 2. SIDS-polyacrylamide gel of purified S. roseochronrogeoes 16x- 
hydroxylase cytochrome P-450. roseoredoxin and roseoredoxin re- 
ductase. From left to right, lane I. roseoredoxin reductase (3.1 pg 
M, 65 x 103); lane 2, roseoredoxin (2.5 µg M, 14 x 103); lane 3, pro- 
gesterone 16x-hydroxylase cytochrome P451) (4 jig Mr 63 x 10'); lane 
4, wide range protein size ladder M, 205 x 1()3 14.2 x 103; lane 5, E 
lower range protein size ladder M, 66 x 103-14 2x 10;; and lane 6. o o 
upper range protein size ladder M, 205 x 103-45 x 10'. Lanes 46 E r. "t. -° 
CäN 
contained 35 pg total protein. °" " 
°o°-- "' Cl 
portional to S15 concentrations between I to 6 mg 
protein ml. Hydroxylation was 50% inhibited by I µg 
nil ketoconazole and 100% inhibited by 4 µg/ml. This E öö 
ketokonazole inhibition is supportive of cytochrome 
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P450 as the progesterone 16a-hydroxylase enzyme. 
c 
3.5. Purification of progesterone 16x-ht'dro. vt lase - Cl, axx ON 0 . 
evtochrome P450 from S. roseochromogenes strain 
v, x ýoc 
o ri 
10984 - 0 
A three step procedure was used to purify progester- 
one 16x-hydroxylase cytochrome P450 to homogeneity 
judged by SDS-PAGE and silver staining (Fig. 2). S 
Na104 was used in the hydroxylation assays in lieu of >' 
NADH and the electron transfer proteins required in 
the natural P450 pathway. The details of the P450 z 
purification are summarised in Table 3. S. roscochro- 2 
mogcnes S15 extract was applied to a DE52 DEAE-cel- 
lulose column, which was eluted by a step 50 350 mM 
NaCl gradient. The hydroxylase activity was in the 200 z 
mM NaCl fraction. This fraction contained less than ä 
5% of the total protein applied to the column. 2 C 
After dialysis, the DE52 fraction was applied to a °' 
progesterone affinity column and eluted with a NaCl 
step-gradient. The fractions obtained were assayed for 
haemoproteins by absorbance at 417 nm as well as for 
general protein (absorbance at 280 nm). Over 95% of ö 
the general protein applied to this particular column 
failed to bind and eluted in the flow-through and wash L ý 
L3 
. 
fractions. These fractions contained virtually no hae- 
moprotein. The haemoprotein was found to bind mod- nOn 
' eratel tightly to the affiinit ligand and, Y progesterone Y -C 
LW W 7 
together with the remaining 6.5% of protein, eluted in ä 0. 
w. 2 in ooa 
IkL Adi 
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 Dithionite reduced, carbon monoxide difference spectrum of the 120 mM NaCl MIMETIC Blue I affinity column fraction. Each cuvette 
c .;: -d 0.79 mg P450. 
l; Wi rnM NaCl. This fraction contained all the hy- 
d: oxylase activity. 
In the third purification step, the 150 mM NaCl pro- 
e,: -,; z , -one affinity 
fraction was applied to a MIMETIC 
;,: r I affinity column. This column also proved to be 
cx. remely efficient as virtually 
100% of the 417 nm 
a; -. sorbing material 
initially applied, i. e. the haemopro- 
-in, was bound but only 3% of the total protein. All 
r.,;; nd protein and progesterone 16(x-hydroxylase ac- 
t:; it eluted in the 120 mM NaCl fraction. A single 
protein band was seen for this 
fraction on SDS-PAGE 
(Fi . 
2). Single protein bands were also observed on 
h. a n-stained and Coomassie blue-stained 
5% native 
a. r. lamide gels and on 3% isoelectric 
focusing gels 
(;:; alts not shown). An Mr value of 
63 x 103 was 
d tzrmined for the P450 from the SDS-PAGE and a 
-! , alue of 6.6 from the isoelectric focusing gels. 
Ra&cd on CO difference spectroscopy, a 182 fold 
;,:. rifcation and a yield of 1.3% native P450 was cal- 
cz; ':, d for this simple purification procedure. A small 
r.; in ority of the cytochrome P450 was in inactive P420 
krrn (Fig. 3). 
3f, Puricatioii of the progesterone 16a-hydroxylase 
c, tochrome P450 electron transfer proteins roseoredoxin 
' Jictase and roseoredoxin from S. roscochromogenes 
4'cin 10,984 
1F. c DE-52 DEAE-cellulose column flow-through 
s, gash, obtained from the first stage of P450 purifi- 
v; as used as starting material for the purifi- 
of the electron transfer proteins roseoredoxin 
-aasc and roseoredoxin. A two step procedure was 
"d to purify to homogeneity both proteins. The data 
for these methods are shown in Table 4 (roseoredoxin 
reductase) and Table 5 (roseoredoxin) respectively. 
In the case of roseoredoxin reductase, a second 
DEAE column, containing DE32 cellulose, followed 
by dye affinity chromatography on Cibacron Blue 
FG3A resulted in a 258 fold purification of this par- 
ticular protein. Roseoredoxin co-eluted with the 
roseoredoxin reductase in the DE32 300 mM NaCl 
fraction, but was separated from the latter protein by 
NAD-Sepharose affinity chromatography to give a 
final 163 fold purification. Both proteins gave single 
bands in SDS-PAGE (Fig. 2). Mr values of 14 x 103 
and 65 x 103 were determined from the SDS-PAGE 
gels for roseoredoxin and roseoredoxin reductase re- 
spectively (Fig. 2). 
3.7. Comparison of progesterone metabolism catalysed 
by a reconstituted natural cytochr"ome P450 dependent 
hydroxylation pathway and an Na104 dependent 
peroxide shunt pathway 
The roseoredoxin, roseoredoxin reductase and 
NADH requirement in the natural progesterone 16a- 
hydroxylase cytochrome P450 hydroxylation pathway 
is replaceable by an organic or inorganic peroxy or 
hydroperoxy compound (XOOH) such as NaI04. 
When these two pathways were compared for pro- 
gesterone transformation catalysed by highly purified 
S. roseochromogenes progesterone 16a hydroxylase 
cytochrome P450, it was found that the initial rate of 
hydroxylation was nearly 40% greater in the Na104 
peroxide shunt pathway (1.62 mmol progesterone con- 
verted/mmol P-450/h) than in the natural reconstituted 
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Table 6 
Comparison of progesterone metabolism catalysed by the reconstituted natural cytochrome 
P450 dependent hydroxylation pathway and the 
Nal04 dependent pathway 
Pathway Initial rate of progesterone transformation (mmol progesterone/mmol P-450/h) Turnover (mol progesterone/mol P-450) 
Reconstituted 1.18 6.00 
Na104 1.62 0.45 
450/h). By contrast, the peroxide shunt pathway sup- 
ported 13 fold fewer hydroxylation events per molecule 
of P450 (0.45 mol progesterone converted/mol P-450) 
than the reconstituted pathway (6.0 mol progesterone 
converted/mol P-450) (Table 6). 
4. Discussion 
S. roseochromogenes was first identified as catalysing 
steroid 20- and 16a-hydroxylation 40 yr ago during 
the search for microorganisms capable of efficient and 
mild stereospecific access of the 16 site of the steroid 
nucleus [e. g. [23-24]]. Microbial access of this site was 
eventually employed for the synthesis of a new gener- 
ation of highly potent, synthetic, anti-inflammatory 
pharmaceuticals exemplified by triamcinalone (9a- 
fluoro-11 0,16a, 17a, 21-tetrahydroxy-pregna-1,4-diene- 
3,20-dione) developed to replace natural corticoster- 
oids found to suffer mineralocorticoid contraindica- 
tions. 
S. roseochromogenes 10,984 possesses strong pro- 
gesterone 2ß- and 16a-hydroxylation activities. The 
time course of progesterone transformation (Table 2) 
shows 16a-hydroxylation to be the primary event and 
2ß-hydroxylation to be a second phase reaction using 
16oc-monohydroxyprogesterone as substrate. Thus, 
16a-monohydroxyprogesterone was first detected in 
the culture medium after 6h of incubation and 
20,16a-dihydroxyprogesterone appeared 2h thereafter 
at 8 h. That this is the true route of progesterone bio- 
conversion was shown when S. roseochromogenes 
transformed exogenous 16a-hydroxyprogesterone to 
20,16a-dihydroxyprogesterone. Moreover, free 2(3- 
monohydroxyprogesterone was never detected in our 
system even in transformation incubations containing 
20 mg of progesterone and a metabolite detection 
threshold of under 0.1 mg of steroid. 
There is now a wealth of compelling evidence identi- 
fying cytochrome P450 as responsible for steroid hy- 
droxylation reactions in both bacteria and filamentous 
fungi e. g. in bacteria - 6ß in Bacillus therrnoglucosida- 
sius [25] and 15[3 in Bacillus megaterium [17]: in fila- 
mentous fungi - 7a in Phycom}ices blakesleeanus [26]; 11 a in Aspergillus funzigatus [27], Aspergillus ochraceus 
[28], Nectria haematococca [29] and Rhizopus nigricans 
[30]; II P in Cochliobolus lunatus [31]; and 15a in 
Penicillium raistrickii [32]. Despite the long history and 
extensive literature on microbial steroid hydroxylation 
no such role has so far been indisputably assigned to 
P450 for this reaction in Streptomyces species. 
Therefore, this paper is the first report to identify 
unequivocally cytochrome P450 as a steroid hydroxyl- 
ase enzyme in the Streptomyces genus. 
A turnover number of ca 0.02/min was calculated 
for S. roseochronzogenes P450 catalysed progesterone 
hydroxylation in the reconstituted pathway and a com- 
parable value of ca 0.03/min for the Na104 dependent 
pathway. Both numbers are now the lowest reported 
for a purified P450 being an approximate order of 
magnitude lower than the previous bottom of the table 
turnover numbers of 0.6/min reported for the steroid 
153-hydroxylase cytochrome P-450 (P-450,,, es) of Bacillus megateritun [33] and of 1.8/min and 2.1/min 
reported for precocene II and 7-ethoxy coumarin hy- 
droxylation respectively catalysed by a crude fraction 
of S. griseus P450 [6]. The reason for this catalytic 
inefficiency is unclear, but it may be connected with 
the fact that progesterone is almost certainly not the 
physiological substrate for the S. roseochromogenes 
P450. Thus, a meaningful comparison of the true effi- 
ciency of this enzyme with its bacterial counterparts 
cannot be made until a natural substrate is identified. 
However these data show that in the natural pathway 
highly pure S. roseochromogenes P450 catalyses mul- 
tiple cycles of hydroxylation even with the unnatural 
steroid substrate. 
In contrast to steroid hydroxylation, cytochrome 
P450 has been identified in several Streptomyces path- 
ways of secondary metabolism. Thus, this enzyme par- 
ticipates in oleandomycin biosynthesis in Streptomyces 
antibioticus [1], the hydroxylation of compactin to pre- 
vastatin by Streptomyces carbophilus [3] and in a wide 
variety of xenobiotic transformations in Streptomyces 
griseus [4-6]. 
Cytochrome P450 genes have been cloned from only 
two Streptomyces species, S. griseohis and S. griseus. 
In S. griseolus, genes for the herbicide-inducible cyto- 
chromes P450, P450SU1 and P450SU2, have been 
sequenced and the amino acid sequence of segments of 
the encoded proteins deduced. These proteins were 
found to possess high sequence identity to the 
Pseudomonas putida camphor hydroxylase P450 (P450 
101, P450cam) particularly in the haem binding domain 
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[34]. A DNA segment carrying the structural gene 
encoding P-450, y (soyC), has 
been cloned from S. gri- 
seus. It is noteworthy that this cytochrome P450 also 
has high sequence conservation with P450cam in the 
haem binding region [35]. It would be interesting to 
compare the primary sequence of the S. roseochronzo- 
genes progesterone 16u-hydroxylase cytochrome P450 
with those of these other Streptomyces P450s. 
Ferredoxin electron transfer proteins have also been 
purified from the above two Streptonryces species. S. 
griseolus was found to contain two 7 kDa isoforms, 
designated Fd-1 and Fd-2. These proteins have 52% 
identity and both contain single [3Fe-4S] clusters [36]. 
Both ferredoxins are active in reconstituted cell-free 
systems containing the SUI P-450 isoform, although 
Fd-2 is more effective. The genes for the ferredoxins 
and the sulfonylurea P450 monooxygenases are vir- 
tually contiguous. Thus P-450SU1 and the downstream 
Fd-1 form a closed spaced pair, similarly P-450SU2 
and Fd-2. In S. griseolus only a single ferredoxin 
encoded by SOY B has been putatively identified. The 
situation in S. roseochrornogenes remains to be 
resolved. 
Acknowledgements 
NMR spectroscopy was performed under the 
ULIRS WH-400 NMR service at Queen Mary and 
Westfield College by Mr Peter Haycock and at Kings 
College by Mrs Jane Hawkes. 
References 
[1] A. M. Rodriguez, C. Olano, C. Mendez, C. R. Hutchinson, J. A. 
Salas, A cytochrome P450-like gene possibly involved in olean- 
domycin biosynthesis by Streptomyces antibioticurs, FEMS 
Microbiol. Lett. 127 (1995) 117-120. 
[2] A. Shafiee, C. R. Hutchinson, Macrolide antibiotic biosynthesis: 
isolation and properties of two forms of 6-deoxyerythronolide 
B hydroxylase from Saccharopolyspora erythraea (Streptomyces 
erythreus), Biochemistry 6 (1987) 6204-6210. 
[3] T. Matsuoka, S. Miyakoshi, K. Tanzawa, K. Nakahara, M. 
Hosobuchi, N. Serizawa, Purification of cytochrome P450sca 
from Streptomyces carbophilus: ML-236B (compactin) induces 
a cytochrome P450sca in Streptomyces carbophilus that hy- 
droxylates ML-236B to prevastatin sodium (CS-514), a tissue- 
selective inhibitor of 3-hydroxy-3-methylglutamyl-coenzyme-A 
reductase, Eur. J Biochem. 184 (1989) 707-713. 
[4] D. P. O'Keefe, J. A. Romesser, K. J. Leto, Identification of con- 
stitutive and herbicide inducible cytochromes P450 in 
Streptomyces griseolus, Arch. Microbiol. 149 (1988) 406-412. 
[5] F. S. Sariaslani, D. A. Kurtz, Induction of cytochrome P450 in 
Streptomyces griseus by soybean flour, Biochem. Biophys. "Rbs. 
Commun. 141 (1986) 405-410. 
[6] M. K. Trower, F. S. Sariaslani, F. G. Kitson, Xenobiotic oxi- 
dation by cytochrome P450-enriched extracts of Streptotnyces 
grisezis, Biochem. Biophys. Res. Commun. 157 (1988) 1417- 
1422. 
[7] M. Horii, T. Ishizaki, S. Y. Paik, T. Manome, Y. Murooka, An 
operon containing the genes for cholesterol oxidase and a 
cytochromeP450-like proten from Streptomyces sp, J. Bacteriol. 
172 (1989) 3644-3653. 
[8] D. R. Colingsworth, M. P. Brunner, W. J. Haines, A partial 
microbiological synthesis of adrenal cortex hormones, J. Am. 
Chem. Soc. 74 (1952) 2381-2382. 
[9] J. Fried, 7- and 15-Hydroxyprogesterone, US Patent 2,753,290, 
1956. 
[10] H. L. Herzog, M. J. Gentles, E. B. Hershberg, F. Carvajal, D. 
Sutter, W. Charney, C. P. Schaffner, Microbial transformation 
of steroids. 2ß-Hydroxylation, J. Am. Chem. Soc. 79 (1957) 
3921-3922. 
[11] W. J. McAleer, et al., 1-Hydroxylation of 9a-fluorocortisone, J. 
Org. Chem. 23 (1958) 508. 
[12] Y. Nazaki, M. Mayama, K. Akaki, D. Satoh, Microbial 12p- 
hydroxylation of digitoxin, a steroidal glycoside, Agric. Biol. 
Chem. (Jpn. ) 29 (1965) 783. 
[13] M. Shirasaka, M. Tsuruta, I la-Hydroxylation of steroids by 
Streptoanyces species, Nature 185 (1960) 845. 
[14] L. L. Smith, et al., 2p-hydroxylation of 9a-fluorohydrocortisone 
by Streptonnyces roseochromogenes, J. Org. Chem. 26 (1961) 
2859. 
[15] O. Vondrova, A. Capek, Transformation reactions of steroids 
as a diagnostic feature in the classification of Aciinomycetes, 
Folia Microbiol. 8 (1963) 117. 
[16] J. E. Wilson, R. E. Ober, C. S. Vesting, Hydroxylation of deoxy- 
corticosterone by Bacillus cereus, strain T, Arch. Biochem. 
Biophys. 114 (1966) 166-177. 
[17] A. Berg, J. A. Gustafsson, M. Ingelman-Sundberg, K. 
Carlstrom, Characterisation of a cytochrome P450-dependent 
steroid hydroxylase system present in Bacillus megateriurn, J. 
Biol. Chem. 251 (1976) 2831-2838. 
[18] K. E. Smith, S. Latif, D. N. Kirk, K. A. White, Microbial trans- 
formations of Steroids-I. Rare transformations of progesterone 
by Apiocrea clirysospenna, J. Steroid Biochem. 31 (1988) 83- 
89. 
[19] D. N. Kirk, H. C. Toms, C. Douglas, K. A. White, K. E. Smith, 
S. Latif, R. W. P. Hubbard, A survey of the high-field 1H NMR 
spectra of the steroid hormones, their hydroxylated derivatives 
and related compounds, J. Chem. Soc. Perkin Trans. 2 (1990) 
1567-1594. 
[20] U. K. Laemmli, Cleavage of structural proteins during the 
assembly of the head of bacteriophage T 4, Nature 227 (1970) 
680-685. 
[21] T. Rabilloud, G. Carpenter, P. Tarroux, Mechanism of silver 
staining in polyacrylamide gels, Electrophoresis 9 (1988) 288- 
291. 
[22] K. E. Smith, K. A. White, D. N. Kirk, Microbial transform- 
ations of steroids - III: Transformation of progesterone by 
Sepedonium arnpu losporu, n. , J. Steroid Biochem. 33 (1989) 81- 88. 
[23] R. W. Thoma, et al., Oxidations of steroids by microorganisms. 
16a-Hydroxylation of 9a-tluorohydrocortisone and 9a-fluoro- 
prednisolone by Streptomyces roseochromogenes, J. Am. Chem. 
Soc. 79 (1957) 4818. 
[24] J. J. Goodman, L. L. Smith, 2(3 and 16a-Hydroxylation of 9a- 
tluorohydrocortisone by a strain of Streptomyces roseochromo- 
genes, Appl. Microbiol. 9 (1961) 372. 
[25] O. Sideso, R. A. D. Williams, S. G. Welch, K. E. Smith, 
Progesterone 6-hydroxylation catalysed by cytochrome P450 in 
the moderate thermophile Bacillus thermoglucosidasius strain 
12060. , J. Steroid Biochem. Mol. Biol. 67 (1998) 163-169. 
[26] F. Ahmed, R. A. D. Williams, K. E. Smith, Microbial transform- 
ation of steroids-IX. Purification of progesterone hydroxylase 
cytochrome P-450 from Phycomyces blakesleeanus, J. Steroid 
Biochem. Mol. Biol. 52 (1995) 203-208. 
J. R. Berrie et al. / Journal of Steroid Biochemistry & Molecular Biology 71 (1999) 153-165 
[27] K. E. Smith, F. Ahmed, R. A. D. Williams, S. Kelley, Microbial 
transformations of steroids-VIII. Transformation of progester- 
one by whole cells and microsomes of Aspetgillus jumigatus, J. 
Steroid Biochem. Mol. Biol. 49 (1994) 93-100. 
[28] T. B. Samanta, D. K. Ghosh, Characterisation of progesterone 
I la hydroxylase of Aspergillus ochraceus TS: a cytochrome P- 
450 linked monooxygenase, J. Steroid Biochem. 28 (1987) 327- 
332. 
[29] F. Ahmed, R. A. D. Williams, K. E. Smith, Cytochromes P-450 
lla-Hydroxylase and C17-C20 lyase and a I-ene-dehydrogen- 
ase transform steroids in Nectria haenmtococca, J. Steroid 
Biochem. Mol. Biol. 58 (1996) 337-349. 
[30] K. Breskvar, B. Cresnar, T. Hudnik-Plevnik, Resolution and 
reconstitution of cytochrome P-450 containing steroid hydrox- 
ylation system of Rhizoptts nigricans, J. Steroid Biochem. 14 
(1987) 395-399. 
[31] G. R. Janig, D. Pfeil, M. Muller-Frohme, H. Riemer, M. 
Henning, W. Schwarze, K. Ruckpaul, Steroid 113-hydroxyl- 
ation by a fungal microsomal cytochrome P450, J. Steroid 
Biochem. Mol. Biol. 43 (1992) 1117-1123. 
165 
[32] S. Irrgang, D. Schlosser, W. Fritsche, Involvement of cyto- 
chrome P-450 in the l5a-hydroxylation of 13-ethyl-gon-4-ene- 
3,17-dione by Penicillium raisirickii, J. Steroid Biochem. Mol. 
Biol. 60 (1997) 339-346. 
[33] A. Berg, M. Ingelman-Sundberg, J. A. Gustafsson, Purification 
and characterisation of cytochrome P-450mcs, J. Biol. Chem. 
254 (1979) 5264-5271. 
[34] C. A. Omer, R. Lenstra, P. J. Little, C. Dean, J. M. Tepperman, 
K. J. Leto, R. A. Romesser, D. P. O'Keefe, Genes for two herbi- 
cide-indicible cytochromes P-450 from Streptonnyces griseolus, 
J. Bacteriol. 172 (1990) 3335-3345. 
[35] M. K. Trower, R. Lenstra, C. Omer, S. E. Buchholz, F. S. 
Sariaslani, Cloning, nucleotide sequence determination and ex- 
pression of the genes encoding cytochrome P-450,0 (SOYC) 
and ferredoxin, 0 (SOYB) from Streptomyces griseus, Mol. 
Microbiol. 6 (1992) 2125-2134. 
[36] D. P. O'Keefe, K. J. Gibson, M. Emptage, R. Lenstra, J. A. 
Romesser, P. J. Litle, C. A. Omer, Ferredoxins from two sulpho- 
nylurea monooxygenase systems in Streptomyces griseolus, 
Biochemistry 30 (1991) 447-455. 




PERGAMON Journal of Steroid Biochemistry & Molecular Biology 000 (2000) 000-000 
www. elsevier. com/locate/jsbmb 
Microbial transformations of steroids-XII. Progesterone 
hydroxylation profiles are modulated by post-translational 
modification of an electron transfer protein in Streptomyces 
roseochromogenes 
James R. Berrie, Ralph A. D. Williams, Kelvin E. Smith * 
Molecular and Cellular Biology, Division of Biomedical Sciences, Queen Mary and Westfleld College Medical School, University of London, 
Mile End Road, London El 4NS, UK 
Received 21 July 2000; accepted 21 November 2000 
Abstract 
When Streptomyces roseochromogenes strain 10984 was incubated with exogenous progesterone for 25 b the major monohy- 
droxylated metabolite, 16x-hydroxyprogesterone was produced in 3.6 fold excess to the minor metabolite 23,16 t-dihydroxyproges- 
terone. In a reconstituted system containing highly purified progesterone 16a-hydroxylase eytochrome P-450, and electron transfer 
proteins ferredoxin-like redoxin (roseoredoxin) and redoxin reductase (roseoredoxin reductase), both metabolites were produced 
but in a 10: 1 ratio. When S. roseochromogenes was pre-incubated for 8h with 0.32 mM progesterone and the purified components 
of the hydroxylase system incubated as before, the ratio of 16oe-hydroxyprogesterone to 20,16a-dihydroxyprogesterone produced 
decreased to 2.8: 1, virtually identical to the ratio in whole cell transformations. Reconstitution assays containing all combinations 
of hydroxylase proteins purified from progesterone pre-incubated and control cells showed that the roseoredoxin was solely 
responsible for the observed changes in in vitro metabolite ratios. The fact that the lower 16a-hydroxyprogesterone to 
2ß, 16a-dihydroxyprogesterone ratio was also obtained when S,, roseochromogenes was exposed to 0.335 mM cycloheximide for 8 
h prior to the progesterone pre-incubation, pointed to post-translation modification of the roseoredoxin. Separation of two 
isoforms of roseoredoxin by isoelectric focusing supported this proposition. © 2001 Elsevier Science Ltd. All rights reserved. 
Keywords: Microbial transformation; Progesterone hydräxylatidn; Electron transfer protien 
1. Introduction 
There is now a wealth of compelling evidence identi- 
fying cytochrome P450 as -responsible for steroid hy- 
droxylation reactions in both bacteria and filamentous 
fungi e. g. in bacteria-60 in Bacillus thermoglucosidasius 
[1] and 15f in Bacillus megaterium [2]: in filamentous 
fungi-7a in Phycomyces-blakesleeanus [3]; 11a in Asper- 
gillus fumigatus [4], Aspergillus ochraceus [5] Nectria 
haematococca [6], and Rhiaopur nigricans [7]; 110 in 
Cochliobolus lunatus [8]; and 15a in Penicillium 
raistrickii [9]. 
*Corresponding author. Tel.: + 44-20-78826342; fax: + 44-20- 
89830531. 
E-mail address: k. e. smith@gmw. ac. uk (K. E. Smith). 
A plethora of Streptomyces species has been widely 
reported as excellent steroid hydroxylators but the na- 
ture of the enzyme responsible for these conversions 
was until very recently unproven. The skeletal sites of 
non-phenolic steroids transformed include ý1,20, 
6ß, 7ß, 9a I la, 11ß, 15a and l6a [for examples see [10- 
17]]. By analogy with steroid hydroxylation in the 
bacterial species Bacillus cereus [18] and B. megaterium 
[2] the tacit assumption was that these hydroxylases are 
site-selective cytochrome P450 monooxygenases. Indi- 
rect evidence supported this assumption in the case of 
C2 and C4 hydroxylation of the phenolic steroid oestra- 
diol by extracts of Streptomyces griseus [19]. Recently a 
cytochrome P450 has been purified from S. roseochro- 
mogenes strain 10984 which catalyses progesterone 16r 
hydroxylation and a second phase 21 hydroxylation 
[20]. 
0960.0760/01/$ - see front matter © 
2001 Elsevier Science Ltd. All rights reserved. 
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Bacterial cytochromes P450 are the terminal proteins 
in a soluble three component system (Type I system) 
that transfer electrons to acceptor molecular dioxygen. 
P450 catalyses the reductive cleavage of the dioxygen 
producing H2O and an -OH group which is ultimately 
covalently bonded to enzyme-bound substrate by the 
P450 apoprotein. The stereochemistry of the hydroxyla- 
tion is determined by the particular structural architec- 
ture of the catalytic active centre of the apoprotein. The 
electrons that drive the hydroxylation originate from 
NADH passing to P450 via intermediate redox 
proteins. In Type-I systems these proteins are a low 
molecular weight ferredoxin-like redoxin that directly 
interacts with the P450, and a larger flavin-containing 
redoxin reductase that is a one electron transducer 
positioned between NADH and the redoxin. This solu- 
ble three component system has been identified in the 
P4500 system of S. griseus [21] and in the sulfonylurea 
herbicide P450 monooxygenase system in S. griseolus 
[22] where the component proteins have been purified. 
During a 25 h incubation of exogenous progesterone 
with S. roseochroinogenes strain 10984,16a-monohy- 
droxyprogesterone is produced in a first phase of trans- 
formation followed shortly thereafter in a second phase 
by 20,16a-dihydroxyprogesterone [20]. A cytochrome 
P450 was purified from this organism and was shown in 
vitro to synthesise the whole cell metabolites 16a-hy- 
droxyprogesterone and 20,16a-dihydroxyprogesterone. 
Two other proteins, a redoxin and a redoxin reductase 
together with the electron donor NADH were abso- 
lutely required for these hydroxylations [20]. 
In this paper we show that the ratio of 16a-monohy- 
droxyprogesterone to 20,16a-dihydroxyprogesterone 
produced in a reconstituted cell-free system containing 
all three highly purified protein components depends on 
the growth history of the S. roscochrwnogenes and that 
the change in metabolite ratio is manifested by the 
roseoredoxin rather than the roseoredoxin reductas e or 
progesterone 16a-hydroxylase cytochrome P450. 
extract-malt extract-glucose (YMG) agar slopes and 
plates. YMG contained yeast extract (4 g), malt ex- 
tract (10 g), glucose (4 g) and agar (15 g1l) of de- 
ionised H2O and pH 7.2. The organism was stored at 
4°C and subcultured every 3 months. The agar was 
omitted from liquid YMG. Growth of S. roseochromo- 
genes was completely inhibited by 100 µg/ml cyclohex- 
imide. 
In pre-incubation experiments, 0.32 mM proges- 
terone was added to the growth medium for 8h prior 
harvesting the cells. 
2.3. Determination of progesterone metabolite yields 
produced by S. roseochronzogenes train 10984 
Yields of progesterone metabolites produced in 
whole cell and cell-free incubations were determined 
by HPLC as described previously [20]. Incubations 
were extracted twice for 5 min by vigorously mixing 
the aqueous fraction with equal. volumes of chloro- 
form. The organic layers were collected, combined, 
evaporated to dryness and dissolved in HPLC grade 
methanol. The metabolite mixtures were dissolved and 
separated in 60% aqueous methanol on an analytical 
reverse-phase Whatman Partisil PXS 5/25 ODS 
column. Column effluent was passed through a Pye 
Unicam PU 4020 UV detector set at 254 nm. 
Metabolite concentrations were calculated from the 
areas of the individual peaks eluting from the column 
measured on a Hewlett Packard Integrator. The indi- 
vidual metabolites were identified by their retention 
time on -HPLC compared to authentic standards of 
l6a-hydroxyprogesterone and 2ß, 16a-dihydrox- 
yprogesterone. 
2.4. Purification of progesterone 16r -hydroxylase 




S. roseochromogenes strain 10984 was purchased 
from the National Collection of Industrial and Marine 
Bacteria (NCIB) Ltd., Aberdeen, UK. 
Media and general chemicals were purchased from 
the sources previously described [23]. Cibacron Blue 
FG3A and NAD-Sepharose affinity gel were from 
Sigma Chemical Co., Poole, Dorset, UK. 
2.2. Media, culture maintenance and cultivation of S. 
roseochromogenes strain 10984 
S. roseochromogenes was grown at 25°C on yeast 
S. roseochromogenes progesterone 16a-hydroxylase 
cytochrome P450 was purified as previously described 
[201. With progesterone as substrate (Fig. 1), the P450 
exhibited a typical set of type I substrate binding 
spectra with maxima at 384 nm, minima at 420 nm 
and an isosbestic point at 401 nm [[24] and references 
therein). Scatchard analysis of these binding curves 
gave a Ka value for progesterone of 1.95 x 10-IM. 
2.5. Cytochronne P450-dependent progesterone 
hydroxylation 
The progesterone 16a-hydroxylase activity was deter- 
mined using 4 mM progesterone and 2 mM NADH, 0.3 
pM progesterone 16a. -hydroxylase cytochrome P450, 
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0.05 units of roseoredoxin and 0.1 units of roseoredoxin 
reductase made up to 1 ml with 0.1 M Na phosphate, 5 
mM EDTA, 0.25 mM DTT (buffer A) and 10% glyc- 
erol in Bijou bottles. Bottles were fixed to a turn-table 
that was vertically rotated at 40 rpm for 2h at 25°C. 
Steroid metabolites were extracted from the incubations 
by shaking the mixtures with 1 ml chloroform for I 
min. The chloroform layer was removed and evapo- 
rated to dryness at 60°C. The residue was dissolved in 
10 pl methanol and separated on HPLC as described 
above. 
2.6. Purification of roseoredoxin and roseoredoxin 
reductase electron transfer proteins from S. 
roseochroinogenes strain 10984 
The roseoredoxin reductase was purified before rose- 
oredoxin from the flow-through wash of the DE-52 
DEAE-cellulose column obtained in the first stage of 
P450 purification [20]. This fraction was directly loaded 
onto a Whatman DE-32 DEAE-cellulose column and 
eluted with a linear 0-300 mM NaCl gradient made up 
in buffer A and 10% glycerol. Fractions (5 ml) were 
collected and assayed for cytochrome c reductase activ- 
ity at 550 nm and for NADH oxidation at 340 nm. 
Also, the spectrum of each fraction was recorded from 
260 to 460 nm and compared to that of a standard of 
authentic FAD. 
Fractions which reduced cytochrome c, oxidised 
NADH, and contained FAD, were pooled and dialysed 
for 8h against buffer A before loading on to a 
Cibacron Blue FG3A column and eluted with a linear 
0-200 mM NaCl gradient in buffer A. Fractions (2.0 
ml) were collected and assayed as described above. 
Active fractions that contained roseoredoxin reductase 
were pooled, dialysed against buffer A+ 20% glycerol 
(buffer C), and stored at - 70°C. The purification data 
are shown in Table 1(a) and the 15% polyacrylamide 
gel electrophoresis analysis in Fig. 2. 
The roseoredoxin reductase DE-32 cellulose column 
fractions obtained above were used to purify roseore- 
doxin, the second electron transfer protein in the S. 
roseochromogenes progesterone 16a-hydroxylase cy- 
tochrome P450 pathway. Roseoredoxin activity was 
assayed by measuring the rate of cytochrome c reduc- 
tion in the presence of NADH and purified roseore- 
doxin reductase (Cibacron Blue fraction). The 
stimulation of the basal rate of electron transfer, from 
roseoredoxin reductase directly to cytochrome c, was 
the measure of roseoredoxin activity. Active fractions 
were pooled and dialysed as described above and then 
applied to an NAD-Sepharose affinity column. Proteins 
were eluted with a linear 0-100 mM KCl gradient in 
buffer A. KCI buffers were required due to loss of 
electron transfer activity in NaCl, Fractions were as- 
sayed for cytochrome c reduc ase activity as described 
above and the absorbance of these fractions was mea- 
sured at 280 and 414 nm. Active fractions containing 
the highest A4141A280 ratios were pooled, dialysed 
against buffer C and stored at - 70°C. The final 
purified roseoredoxin solution was pale yellow. 
The purification data are shown in Table lb and the 
gel analyses in Fig. 2, Fig. 3 and Fig. 4. The absolute 
absorbänce spectrum of oxidised roseoredoxin showed 
maxima at 280 and 400 nm with a shoulder at 310 nm 
Fig. 5. : The absorbance profile was mainly preserved 
after reduction of the roseoredoxin with a 15 fold 
excess of dithionite. Thus, the 280 and 400 nm maxima 
Fig. 1. S. roseochromogenes cytochrome P450 progesterone substrate binding spectra. The amount of cytochromc P450 was 3 pmol in all 
incubations. Curve 1,0.1 pmol progesterone; curve 2,0.3 pmol progesterone; curve 3,0.5 pmol progesterone; curve 4,1.0 pmol progesterone and 
curve 5,1.4 pmol progesterone. 
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Table I 












(a) Purification of 
S. roseochromogenes 
roseoredoxin reductase 
S15 extract 1050 32 0.03 100 
DEAE 52 column 800 30.5 0.04 95.31 1.3 
How-through 
DE 32 0-300mM NaCl 6.84 19.96 2.92 62.38 97.3 
fraction 
Cibacron Blue FG3A 1.88 13.03 6.93 40.72 231 
0-200 mM NaCl 
fraction, dialysed 
Total roseoredoxin Yield roseoredoxin Recovery 
(nmol) (nmol/mg protein) roseoredoxin (%) 
(b) Purification of 
S. roseoehromogene. e
roseoredoxin 
S15 extract 1050 51 0.05 100 1 
DEAE 52 column 800 39.10 0.05 76.67 1 
Flow-through 
DE 32 0-300 mM NaCI 6.84 18.79 2.75 36.80 55 
fraction 
Sepharose-NAD affinity 1.95 9.81 5.03 19.20 101 
0-100 mM KCI fraction 
Pooled Abs 414/A280 1.10 8.95 8.14 17.55 163 
fraction, dialysed 
were retained but not the 310 nm shoulder. Reduction 
decreased the absolute absorbance above 300 nm. 
These spectra are typical of a7 Fe-containing ferre- 
doxin [25]. 




The roseoredoxin obtained from the NAD-Sepharose 
affinity purification step was separated into two activity 
fractions on Whatman CM-52 cellulose by elution at 
50-100 mM KCI and 240 280 mM KCI. The isoforms 
co-migrated in l0% SDS-PAGE (Fig. 3). 
2.8. Measurement of S. roseochromogenes roseoredoxin 
and roseoredoxin reductase activity 
Roseoredoxin activity was measured in a final vol- 
ume of 1 ml containing 100 mM Na phosphate, 5.2 
mM MgCl2 buffer pH 7.2,0.05 mM cytochrome c, 0.05 
units roseoredoxin reductase and 0.2 mM NADH. (I 
unit of roseoredoxin reductase is the amount of protein 
required to reduce 0.5 pmol of cytochrome c per min in 
the presence of excess roseoredoxin). The rate of cy- 
tochrome c reduction was measured at 550 nm against 
a control incubation without NADH. Cytochrome c 
reduction was measured to completion of the reaction 
Fig. 2. SDS-15% polyacrylamide gel of purified S. roweochromogene. s 
16a-hydroxylase cytochrome P-450, roseoredoxin and roseoredoxin 
reductase. From left to right, lane 1, roseorcdoxin reductase (3.1 µg 
M,. 65 x I03); lane 2, roseoredoxin (2.8 µg M, 14 x I0'); lane 3, 
progesterone 16a-hydroxylase cytochrome P450 (4 µg M,. 63 x 101); 
lane 4, wide range protein size ladder M,. 205 x 103- 14.2 x 103; lane 
5, lower range protein size ladder M, 66 x 10'-14.2 x 10'; and lane 6, 
upper range protein size ladder M, 205 x 103-45 x I& . Lanes 4-6 
contained 35 µg total protein. 
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Fig. 3.101/6 SDS-polyacrylamide gel of purified S. roseochromogenes 
roseoredoxin isoforms. Lane 1,50-100 mM KCI roseoredoxin iso- 
form fraction from CM 52 (2.8 µg M, 14 x 103); Lane 2,240-280 
mM KCI roseoredoxin isoform fraction from CM 52 (2.8 µg M,. 
14 x 10'); lane 3, protein ladder (35 µg total protein, M, 66 x 101- 
14.2 x 10' (M, x 10' from the top of the gel to bottom: 66, BSA; 45, 
chicken egg ovalbumin; 36, rabbit muscle glyceraldehyde-3-phosphate 
dehydrogenase; 29, bovine erythrocyte carbonic anhydrase; 24, 
bovine pancreas trypsinogen; 20, soybean trypsin inhibitor and 14.2, 




Fig. 4.2-D, IEF gel of S. roseochromogenes roseoredoxin, roseore- 
doxin reductase and 16i -hydroxylase cytochrome P-450. Clockwise 
left to right, roseoredoxin reductase pl 6.9,16a-hydroxylase cy- 
tochrome P-450 pI 6.6, ß-lactoglobulin pI 5.2 (M, 37,100), and the 
two isoforms of roseoredoxin pI 5.6 and 7.45. The gel was silver 
stained. 
at 25°C. The absolute amount reduced was calculated 
by measuring the absorbance difference between the 
test and control incubations at 550 nm. An absorbance 
coefficient of 29.9 mM -' cm -' was used to calculate 
reduced cytochrome c and 8.9 mM ' cm ' for oxi- 
dised cytochrome c. 
Roseoredoxin reductase activity was measured as 
described above except that roseoredoxin was omitted 
from the incubations. 
2.9. Polyacrylamide gel electrophoresis 
SDS-PAGE (10 and 15% w/v) was performed accord- 
ing to the method of Laemmli [26] except that the 
running buffer contained glycerol (100/> v/v). Gels were 
run at 125 V for 3 h, stained with Coomassie Brilliant 
Blue, and if necessary, over-stained with silver [27]. 
Isoelectric focusing was carried out on the NAD-Sep- 
harose affinity gel fractions described above in a Bioh- 
Rad Mini Protean electrophoresis apparatus with a 
Bio-Rad rod gel rack attachment, essentially according 
to the method of Harrington et al. [28]. Separation in 
the first dimension was by electrofocusing using 5% 
acrylamide rod gels containing equal concentrations of 
ampholines pH 4-9 and pH 5-8 (0.5 ml/6 ml gel 
solution). The second dimension was 10% acrylamide, 
SDS slab gels. 
2.10. Protein determinations 
Protein concentrations were determined using a Bio- 
Rad Protein Assay Kit (Bio-Rad Laboratories, Hemel 
Hempstead, Herts., UK). 
3. Results 
3.1. Hydroxyprogesterone metabolite production by 
intact S. rosechromogenes cells 
The HPLC trace of the hydroxyprogesterone 
metabolites produced in a 25 h whole cell transforma- 
tion of progesterone by S. roseochromogenes is shown 
in Fig. 6. Two metabolites were identified. The minor 
Fig. 5. Absorbance spectrum of S. roseoehromogene. e roseoredoxiu. 
The solid line is the absorbance of 8µM native oxidised roseoredoxin 
in 0.1 M K, HPO4 buffer pH 7, the dotted line is the absorbance of 
the reduced form treated with a 15 fold excess of sodium dithionite. 
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Fig. 6. HPLC of 25 h progesterone transformation incubation by S. roseochromogenes. From left to right, peak 1,16a-dibydroxyprogesterone 
(retention time 14 min); Peak 2,16a-monohydroxyprogesterone (retention time 27 min); Peak 3, progesterone (retention time 89 min). 
peak 1 (retention time 14 min) is 20,16a-dihydrox- 
yprogesterone and the major peak 2 (retention time 27 
min) is 16a-monohydroxyprogesterone. Peak 3 is un- 
transformed substrate progesterone. The NMR identi- 
fying features of these compounds have been published 
[29,30]. 
Ratios of 16a-monohydroxyprogesterone to 20,16a- 
dihydroxyprogesterone produced during this 25 h incu- 
bation are shown in Table 2. From 6 to 7h only 
]6a-monohydroxyprogesterone was detected in the cul- 
ture medium. From 8h onward 2ß, 16a-dihydrox- 
yprogesterone also accumulated. The ratio of 
l 6a-monohydroxyprogesterone to 20,16a-dihydrox- 
yprogesterone gradually declined from an initial value 
of 61 at 8h to a final value of 3.6 from 21 h onward. 
This declining ratio reflected dihydroxylated metabolite 
enrichment consequent on second phase 20= 
hydroxylation. 
3.2. Hydroxyprogesterone metabolite production in 
reconstituted progesterone hydroxylation cell free 
systems 
The two progesterone metabolites produced in whole 
cell transformations were also produced in reconsti- 
tuted cell-free -incubations containing highly purified 
progesterone hydroxylase cytochrome P450, roseore- 
doxin and roseoredoxin reductase. When all three 
proteins were from control i. e. non progesterone pre-in- 
cubated cells, a value of 10.07 was calculated for the 
relative synthesis of 16«-monohydroxyprogesterone to 
20,16a-dihydroxyprogesterone in a 40 min incubation 
(Table 3, line 1). 
3.3. Effect of an 8h progesterone pre-incubation on 
the relative synthesis of 16.. monohydroxyprogesterone 
and 2/i, 16x-dihydroxyprogesterone in reconstituted 
progesterone hydroxylation cell free systems 
The growth history of the cells was immaterial to the 
ultimate relative synthesis of the two hydroxylated 
progesterone metabolites only if the cell-free incuba- 
tions contained either progesterone hydroxylase cy- 
tochrome P450 or roseoredoxin reductase (or both) 
from control or 8h progesterone pre-incubated cells 
Table 2 
Ratio of 16m-monohydroxyprogesterone to 2ß, 16n-dihydroxyproges- 
terone produced during a 25 h progesterone transformation by S. 
roseochromogenes 
Time (h) Ratio of 16a-HP to 2ß, 16a-DHP produced 
1.5-5 No products detectedced 
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Table 3 
The effect of growth in progesterone containing medium on hydroxyprogesterone metabolite synthesis in reconstituted cell free incubations 
containing purified roseoredoxin, roseoredoxin reductase and cytochrome P-450' 
Assay after 40 min 213,162-DHP %, total 16a-HP % total Ratio of 16a-HP to 
transformation products trtnsfomtation products 2ß, 16a-DHP 
Roseoredoxiu(a)+Roseoredoxin 9.03 90.97 10.1 
reductase(a) + P-450(x) 
Roseoredoxin(a)+Roseoredoxin 8.81 91.19 10.4 
re du cta se(a) + P-450(p) 
Roseoredoxin(a)+Roseoredoxin 9.65 90.35 9.4 
reductasc(p)+P-450(p) 
Roseoredoxin(a)+Roseoredoxin 8.95 91.05 10.2 
reductase(p)+P-450(a) 
Roseoredoxin(p)+Roseoredoxin 25.97 74.03 2.9 
reductase(p)+P-450(p) 
Roseoredoxin(p)+Roseoredoxin 26.03 73.97 2.8 
reductase(p) +P-450 (a) 
Roseoredoxin(p)+Roseoredoxin 25.9 74.1 2.9 
reductase(a) + P-450(p) 
Roseoredoxin(p)+Roseoredoxiu 26.36 73.64 2. $ 
reductase(a)+P-450(a) 
Whole cells Minor Major 
(a) is the protein purified from cells grown in the absence of progesterone and (p) is the protein purified from cells grown in the presence of 
progesterone. (HP, hydroxyprogesterone, DHP, dihydroxyprogesterone). The three proteins were substituted with counterparts purified from cells 
grown in the presence of cycloheximide but in the absence of progesterone. Identical results to those in the table were obtained. 
(Table 3, lines 2,3 and 4). Thus relative synthesis ratios 
of 10.35,10.17 and 9.36, respectively were obtained 
when the P450 and the roseoredoxin reductase origi- 
nated from progesterone pre-incubated or control cells 
but only the roseoredoxin was from control cells. By 
contrast the relative synthesis of 16ce-monohydrox- 
yprogesterone to 2ß, 16a-dihydroxyprogesterone was 
2.79 when the roseoredoxin originated from proges- 
terone pre-incubated cells but the P450 and roseore- 
doxin reductase were from control or progesterone 
pre-incubated cells. No substantive difference in the 
product ratio produced (2.85) was noted if all the 
cell-free protein components were derived from proges- 
terone pre-incubated S. roseochromogenes (Table 3, line 
5). Incubation time was not a factor in the roseoredoxin 
effect. Thus, although the absolute amount of` both 
metabolites increased in incubations. lasting from 2 to 
40 min, the same metabolite ratios shown in Table 3 
were always obtained (data not shown). 
examined whether progesterone pre-incubation induced 
de novo synthesis of a roseoredoxin isoform or whether 
a post-translational' modification of the protein occurs. 
Gene expression was inhibited in 8h progesterone 
pre-incubated cells by blocking protein synthesis with 
0.335 mM cycloheximide, a concentration in excess of 
that required totally to inhibit cell growth. The proges- 
terone hydroxylation profile of the reconstituted cell- 
free incubations containing roseoredoxin purified from 
these cycloheximide and progesterone pre-treated cells 
(16a-monohydroxyprogesterone to 20,16a-dihydrox- 
yprogesterone ratio 2.8) was identical to the proges- 
terone only pre-incubated counterpart (ratio 2.8) 
contrasting the 10: 1 ratio in the non pre-incubated 
cell-free assays (data not shown). These results are 
consistent with post-translational modification of the 
roseoredoxin rather than there being multiple roseore- 
doxin genes. 
3.4. Effect of cycloheximide pre-incubation on the 
relative synthesis of 16a-monohydroxyprogesterone and 
2ß, 16x-dihydroxyprogesterone in reconstituted S. 
roseochromogenes progesterone hydroxylation cell free 
systems containing control and progesterone 
pre-incubated roseoredoxin 
The data in Table 3 clearly show that the roseore- 
doxin component of the P450 electron transfer chain 
modulates the relative synthesis of 16a-monohydrox- 
yprogesterone and 20,16a-dihydroxyprogesterone. We 
3.5. Identification of two isoforms of S. 
roseochromogenes roseodoxin in progesterone 
pre-incubated cells 
The roseoredoxin at the NAD-Sepharose purification 
stage from control and progesterone pre-incubated cells 
was analysed by isoelectric focusing (IEF). Control, 
non progesterone pre-incubated cells, contained only 
the pI 7.45 roseoredoxin isoform (Fig. 7a). By contrast 
the pI 5.6 isoform predominated in 8h progesterone 
pre-incubated cells and only a minor pl 7.45 band was 
observed (Fig. 7b). Interestingly, both isoforms were 
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present in approximately equal amounts in 4h proges- 4. Discussion 
terone pre-incubated cells (Fig. 7c). The two roseore- 
doxin isoforms were separable by CM-52 cellulose ion Ferredoxin-like iron sulphur containing proteins re- 








Separation of two isoforms of S. roseochromogenes roseoredoxin by CM-52 cellulose ion exchange chromatography 
Purification Stage Total protein (mg) Total Yield roseoredoxin (nmol/mg Recovery 
roseoredoxin total protein) roseoredoxin 
(nmol) 
(A) CM cellulose 50-100 mM 2.0 mg protein applied to column and 79.2 39.6 55.4 
KCI fraction purified into A and B fractions 
(B) CM cellulose 240-280 mM 63.7 31.85 44.6 
KCI fraction 
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i have been identified in a wide variety of bacteria e. g. 
Bacillus megaterium ATCC 13368 [31], Bradyrhizobium 
japonicium [32], Pseudomonas incognita [33], Pseu- 
domonas putida [34], Rhodococcus SP strain N186/21 [35], 
Saccharopolyspora erythraea, CA340 [36], S. griseolus 
[22], S. griseus [37], Xanthobacter sp. [38]. Where se- 
quence analysis has been performed, these ferredoxin- 
like genes seem to be constituents of operons containing 
also the P450 and the redoxin reductase gene. 
In the case of S. griseolus two 7 kDa isoforms, 
designated Fd-1 and Fd-2 have also been purified. These 
proteins have 52% mutual identity and both contain 
single [3Fe-4S] clusters [22]. Both ferredoxins function 
in reconstituted cell-free systems containing the SU1 
isoform of P-450 although Fd-2 is the more active 
protein. The genes for the ferredoxins and the sulfony- 
lurea P450 monooxygenases are virtually contiguous. 
Thus P-450SU1 and the downstream Fd-1 form a closed- 
spaced pair; similarly P-450SU2 and Fd-2 pair. 
Less in known about the situation in S. griseus where 
only a single ferredoxin encoded by SOY B has been 
putatively identified [37]. 
Our results suggest that a novel system for ferredoxin- 
like protein expression, namely post-translational mod- 
ification, may well operate in Streptomyces. In control 
cells grown in a standard medium a single, mildly basic, 
and soluble form of roseorodoxin (pI 7.45) is present. 
This protein, like its published bacterial counterparts 
forms the middle component of a natural cytochrome 
P450 electron transfer chain. In vitro this S. roseochro- 
mogenes system predominantly catalyses 16c monohy- 
droxylation of progesterone and as a rather minor 
secondary reaction, 2I hydroxylation of the primary 
product. By contrast, pre-incubating the organism with 
progesterone results in the appearance of different, 
second, more acidic, soluble form of roseredoxin (pI 
5.6). This modified form increases the 20 hydroxylation 
capability of the cytochrome P450. This is achieved by 
increasing the hydroxylation turnover number of, the 
P450 thereby increasing the number of 20 hydroxylation 
events. The result is seen as a decline in the 16a-mono- 
hydroxy to 2ß, 16a-dihydroxprogesterone ratio. That a 
growth inhibitory dose of cycloheximide added to the 
cells for 8h prior to the progesterone pre-incubation had 
no effect on the appearance of the p1 5.6 isoform is 
strongly consistent with "a progesterone dependent post- 
translational modification of the roseodoxin rather than 
for transcriptional; activation of a second gene. There is 
no literature precedent for the regulation of ferredoxin 
activity by post-translational modification. 
What is, the nature of the post-translational modifica- 
tion and höw. does it modulate the activity of the P450? 
The covalent` attachment of an acidic group such as 
phosphate is an obvious candidate to account for the 
1.85 pH unit decrease in the pI value of the roseodoxin. 
This enhanced 20 hydroxylation capacity of the P450 
stimulated by the modified roseoredoxin isoform could 
be accounted for by increased electron shuttling from the 
roseoredoxin reductase to the P450. This improved 
shuttling could result from enhanced interaction of the 
roseoredoxin with its adjacent electron transfer protein 
partners or an inherently superior electron transfer 
velocity of the modified roseoredoxin. The results of 
NMR experiments involving cytochrome P450,,,, 
(CYP101) and its Fe2S2 ferredoxin electron transfer 
partner, putidaredoxin, indicate that conformational 
gating of the electron transfer complex between these 
two proteins may be important in their redox reactions 
[39]. For example, the enzymatic removal or modifica- 
tion of the C-terminal tryptophan of putidaredoxin is 
known to cause a much reduced rate of enzymatic 
activity in the reconstituted camphor hydroxylase system 
[40,41]. 
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